Document and Entity Information
Document and Entity Information - shares | 9 Months Ended | |
Sep. 30, 2017 | Oct. 31, 2017 | |
Document and Entity Information [Abstract] | ||
Entity Registrant Name | VALIDUS HOLDINGS LTD | |
Entity Central Index Key | 1,348,259 | |
Document Type | 10-Q | |
Document Period End Date | Sep. 30, 2017 | |
Amendment Flag | false | |
Document Fiscal Year Focus | 2,017 | |
Document Fiscal Period Focus | Q3 | |
Current Fiscal Year End Date | --12-31 | |
Entity Well-known Seasoned Issuer | Yes | |
Entity Voluntary Filers | No | |
Entity Current Reporting Status | Yes | |
Entity Filer Category | Large Accelerated Filer | |
Entity Common Stock, Shares Outstanding | 79,461,813 |
Consolidated Balance Sheets (Un
Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands | Sep. 30, 2017 | Dec. 31, 2016 |
Assets | ||
Fixed maturity investments trading, at fair value (amortized cost: 2017—$5,421,546; 2016—$5,584,599) | $ 5,419,966 | $ 5,543,030 |
Short-term investments trading, at fair value (amortized cost: 2017—$2,992,939; 2016—$2,796,358) | 2,993,246 | 2,796,170 |
Other investments, at fair value (cost: 2017—$439,991; 2016—$380,130) | 471,300 | 405,712 |
Investments in investment affiliates, equity method (cost: 2017—$60,228; 2016—$84,840) | 92,079 | 100,431 |
Cash and cash equivalents | 965,630 | 419,976 |
Restricted cash | 89,403 | 70,956 |
Total investments and cash | 10,031,624 | 9,336,275 |
Premiums receivable | 1,569,374 | 725,390 |
Deferred acquisition costs | 258,078 | 209,227 |
Prepaid reinsurance premiums | 207,618 | 77,996 |
Securities lending collateral | 2,115 | 9,779 |
Loss reserves recoverable | 1,335,016 | 430,421 |
Paid losses recoverable | 77,730 | 35,247 |
Income taxes recoverable | 9,704 | 4,870 |
Deferred tax asset | 52,228 | 43,529 |
Receivable for investments sold | 37,493 | 3,901 |
Intangible assets | 173,398 | 115,592 |
Goodwill | 227,701 | 196,758 |
Accrued investment income | 27,976 | 26,488 |
Other assets | 591,185 | 134,282 |
Total assets | 14,601,240 | 11,349,755 |
Liabilities | ||
Reserve for losses and loss expenses | 4,935,637 | 2,995,195 |
Unearned premiums | 1,526,465 | 1,076,049 |
Reinsurance balances payable | 527,881 | 54,781 |
Securities lending payable | 2,581 | 10,245 |
Deferred tax liability | 4,198 | 3,331 |
Payable for investments purchased | 84,431 | 29,447 |
Accounts payable and accrued expenses | 478,892 | 587,648 |
Notes payable to AlphaCat investors | 1,107,618 | 278,202 |
Senior notes payable | 245,513 | 245,362 |
Debentures payable | 538,910 | 537,226 |
Total liabilities | 9,452,126 | 5,817,486 |
Commitments and contingent liabilities | ||
Redeemable noncontrolling interests | 1,133,880 | 1,528,001 |
Shareholders' equity | ||
Preferred shares (Issued and Outstanding: 2017—16,000; 2016—6,000) | 400,000 | 150,000 |
Common shares (Issued: 2017—161,956,886; 2016—161,279,976; Outstanding: 2017—79,457,253; 2016—79,132,252) | 28,342 | 28,224 |
Treasury shares (2017—82,499,633; 2016—82,147,724) | (14,437) | (14,376) |
Additional paid-in capital | 812,266 | 821,023 |
Accumulated other comprehensive loss | (18,430) | (23,216) |
Retained earnings | 2,728,546 | 2,876,636 |
Total shareholders' equity available to Validus | 3,936,287 | 3,838,291 |
Noncontrolling interests | 78,947 | 165,977 |
Total shareholders' equity | 4,015,234 | 4,004,268 |
Total liabilities, noncontrolling interests and shareholders’ equity | $ 14,601,240 | $ 11,349,755 |
Consolidated Balance Sheets (Pa
Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands | Sep. 30, 2017 | Dec. 31, 2016 | Sep. 30, 2016 | Dec. 31, 2015 |
Assets | ||||
Fixed maturities, at amortized cost or cost | $ 5,421,546 | $ 5,584,599 | ||
Short-term investments, at amortized cost or cost | 2,992,939 | 2,796,358 | ||
Other investments, at amortized cost or cost | 439,991 | 380,130 | ||
Investments in and advance to affiliates, subsidiaries, associates, and joint ventures, at cost | $ 60,228 | $ 84,840 | ||
Preferred shares - Shareholders' Equity | ||||
Preferred shares, shares issued | 16,000 | 6,000 | 6,000 | 0 |
Preferred shares, shares outstanding | 16,000 | 6,000 | 6,000 | 0 |
Common Shares - Shareholders' Equity | ||||
Common shares, shares issued | 161,956,886 | 161,279,976 | 161,273,353 | 160,570,772 |
Common shares, shares outstanding | 79,457,253 | 79,132,252 | 79,443,030 | |
Treasury shares, common shares | 82,499,633 | 82,147,724 | 81,830,323 |
Consolidated Statements of Inco
Consolidated Statements of Income and Comprehensive Income (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2017 | Sep. 30, 2016 | Sep. 30, 2017 | Sep. 30, 2016 | |
Revenues | ||||
Gross premiums written | $ 523,856 | $ 372,418 | $ 2,507,615 | $ 2,309,251 |
Reinsurance premiums ceded | (116,860) | (45,006) | (373,188) | (249,070) |
Net premiums written | 406,996 | 327,412 | 2,134,427 | 2,060,181 |
Change in unearned premiums | 316,212 | 236,363 | (204,816) | (351,415) |
Net premiums earned | 723,208 | 563,775 | 1,929,611 | 1,708,766 |
Net investment income | 44,458 | 43,514 | 128,913 | 112,232 |
Net realized gains on investments | 906 | 4,397 | 2,016 | 6,537 |
Change in net unrealized (losses) gains on investments | (5,197) | 5,459 | 24,472 | 84,331 |
Income (loss) from investment affiliates | 1,011 | 453 | 15,665 | (4,249) |
Other insurance related income and other income (loss) | 3,571 | (610) | 6,240 | 1,627 |
Foreign exchange (losses) gains | (1,404) | (766) | (7,164) | 11,765 |
Total revenues | 766,553 | 616,222 | 2,099,753 | 1,921,009 |
Expenses | ||||
Losses and loss expenses | 1,254,602 | 258,394 | 1,820,336 | 789,971 |
Policy acquisition costs | 115,590 | 113,434 | 344,486 | 328,593 |
General and administrative expenses | 70,342 | 82,443 | 254,615 | 258,339 |
Share compensation expenses | 9,443 | 10,501 | 30,080 | 32,465 |
Finance expenses | 14,523 | 14,521 | 42,675 | 43,890 |
Transaction expenses | 0 | 0 | 4,427 | 0 |
Total expenses | 1,464,500 | 479,293 | 2,496,619 | 1,453,258 |
(Loss) income before taxes, (loss) from operating affiliate and loss (income) attributable to AlphaCat investors | (697,947) | 136,929 | (396,866) | 467,751 |
Tax benefit (expense) | 2,632 | (1,830) | 7,168 | (1,418) |
(Loss) from operating affiliate | 0 | 0 | 0 | (23) |
Loss (income) attributable to AlphaCat investors | 74,130 | (5,564) | 54,797 | (16,278) |
Net (loss) income | (621,185) | 129,535 | (334,901) | 450,032 |
Net (income) attributable to noncontrolling interests | 376,366 | (37,439) | 290,144 | (96,163) |
Net (loss) income (attributable) available to Validus | (244,819) | 92,096 | (44,757) | 353,869 |
Dividends on preferred shares | (5,627) | (2,252) | (10,033) | (2,252) |
Net (loss) income (attributable) available to Validus common shareholders | (250,446) | 89,844 | (54,790) | 351,617 |
Comprehensive (loss) income | ||||
Net (loss) income | (621,185) | 129,535 | (334,901) | 450,032 |
Other comprehensive income (loss) | ||||
Change in foreign currency translation adjustments | 1,481 | (1,370) | 3,567 | (6,685) |
Change in minimum pension liability, net of tax | 0 | (1,101) | 1,252 | (705) |
Change in fair value of cash flow hedge | 13 | (439) | (33) | (1,133) |
Other comprehensive income (loss) | 1,494 | (2,910) | 4,786 | (8,523) |
Comprehensive loss (income) attributable to noncontrolling interests | 376,366 | (37,439) | 290,144 | (96,163) |
Comprehensive (loss) income (attributable) available to Validus | $ (243,325) | $ 89,186 | $ (39,971) | $ 345,346 |
Earnings per common share | ||||
Basic (loss) earnings per share (attributable) available to Validus common shareholders | $ (3.17) | $ 1.12 | $ (0.69) | $ 4.31 |
(Loss) earnings per diluted share (attributable) available to Validus common shareholders | (3.17) | 1.11 | (0.69) | 4.24 |
Cash dividends declared per common share | $ 0.38 | $ 0.35 | $ 1.14 | $ 1.05 |
Weighted average number of common shares and common share equivalents outstanding: | ||||
Basic (in shares) | 78,994,335 | 80,134,394 | 79,132,856 | 81,635,496 |
Diluted (in shares) | 78,994,335 | 81,244,556 | 79,132,856 | 82,938,624 |
Consolidated Statements of Shar
Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($) $ in Thousands | Total | Preferred shares | Common shares | Treasury shares | Additional paid-in capital | Accumulated other comprehensive loss | Retained earnings |
Balance - Beginning of period at Dec. 31, 2015 | $ 0 | $ 28,100 | $ (13,592) | $ 1,002,980 | $ (12,569) | $ 2,634,056 | |
Preferred shares issued | 150,000 | ||||||
Common shares issued (redeemed), net | 123 | (7,754) | |||||
Offering expenses on preferred shares | (5,148) | ||||||
Repurchase of common shares | (728) | (195,287) | |||||
Share compensation expenses | 32,465 | ||||||
Other comprehensive (loss) income | $ (8,523) | (8,523) | |||||
Net (loss) income | 450,032 | 450,032 | |||||
Net (income) attributable to noncontrolling interests | (96,163) | (96,163) | |||||
Dividends on preferred shares | (2,252) | ||||||
Dividends on common shares | (88,120) | ||||||
Balance - End of period at Sep. 30, 2016 | 3,867,620 | 150,000 | 28,223 | (14,320) | 827,256 | (21,092) | 2,897,553 |
Noncontrolling interests at Sep. 30, 2016 | 222,996 | ||||||
Total shareholders' equity at Sep. 30, 2016 | 4,090,616 | (21,092) | |||||
Other comprehensive (loss) income | (2,910) | ||||||
Net (loss) income | 129,535 | ||||||
Net (income) attributable to noncontrolling interests | (37,439) | ||||||
Balance - End of period at Sep. 30, 2016 | 3,867,620 | 150,000 | 28,223 | (14,320) | 827,256 | (21,092) | 2,897,553 |
Noncontrolling interests at Sep. 30, 2016 | 222,996 | ||||||
Total shareholders' equity at Sep. 30, 2016 | 4,090,616 | (21,092) | |||||
Balance - Beginning of period at Dec. 31, 2016 | 3,838,291 | 150,000 | 28,224 | (14,376) | 821,023 | (23,216) | 2,876,636 |
Preferred shares issued | 250,000 | ||||||
Common shares issued (redeemed), net | 118 | (12,241) | |||||
Offering expenses on preferred shares | (8,314) | ||||||
Repurchase of common shares | (61) | (18,282) | |||||
Share compensation expenses | 30,080 | ||||||
Other comprehensive (loss) income | 4,786 | 4,786 | |||||
Net (loss) income | (334,901) | (334,901) | |||||
Net (income) attributable to noncontrolling interests | 290,144 | 290,144 | |||||
Dividends on preferred shares | (10,033) | ||||||
Dividends on common shares | (93,300) | ||||||
Balance - End of period at Sep. 30, 2017 | 3,936,287 | 400,000 | 28,342 | (14,437) | 812,266 | (18,430) | 2,728,546 |
Noncontrolling interests at Sep. 30, 2017 | 78,947 | ||||||
Total shareholders' equity at Sep. 30, 2017 | 4,015,234 | (18,430) | |||||
Other comprehensive (loss) income | 1,494 | ||||||
Net (loss) income | (621,185) | ||||||
Net (income) attributable to noncontrolling interests | 376,366 | ||||||
Balance - End of period at Sep. 30, 2017 | 3,936,287 | $ 400,000 | $ 28,342 | $ (14,437) | $ 812,266 | (18,430) | $ 2,728,546 |
Noncontrolling interests at Sep. 30, 2017 | 78,947 | ||||||
Total shareholders' equity at Sep. 30, 2017 | $ 4,015,234 | $ (18,430) |
Consolidated Statements of Cash
Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands | 9 Months Ended | |
Sep. 30, 2017 | Sep. 30, 2016 | |
Cash flows provided by (used in) operating activities | ||
Net (loss) income | $ (334,901) | $ 450,032 |
Adjustments to reconcile net income to cash provided by (used in) operating activities: | ||
Share compensation expenses | 30,080 | 32,465 |
Loss on deconsolidation of AlphaCat ILS fund | 402 | 0 |
Amortization of discount on senior notes | 81 | 81 |
(Income) loss from investment affiliates | (15,665) | 4,249 |
Net realized and change in net unrealized gains on investments | (26,488) | (90,868) |
Amortization of intangible assets | 6,115 | 4,248 |
Loss from operating affiliate | 0 | 23 |
Foreign exchange gains included in net income | (14,179) | (4,585) |
Amortization of premium on fixed maturities | 11,178 | 13,381 |
Change in: | ||
Premiums receivable | (275,782) | (288,048) |
Deferred acquisition costs | (52,967) | (68,920) |
Prepaid reinsurance premiums | 97,535 | (41,813) |
Loss reserves recoverable | (847,186) | (97,742) |
Paid losses recoverable | (24,598) | (13,165) |
Reserve for losses and loss expenses | 1,822,992 | 66,561 |
Unearned premiums | 43,767 | 393,228 |
Reinsurance balances payable | 177,798 | 2,726 |
Other operational balance sheet items, net | (294,300) | (107,257) |
Net cash provided by operating activities | 303,882 | 254,596 |
Cash flows provided by (used in) investing activities | ||
Proceeds on sales of fixed maturity investments | 2,533,122 | 2,047,496 |
Proceeds on maturities of fixed maturity investments | 356,073 | 256,082 |
Purchases of fixed maturity investments | (2,746,360) | (2,317,674) |
Purchases of short-term investments, net | (188,928) | (540,102) |
Purchases of other investments, net | (53,617) | (53,627) |
Decrease (increase) in securities lending collateral | 7,664 | (5,766) |
Redemption from operating affiliates | 0 | 369 |
Distributions from (investments in) investment affiliates, net | 24,017 | (16,307) |
Increase in restricted cash | (18,447) | (39,778) |
Purchase of subsidiary, net of cash acquired | 183,923 | 0 |
Net cash used in investing activities | (270,399) | (669,307) |
Cash flows provided by (used in) financing activities | ||
Net proceeds on issuance of notes payable to AlphaCat investors | 310,548 | 296,527 |
Net proceeds on issuance of preferred shares | 241,686 | 144,852 |
Redemption of common shares, net | (12,123) | (7,631) |
Purchases of common shares under share repurchase program | (18,343) | (196,015) |
Dividends paid on preferred shares | (10,033) | (2,252) |
Dividends paid on common shares | (93,615) | (87,901) |
(Decrease) increase in securities lending payable | (7,664) | 5,766 |
Third party investment in redeemable noncontrolling interests | 237,199 | 381,950 |
Third party redemption of redeemable noncontrolling interests | (157,534) | (17,284) |
Third party investment in noncontrolling interests | 258,300 | 171,674 |
Third party distributions of noncontrolling interests | (197,250) | (127,103) |
Third party subscriptions deployed in AlphaCat Funds and Sidecars | (57,452) | (412,736) |
Net cash provided by financing activities | 493,719 | 149,847 |
Effect of foreign currency rate changes on cash and cash equivalents | 18,452 | (14,253) |
Net increase (decrease) in cash and cash equivalents | 545,654 | (279,117) |
Cash and cash equivalents - beginning of period | 419,976 | 723,109 |
Cash and cash equivalents - end of period | 965,630 | 443,992 |
Supplemental disclosure of cash flow information: | ||
Taxes paid during the period | 2,810 | 5,914 |
Interest paid during the period | $ 46,388 | $ 46,072 |
Basis of preparation and consol
Basis of preparation and consolidation | 9 Months Ended |
Sep. 30, 2017 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Basis of presentation and consolidation | Basis of preparation and consolidation These unaudited Consolidated Financial Statements (the “Consolidated Financial Statements”) have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 in Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In addition, the year-end balance sheet data was derived from audited financial statements but does not include all disclosures required by U.S. GAAP. This Quarterly Report on Form 10-Q should be read in conjunction with the financial statements and related notes included in Validus Holdings, Ltd.’s (the “Company”) Annual Report on Form 10-K for the year ended December 31, 2016 , as filed with the U.S. Securities and Exchange Commission (the “SEC”). The Company consolidates in these Consolidated Financial Statements the results of operations and financial position of all voting interest entities (“VOE”) in which the Company has a controlling financial interest and all variable interest entities (“VIE”) in which the Company is considered to be the primary beneficiary. The consolidation assessment, including the determination as to whether an entity qualifies as a VIE or VOE, depends on the facts and circumstances surrounding each entity. In the opinion of management, these unaudited Consolidated Financial Statements reflect all adjustments (including normal recurring adjustments) considered necessary for a fair statement of the Company’s financial position and results of operations as at the end of and for the periods presented. All significant intercompany accounts and transactions have been eliminated. The results of operations for any interim period are not necessarily indicative of the results for a full year. The preparation of these financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. While management believes that the amounts included in the Consolidated Financial Statements reflect its best estimates and assumptions, actual results could differ materially from those estimates. The Company’s principal estimates include: • reserve for losses and loss expenses; • premium estimates for business written on a line slip or proportional basis; • the valuation of goodwill and intangible assets; • reinsurance recoverable balances including the provision for uncollectible amounts; and • investment valuation of financial assets. The term “ASC” used in these notes refers to Accounting Standard Codification issued by the United States Financial Accounting Standards Board (the “FASB”). |
Recent accounting pronouncement
Recent accounting pronouncements | 9 Months Ended |
Sep. 30, 2017 | |
New Accounting Pronouncements and Changes in Accounting Principles [Abstract] | |
Recent accounting pronouncements | Recent accounting pronouncements Recently issued accounting standards not yet adopted In August 2017, the FASB issued ASU 2017-12, “Derivatives and Hedging (Topic 815).” This ASU is directed at targeted improvements to accounting for hedging activities. This ASU is effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted, including adoption in an interim period. The Company is currently evaluating the impact of this guidance on the Company’s Consolidated Financial Statements. |
Business combination
Business combination | 9 Months Ended |
Sep. 30, 2017 | |
Business Combinations [Abstract] | |
Business combination | Business combination On May 1, 2017, Western World Insurance Group, Inc. (“Western World”), a wholly owned subsidiary of the Company acquired all of the outstanding capital stock of Crop Risk Services (“CRS”) for an aggregate purchase price of $185,576 in cash. CRS is a primary crop insurance managing general agent (“MGA”) based in Decatur, Illinois with 1,170 agents across 36 states. CRS does not have insurance licenses of its own, but acts solely as an MGA in that it can produce business for any properly licensed entity on a commission basis. Concurrent with closing of the transaction, Stratford Insurance Company (“Stratford”), a wholly–owned subsidiary of Western World, was granted the required licenses to write crop insurance in the United States and executed several agreements to transfer the related agriculture book of business to Stratford. The CRS acquisition was undertaken to expand the Company’s presence in U.S. primary specialty lines. For segmental reporting purposes, the results of CRS’ operations, including the related agricultural book of business have been included within the Western World segment in the Consolidated Financial Statements from the date of acquisition. On closing, the Company recorded intangible assets totaling $63,921 for Distribution Channels, Brand Name and Technology. Distribution Channels and Brand Name were estimated to have finite useful economic lives of ten years on acquisition and are being amortized on a straight line basis over such period. Technology was estimated to have a finite useful economic life of two years on acquisition and is being amortized on a straight line basis over such a period. The purchase price was allocated to the acquired assets and liabilities of CRS based on estimated fair values on May 1, 2017, the date the transaction closed, as detailed below. The Company recognized goodwill of $30,943 primarily attributable to CRS’s assembled workforce and synergies expected to result upon the integration of CRS and its related book of business into the Company’s operations. The estimates of fair values for tangible assets acquired and liabilities assumed were determined by management based on various market and income analyses. The Company estimated the fair values of intangible assets acquired based on variations of the income and cost approaches. Significant judgment was required to arrive at these estimates of fair value and changes to assumptions used could have led to materially different results. The purchase of CRS was a taxable transaction and as such, goodwill and intangibles recorded at closing will be deductible for income tax purposes. The Company has recognized and recorded a deferred tax asset of $6,443 which results from the excess of tax-deductible goodwill over book value goodwill as recognized in the purchase price allocation. The fair value of net assets acquired, including GAAP adjustments, are summarized as follows: Total purchase price $ 185,576 Assets acquired Cash and cash equivalents $ 1,653 Premiums receivable 564,453 Prepaid reinsurance premiums 227,157 Other assets 157,146 Assets acquired 950,409 Liabilities acquired Reinsurance balances payable $ 294,201 Unearned premiums 406,649 Net loss reserves 42,575 Other liabilities 122,715 Liabilities acquired 866,140 Excess purchase price $ 101,307 Goodwill and other intangible assets acquired Intangible asset - Distribution channels $ 52,898 Intangible asset - Brand name 9,568 Intangible asset - Technology 1,455 Total intangible assets 63,921 Goodwill 30,943 Deferred tax arising on Goodwill 6,443 Total goodwill and intangible assets $ 101,307 The Company also incurred transaction expenses related to the CRS acquisition of $4,427 . Transaction expenses included legal, financial advisory and audit related services. The following tables reconcile the carrying amount of goodwill and intangible assets from December 31, 2016 to September 30, 2017 : Goodwill Nine Months Ended September 30, 2017 Talbot Western World Total Balance at December 31, 2016 $ 20,393 $ 176,365 $ 196,758 Additions — 30,943 30,943 Balance at September 30, 2017 $ 20,393 $ 207,308 $ 227,701 Intangible assets Nine Months Ended September 30, 2017 Talbot Western World Total Balance at December 31, 2016 $ 93,924 $ 21,668 $ 115,592 Additions — 63,921 63,921 Amortization (2,081 ) (4,034 ) (6,115 ) Balance at September 30, 2017 $ 91,843 $ 81,555 $ 173,398 Intangible assets Nine Months Ended September 30, 2017 With a Finite Life With an Indefinite Life Total Balance at December 31, 2016 $ 11,424 $ 104,168 $ 115,592 Additions 63,921 — 63,921 Amortization (6,115 ) — (6,115 ) Balance at September 30, 2017 $ 69,230 $ 104,168 $ 173,398 Operating results of CRS have been included in the Consolidated Financial Statements from the May 1, 2017 acquisition date. The following selected unaudited information has been provided to present a summary of the results of CRS that have been included in the Consolidated Financial Statements for the three and nine months ended September 30, 2017 . Three Months Ended September 30, 2017 Nine Months Ended September 30, 2017 Net premiums written $ 32,852 $ 39,840 Net premiums earned $ 98,757 $ 148,801 Total underwriting deductions $ 84,826 $ 129,606 Underwriting income, before general and administrative expenses $ 13,931 $ 19,195 |
Investments
Investments | 9 Months Ended |
Sep. 30, 2017 | |
Investments [Abstract] | |
Investments | Investments Managed investments represent assets governed by the Company’s investment policy statement (“IPS”) whereas, non-managed investments represent assets held in support of consolidated AlphaCat VIEs which are not governed by the Company’s IPS. Refer to Note 6 , “Variable interest entities,” for further details. The Company classifies its fixed maturity and short-term investments as trading and accounts for its other investments in accordance with ASC Topic 825 “ Financial Instruments. ” As such, all investments are carried at fair value with interest and dividend income and realized and unrealized gains and losses included in net income for the period. The amortized cost (or cost) and fair value of the Company’s investments as at September 30, 2017 and December 31, 2016 were as follows: September 30, 2017 December 31, 2016 Amortized Amortized Fair Value Managed investments U.S. government and government agency $ 598,607 $ 595,694 $ 809,392 $ 804,126 Non-U.S. government and government agency 288,296 290,538 245,651 240,791 U.S. states, municipalities and political subdivisions 205,880 206,667 271,742 271,830 Agency residential mortgage-backed securities 830,542 828,400 684,490 679,595 Non-agency residential mortgage-backed securities 38,806 38,993 15,858 15,477 U.S. corporate 1,457,073 1,466,739 1,540,036 1,534,508 Non-U.S. corporate 390,519 392,242 418,520 410,227 Bank loans 471,855 464,464 579,121 570,399 Asset-backed securities 520,594 522,524 528,563 526,814 Commercial mortgage-backed securities 315,585 314,221 333,740 330,932 Total fixed maturities 5,117,757 5,120,482 5,427,113 5,384,699 Short-term investments 258,339 258,646 228,574 228,386 Other investments Fund of hedge funds — — 1,457 955 Hedge funds 11,292 19,233 11,292 17,381 Private equity investments 88,299 107,230 66,383 82,627 Fixed income investment funds 282,707 285,034 247,967 249,275 Overseas deposits 55,775 55,775 50,106 50,106 Mutual funds 1,918 4,028 2,925 5,368 Total other investments 439,991 471,300 380,130 405,712 Investments in investment affiliates (a) 60,228 92,079 84,840 100,431 Total managed investments $ 5,876,315 $ 5,942,507 $ 6,120,657 $ 6,119,228 Non-managed investments Catastrophe bonds $ 303,789 $ 299,484 $ 157,486 $ 158,331 Short-term investments 2,734,600 2,734,600 2,567,784 2,567,784 Total non-managed investments 3,038,389 3,034,084 2,725,270 2,726,115 Total investments $ 8,914,704 $ 8,976,591 $ 8,845,927 $ 8,845,343 (a) The Company’s investments in investment affiliates have been treated as equity method investments with the corresponding gains and losses recorded in income as “Income (loss) from investment affiliates.” (a) Fixed maturity investments The following table sets forth certain information regarding the investment ratings of the Company’s fixed maturity investments as at September 30, 2017 and December 31, 2016 . September 30, 2017 December 31, 2016 Fair Value % of Total Fair Value % of Total Managed fixed maturities AAA $ 2,349,803 43.3 % $ 2,405,597 43.4 % AA 437,215 8.1 % 538,289 9.7 % A 1,060,849 19.6 % 1,081,949 19.5 % BBB 752,808 13.9 % 740,861 13.4 % Total investment grade managed fixed maturities 4,600,675 84.9 % 4,766,696 86.0 % BB 177,667 3.2 % 213,568 3.9 % B 156,590 2.9 % 177,737 3.2 % CCC 5,286 0.1 % 13,371 0.2 % NR 180,264 3.4 % 213,327 3.8 % Total non-investment grade fixed maturities 519,807 9.6 % 618,003 11.1 % Total managed fixed maturities $ 5,120,482 94.5 % $ 5,384,699 97.1 % Non-managed catastrophe bonds AAA $ 1,650 0.0 % $ — 0.0 % Total investment grade non-managed fixed maturities 1,650 0.0 % — 0.0 % BB 28,031 0.5 % 29,731 0.6 % B 2,755 0.1 % 4,524 0.1 % NR 267,048 4.9 % 124,076 2.2 % Total non-investment grade non-managed fixed maturities 297,834 5.5 % 158,331 2.9 % Total non-managed fixed maturities 299,484 5.5 % 158,331 2.9 % Total fixed maturities $ 5,419,966 100.0 % $ 5,543,030 100.0 % The amortized cost and fair value amounts for the Company’s fixed maturity investments held at September 30, 2017 and December 31, 2016 are shown below by contractual maturity. Actual maturity may differ from contractual maturity because certain borrowers may have the right to call or prepay certain obligations with or without call or prepayment penalties. September 30, 2017 December 31, 2016 Amortized Cost Fair Value Amortized Cost Fair Value Managed fixed maturities Due in one year or less $ 279,069 $ 278,118 $ 350,733 $ 346,161 Due after one year through five years 2,418,737 2,416,963 2,954,856 2,933,146 Due after five years through ten years 534,922 535,538 430,365 426,647 Due after ten years 179,502 185,725 128,508 125,927 3,412,230 3,416,344 3,864,462 3,831,881 Asset-backed and mortgage-backed securities 1,705,527 1,704,138 1,562,651 1,552,818 Total managed fixed maturities $ 5,117,757 $ 5,120,482 $ 5,427,113 $ 5,384,699 Non-managed catastrophe bonds Due in one year or less $ 88,949 $ 88,202 $ 43,664 $ 45,418 Due after one year through five years 209,340 206,117 112,572 111,656 Due after five years through ten years 5,500 5,165 1,250 1,257 Total non-managed fixed maturities 303,789 299,484 157,486 158,331 Total fixed maturities $ 5,421,546 $ 5,419,966 $ 5,584,599 $ 5,543,030 (b) Other investments The following tables set forth certain information regarding the Company’s other investment portfolio as at September 30, 2017 and December 31, 2016 : September 30, 2017 Fair Value Investments with redemption restrictions Investments without redemption restrictions Redemption frequency (a) Redemption notice period (a) Hedge funds 19,233 19,233 — Private equity investments 107,230 107,230 — Fixed income investment funds 285,034 249,999 35,035 Daily Daily to 2 days Overseas deposits 55,775 55,775 — Mutual funds 4,028 — 4,028 Daily Daily Total other investments $ 471,300 $ 432,237 $ 39,063 December 31, 2016 Fair Value Investments with redemption restrictions Investments without redemption restrictions Redemption frequency (a) Redemption notice period (a) Fund of hedge funds $ 955 $ 955 $ — Hedge funds 17,381 17,381 — Private equity investments 82,627 82,627 — Fixed income investment funds 249,275 218,333 30,942 Daily 2 days Overseas deposits 50,106 50,106 — Mutual funds 5,368 — 5,368 Daily Daily Total other investments $ 405,712 $ 369,402 $ 36,310 (a) The redemption frequency and notice periods only apply to investments without redemption restrictions. Other investments include alternative investments in various funds and pooled investment schemes. These alternative investments employ various investment strategies primarily involving, but not limited to, investments in collateralized obligations, fixed income securities, private equities, distressed debt and equity securities. Certain debt-like investments totaling $274,651 are either rated or consist of underlying securities or instruments which carry credit ratings issued by nationally recognized statistical rating organizations. Other equity-like investments totaling $196,649 are unrated given the nature of their underlying assets, such as private equity investments, and as such do not carry credit ratings. Certain securities included in other investments are subject to redemption restrictions and are unable to be redeemed from the funds. Distributions from these funds will be received as the underlying investments of the funds are liquidated. Currently, it is not known to the Company when these underlying assets will be sold by their investment managers; however, it is estimated that the majority of the underlying assets of the investments would liquidate over five to ten years from inception of the funds. In addition, one of the investment funds with a fair value of $195,903 ( December 31, 2016 : $184,749 ), has various lock-up periods of approximately two years or less as at September 30, 2017 and may also impose a redemption gate. A lock-up period refers to the initial amount of time an investor is contractually required to remain invested before having the ability to redeem. Typically, the imposition of a gate delays a portion of the requested redemption, with the remaining portion settled in cash shortly after the redemption date. The underlying investments held in the overseas deposit funds are liquid and will generally trade freely in an open market. However, the Company’s ability to withdraw from the overseas deposit funds is restricted by an annual and quarterly funding and release process for Lloyd’s market participants. The Company’s maximum exposure to any of these alternative investments is limited to the amount invested and any remaining capital commitments. Refer to Note 15 , “ Commitments and contingencies ,” for further details. As at September 30, 2017 , the Company does not have any plans to sell any of the other investments listed above. (c) Investments in investment affiliates Included in the Company’s managed investment portfolio as at September 30, 2017 were investments in Aquiline Financial Services Fund II L.P. (“Aquiline II”), Aquiline Financial Services Fund III L.P. (“Aquiline III”) and Aquiline Technology Growth Fund L.P. (“Aquiline Tech”). Aquiline II and III For further information regarding Aquiline II and III please refer to Note 7(c), “Investments in investment affiliates,” included within the Company’s Annual Report on Form 10-K for the year ended December 31, 2016 . As at September 30, 2017 , the Company’s total unfunded investment commitment to Aquiline II and III was $3,229 and $66,285 , respectively ( December 31, 2016 : $2,040 and $62,031 ). Aquiline Tech On March 20, 2017, the Company entered into a Subscription Agreement (the “Subscription Agreement”) with Aquiline Technology Growth GP Ltd, (the “General Partner”) pursuant to which the Company committed and agreed to purchase limited partnership or other comparable limited liability equity interests in Aquiline Tech, a Cayman Islands exempted limited partnership, with a capital commitment in an amount equal to $20,000 . The limited partnership interests are governed by the terms of an amended and restated exempted limited partnership agreement. As at September 30, 2017 , the unfunded investment commitment to Aquiline Tech was $17,858 . The following table presents a reconciliation of the Company’s beginning and ending investments in investment affiliates for the three and nine months ended September 30, 2017 and 2016 : Three Months Ended September 30, Nine Months Ended September 30, 2017 2016 2017 2016 Investments in investment affiliates, beginning of period $ 103,377 $ 99,278 $ 100,431 $ 87,673 Net capital (distributions) contributions (12,309 ) — (24,017 ) 16,307 Income (loss) from investment affiliates 1,011 453 15,665 (4,249 ) Investments in investment affiliates, end of period $ 92,079 $ 99,731 $ 92,079 $ 99,731 The following table presents the Company’s investments in investment affiliates as at September 30, 2017 and December 31, 2016 : September 30, 2017 Investment at cost Voting ownership % Equity ownership % Carrying value Aquiline II $ 33,349 — % 8.1 % $ 50,695 Aquiline III 24,737 — % 9.0 % 39,530 Aquiline Tech 2,142 — % 10.6 % 1,854 Total investments in investment affiliates $ 60,228 $ 92,079 December 31, 2016 Investment at cost Voting ownership % Equity ownership % Carrying value Aquiline II $ 46,871 — % 8.1 % $ 61,999 Aquiline III 37,969 — % 9.0 % 38,432 Total investments in investment affiliates $ 84,840 $ 100,431 (d) Net investment income Net investment income was derived from the following sources: Three Months Ended September 30, Nine Months Ended September 30, 2017 2016 2017 2016 Managed investments Fixed maturities and short-term investments $ 30,823 $ 30,572 $ 93,706 $ 89,210 Other investments 7,391 11,768 21,832 20,666 Cash and cash equivalents and restricted cash 1,230 891 2,556 2,136 Securities lending income 3 22 23 39 Total gross investment income 39,447 43,253 118,117 112,051 Investment expenses (2,356 ) (2,182 ) (6,771 ) (6,208 ) Total managed net investment income $ 37,091 $ 41,071 $ 111,346 $ 105,843 Non managed investments Fixed maturities and short-term investments $ 3,941 $ 1,970 $ 11,501 $ 5,242 Restricted cash, cash and cash equivalents 3,426 473 6,066 1,147 Total non-managed net investment income 7,367 2,443 17,567 6,389 Total net investment income $ 44,458 $ 43,514 $ 128,913 $ 112,232 Net investment income from other investments includes distributed and undistributed net income from hedge funds, overseas deposits and certain fixed income investment funds. (e) Net realized and change in net unrealized (losses) gains on investments The following table sets forth an analysis of net realized gains and the change in net unrealized (losses) gains on investments: Three Months Ended September 30, Nine Months Ended September 30, 2017 2016 2017 2016 Managed fixed maturities, short-term and other investments Gross realized gains $ 5,170 $ 4,544 $ 13,035 $ 11,067 Gross realized (losses) (4,267 ) (464 ) (12,755 ) (5,553 ) Net realized gains on investments 903 4,080 280 5,514 Change in net unrealized gains on investments 941 4,652 31,232 81,782 Total net realized and change in net unrealized gains on managed investments $ 1,844 $ 8,732 $ 31,512 $ 87,296 Non-managed fixed maturities and short-term investments Gross realized gains $ 3 $ 317 $ 1,736 $ 1,032 Gross realized (losses) — — — (9 ) Net realized gains on investments 3 317 1,736 1,023 Change in net unrealized (losses) gains on investments (6,138 ) 807 (6,760 ) 2,549 Total net realized and change in net unrealized (losses) gains on non-managed investments (6,135 ) 1,124 (5,024 ) 3,572 Total net realized and change in net unrealized (losses) gains on total investments $ (4,291 ) $ 9,856 $ 26,488 $ 90,868 (f) Pledged cash and investments As at September 30, 2017 , the Company had $5,433,107 ( December 31, 2016 : $5,173,966 ) of cash and cash equivalents, restricted cash, short-term investments and fixed maturity investments that were pledged during the normal course of business. Of those, $5,368,025 were held in trust ( December 31, 2016 : $5,068,092 ). Pledged assets are generally for the benefit of the Company’s cedants and policyholders, to support AlphaCat’s fully collateralized reinsurance transactions and to facilitate the accreditation of Validus Reinsurance, Ltd., Validus Reinsurance (Switzerland) Ltd. (“Validus Re Swiss”) and Talbot as an alien Insurer/Reinsurer by certain regulators. In addition, the Company has pledged cash and investments as collateral under the Company’s credit facilities in the total amount of $265,089 ( December 31, 2016 : $442,184 ). For further details on the credit facilities, please refer to Note 13 , “ Debt and financing arrangements .” |
Fair value measurements
Fair value measurements | 9 Months Ended |
Sep. 30, 2017 | |
Fair Value Disclosures [Abstract] | |
Fair value measurements | Fair value measurements (a) Classification within the fair value hierarchy Fair value is defined as the price to sell an asset or transfer a liability in an orderly transaction between market participants. Under U.S. GAAP, a company must determine the appropriate level in the fair value hierarchy for each fair value measurement. The fair value hierarchy prioritizes the inputs, which refer broadly to assumptions market participants would use in pricing an asset or liability, into three levels. It gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The level in the fair value hierarchy within which a fair value measurement in its entirety falls is determined based on the lowest level input that is significant to the fair value measurement in its entirety. The three levels of the fair value hierarchy are described below: Level 1 - Fair values are measured based on unadjusted quoted prices in active markets for identical assets or liabilities that we have the ability to access. Level 2 - Fair values are measured based on quoted prices in active markets for similar assets or liabilities, quoted prices for identical assets or liabilities in inactive markets, or for which significant inputs are observable (e.g., interest rates, yield curves, prepayment speeds, default rates, loss severities, etc.) or can be corroborated by observable market data. Level 3 - Fair values are measured based on inputs that are unobservable and significant to the overall fair value measurement. The unobservable inputs reflect the Company’s own judgments about assumptions where there is little, if any, market activity for that asset or liability that market participants might use. The availability of observable inputs can vary from financial instrument to financial instrument and is affected by a wide variety of factors including, for example, the type of financial instrument, whether the financial instrument is new and not yet established in the marketplace, and other characteristics particular to the instrument. To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires significantly more judgment. Accordingly, the degree of judgment exercised by management in determining fair value is greatest for instruments categorized in Level 3. In periods of market dislocation, the observability of prices and inputs may be reduced for many instruments. This may lead the Company to change the selection of our valuation technique (for example, from market to cash flow approach) or to use multiple valuation techniques to estimate the fair value of a financial instrument. These circumstances could cause an instrument to be reclassified between levels within the fair value hierarchy. At September 30, 2017 , the Company’s investments were allocated between Levels 1, 2 and 3 as follows: Level 1 Level 2 Level 3 Fair value based on NAV practical expedient (a) Total Managed investments U.S. government and government agency $ — $ 595,694 $ — $ — $ 595,694 Non-U.S. government and government agency — 290,538 — — 290,538 U.S. states, municipalities and political subdivisions — 206,667 — — 206,667 Agency residential mortgage-backed securities — 828,400 — — 828,400 Non-agency residential mortgage-backed securities — 38,993 — — 38,993 U.S. corporate — 1,466,739 — — 1,466,739 Non-U.S. corporate — 392,242 — — 392,242 Bank loans — 240,563 223,901 — 464,464 Asset-backed securities — 486,537 35,987 — 522,524 Commercial mortgage-backed securities — 314,221 — — 314,221 Total fixed maturities — 4,860,594 259,888 — 5,120,482 Short-term investments 251,578 7,068 — — 258,646 Other investments Hedge funds — — — 19,233 19,233 Private equity investments — — — 107,230 107,230 Fixed income investment funds — 35,145 16,886 233,003 285,034 Overseas deposits — — — 55,775 55,775 Mutual funds — 4,028 — — 4,028 Total other investments — 39,173 16,886 415,241 471,300 Investments in investment affiliates (b) — — — — 92,079 Total managed investments $ 251,578 $ 4,906,835 $ 276,774 $ 415,241 $ 5,942,507 Non-managed investments Catastrophe bonds $ — $ 230,775 $ 68,709 $ — $ 299,484 Short-term investments 2,734,600 — — — 2,734,600 Total non-managed investments 2,734,600 230,775 68,709 — 3,034,084 Total investments $ 2,986,178 $ 5,137,610 $ 345,483 $ 415,241 $ 8,976,591 (a) In accordance with ASC Topic 820 “Fair Value Measurements,” investments measured at fair value using the net asset value (“NAV”) per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy. (b) In accordance with ASC Topic 825 “Financial Instruments,” the Company’s investments in investment affiliates have not been classified in the fair value hierarchy. At December 31, 2016 , the Company’s investments were allocated between Levels 1, 2 and 3 as follows: Level 1 Level 2 Level 3 Fair value based on NAV practical expedient (a) Total Managed investments U.S. government and government agency $ — $ 804,126 $ — $ — $ 804,126 Non-U.S. government and government agency — 240,791 — — 240,791 U.S. states, municipalities and political subdivisions — 271,830 — — 271,830 Agency residential mortgage-backed securities — 679,595 — — 679,595 Non-agency residential mortgage-backed securities — 15,477 — — 15,477 U.S. corporate — 1,534,508 — — 1,534,508 Non-U.S. corporate — 410,227 — — 410,227 Bank loans — 323,903 246,496 — 570,399 Asset-backed securities — 502,883 23,931 — 526,814 Commercial mortgage-backed securities — 330,932 — — 330,932 Total fixed maturities — 5,114,272 270,427 — 5,384,699 Short-term investments 209,651 18,735 — — 228,386 Other investments Fund of hedge funds — — — 955 955 Hedge funds — — — 17,381 17,381 Private equity investments — — — 82,627 82,627 Fixed income investment funds — 30,941 12,168 206,166 249,275 Overseas deposits — — — 50,106 50,106 Mutual funds — 5,368 — — 5,368 Total other investments — 36,309 12,168 357,235 405,712 Investments in investment affiliates (b) — — — — 100,431 Total managed investments $ 209,651 $ 5,169,316 $ 282,595 $ 357,235 $ 6,119,228 Non-managed investments Catastrophe bonds $ — $ 109,956 $ 48,375 $ — $ 158,331 Short-term investments 2,567,784 — — — 2,567,784 Total non-managed investments 2,567,784 109,956 48,375 — 2,726,115 Total investments $ 2,777,435 $ 5,279,272 $ 330,970 $ 357,235 $ 8,845,343 (a) In accordance with ASC Topic 820 “Fair Value Measurements,” investments measured at fair value using the net asset value (“NAV”) per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy. (b) In accordance with ASC Topic 825 “Financial Instruments,” the Company’s investments in investment affiliates have not been classified in the fair value hierarchy. At September 30, 2017 , managed Level 3 investments totaled $276,774 (December 31, 2016 : $282,595 ), representing 4.7% (December 31, 2016 : 4.6% ) of total managed investments. (b) Valuation techniques There have been no material changes in the Company’s valuation techniques during the period, or periods, represented by these Consolidated Financial Statements. The following methods and assumptions were used in estimating the fair value of each class of financial instrument recorded in the Consolidated Balance Sheets. Fixed maturity investments In general, valuation of the Company’s fixed maturity investment portfolio is provided by pricing services, such as index providers and pricing vendors, as well as broker quotations. The pricing vendors provide valuations for a high volume of liquid securities that are actively traded. For securities that do not trade on an exchange, the pricing services generally utilize market data and other observable inputs in matrix pricing models to determine month end prices. Prices are generally verified using third party data. Securities which are priced by an index provider are generally included in the index. In general, broker-dealers value securities through their trading desks based on observable inputs. The methodologies include mapping securities based on trade data, bids or offers, observed spreads, and performance on newly issued securities. Broker-dealers also determine valuations by observing secondary trading of similar securities. Prices obtained from broker quotations are considered non-binding, however they are based on observable inputs and by observing secondary trading of similar securities obtained from active, non-distressed markets. The Company considers these Level 2 inputs as they are corroborated with other market observable inputs. The techniques generally used to determine the fair value of the Company’s fixed maturity investments are detailed below by asset class. U.S. government and government agency U.S. government and government agency securities consist primarily of debt securities issued by the U.S. Treasury and mortgage pass-through agencies such as the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation and the Government National Mortgage Association. Fixed maturity investments included in U.S. government and government agency securities are primarily priced by pricing services. When evaluating these securities, the pricing services gather information from market sources and integrate other observations from markets and sector news. Evaluations are updated by obtaining broker dealer quotes and other market information including actual trade volumes, when available. The fair value of each security is individually computed using analytical models which incorporate option adjusted spreads and other daily interest rate data. As the significant inputs used to price these securities are observable, the fair value of these investments are classified as Level 2. Non-U.S. government and government agency Non-U.S. government and government agency securities consist of debt securities issued by non-U.S. governments and their agencies along with supranational organizations (also known as sovereign debt securities). Securities held in these sectors are primarily priced by pricing services who employ proprietary discounted cash flow models to value the securities. Key quantitative inputs for these models are daily observed benchmark curves for treasury, swap and high issuance credits. The pricing services then apply a credit spread for each security which is developed by in-depth and real time market analysis. For securities in which trade volume is low, the pricing services utilize data from more frequently traded securities with similar attributes. These models may also be supplemented by daily market and credit research for international markets. As the significant inputs used to price these securities are observable, the fair value of these investments are classified as Level 2. U.S. states, municipalities and political subdivisions The Company’s U.S. states, municipalities and political subdivisions portfolio contains debt securities issued by U.S. domiciled state and municipal entities. These securities are generally priced by independent pricing services using the techniques described for U.S. government and government agency securities described above. As the significant inputs used to price these securities are observable, the fair value of these investments are classified as Level 2. Agency residential mortgage-backed securities The Company’s agency residential mortgage-backed investments are primarily priced by pricing services using a mortgage pool specific model which utilizes daily inputs from the active to be announced market which is very liquid, as well as the U.S. treasury market. The model also utilizes additional information, such as the weighted average maturity, weighted average coupon and other available pool level data which is provided by the sponsoring agency. Valuations are also corroborated with daily active market quotes. As the significant inputs used to price these securities are observable, the fair value of these investments are classified as Level 2. Non-agency residential mortgage-backed securities The Company’s non-agency mortgage-backed investments include non-agency prime residential mortgage-backed fixed maturity investments. The Company has no fixed maturity investments classified as sub-prime held in its fixed maturity investments portfolio. Securities held in these sectors are primarily priced by pricing services using an option adjusted spread model or other relevant models, which principally utilize inputs including benchmark yields, available trade information or broker quotes, and issuer spreads. The pricing services also review collateral prepayment speeds, loss severity and delinquencies among other collateral performance indicators for the securities valuation, when applicable. As the significant inputs used to price these securities are observable, the fair value of these investments are classified as Level 2. U.S. corporate U.S. corporate debt securities consist primarily of investment-grade debt of a wide variety of U.S. corporate issuers and industries. The Company’s corporate fixed maturity investments are primarily priced by pricing services. When evaluating these securities, the pricing services gather information from market sources regarding the issuer of the security and obtain credit data, as well as other observations, from markets and sector news. Evaluations are updated by obtaining broker dealer quotes and other market information including actual trade volumes, when available. The pricing services also consider the specific terms and conditions of the securities, including any specific features which may influence risk. In certain instances, securities are individually evaluated using a spread which is added to the U.S. treasury curve or a security specific swap curve as appropriate. As the significant inputs used to price these securities are observable, the fair value of these investments are classified as Level 2. Non-U.S. corporate Non-U.S. corporate debt securities consist primarily of investment-grade debt of a wide variety of non-U.S. corporate issuers and industries. The Company’s non-U.S. corporate fixed maturity investments are primarily priced by pricing services. When evaluating these securities, the pricing services gather information from market sources regarding the issuer of the security and obtain credit data, as well as other observations, from markets and sector news. Evaluations are updated by obtaining broker dealer quotes and other market information including actual trade volumes, when available. The pricing services also consider the specific terms and conditions of the securities, including any specific features which may influence risk. As the significant inputs used to price these securities are observable, the fair value of these investments are classified as Level 2. Bank loans The Company’s bank loan investments consist primarily of below-investment-grade debt of a wide variety of corporate issuers and industries. The Company’s bank loans are primarily priced by pricing services. When evaluating these securities, the pricing services gather information from market sources regarding the issuer of the security and obtain credit data, as well as other observations, from markets and sector news. Evaluations are updated by obtaining broker dealer quotes and other market information including actual trade volumes, when available. The pricing services also consider the specific terms and conditions of the securities, including any specific features which may influence risk. As the significant inputs used to price these securities are observable, the fair value of these investments are classified as Level 2. Also, included in the bank loan portfolio is a collection of loan participations held through an intermediary. A third party pricing service provides monthly valuation reports for each loan and participation using a combination of quotations from loan pricing services, leveraged loan indices or market price quotes obtained directly from the intermediary. Significant unobservable inputs used to price these securities include credit spreads and default rates; therefore, the fair value of these investments are classified as Level 3. Asset-backed securities Asset backed securities include mostly investment-grade debt securities backed by pools of loans with a variety of underlying collateral, including automobile loan receivables, student loans, credit card receivables, and collateralized loan obligations originated by a variety of financial institutions. Securities held in these sectors are primarily priced by pricing services. The pricing services apply dealer quotes and other available trade information such as bids and offers, prepayment speeds which may be adjusted for the underlying collateral or current price data, the U.S. treasury curve and swap curve as well as cash settlement. The pricing services determine the expected cash flows for each security held in this sector using historical prepayment and default projections for the underlying collateral and current market data. In addition, a spread is applied to the relevant benchmark and used to discount the cash flows noted above to determine the fair value of the securities held in this sector. As the significant inputs used to price these securities are observable, the fair value of these investments are classified as Level 2. Where pricing is unavailable from pricing services, we obtain non-binding quotes from broker-dealers. This is generally the case when there is a low volume of trading activity and current transactions are not orderly. Broker-dealer quotes for which significant observable inputs are unable to be corroborated with market observable information are classified as Level 3. Commercial mortgage-backed securities Commercial mortgage backed securities are investment-grade debt primarily priced by pricing services. The pricing services apply dealer quotes and other available trade information such as bids and offers, prepayment speeds which may be adjusted for the underlying collateral or current price data, the U.S. treasury curve and swap curve as well as cash settlement. The pricing services determine the expected cash flows for each security held in this sector using historical prepayment and default projections for the underlying collateral and current market data. In addition, a spread is applied to the relevant benchmark and used to discount the cash flows noted above to determine the fair value of the securities held in this sector. As the significant inputs used to price these securities are observable, the fair value of these investments are classified as Level 2. Catastrophe bonds Catastrophe bonds are priced based on broker or underwriter bid indications. As the significant inputs used to price these securities are observable, the fair value of these investments are classified as Level 2. To the extent that these indications are based on significant unobservable inputs, the fair value of the relevant bonds will be classified as a Level 3. Short-term investments Short-term investments consist primarily of highly liquid securities, all with maturities of less than one year from the date of purchase. The fair value of the portfolio is generally determined using amortized cost which approximates fair value. As the highly liquid money market-type funds are actively traded, the fair value of these investments are classified as Level 1. To the extent that the remaining securities are not actively traded due to their approaching maturity, the fair value of these investments are classified as Level 2. Other investments Fund of hedge funds During the three months ended June 30, 2017, the Company’s investment in a fund of hedge funds was liquidated. Prior to liquidation, the fund’s administrator provided a monthly reported NAV with a three month delay in its valuation. The fund manager provided an estimate of the fund NAV at year end based on the estimated performance provided from the underlying funds. To determine the reasonableness of the estimated NAV, the Company compared the fund administrator’s NAV to the fund manager’s estimated NAV that incorporates relevant valuation sources. Prior to liquidation, the fair value of these investments were measured using the NAV practical expedient and therefore were not categorized within the fair value hierarchy. Hedge funds The hedge fund’s administrator provides quarterly NAVs with a three month delay in valuation. The fair value of this investment is measured using the NAV practical expedient and therefore has not been categorized within the fair value hierarchy. Private equity investments The private equity funds provide quarterly or semi-annual partnership capital statements with a three or six month delay which are used as a basis for valuation. These private equity investments vary in investment strategies and are not actively traded in any open markets. The fair value of these investments are measured using the NAV practical expedient and therefore have not been categorized within the fair value hierarchy. Fixed income investment funds The Company’s investment funds classified as Level 2 consist of a pooled investment fund. The pooled investment is invested in fixed income securities with high credit ratings and is only open to Lloyd’s Trust Fund participants. The fair value of units in the investment fund is based on the NAV of the fund and is traded on a daily basis. Included in investment funds is a residual equity tranche of a structured credit fund valued using a dynamic yield that calculates an income accrual based on an underlying valuation model with a typical cash flow waterfall structure. Significant unobservable inputs used to price this fund include default rates and prepayment rates; therefore, the fair value of the investment fund is classified as Level 3. The fair value of the Company’s remaining investment funds is based on the NAV of the fund as reported by the independent fund administrator. The fund’s administrators provide a monthly reported NAV with a one or three month delay in their valuation. The fair value of these investments are measured using the NAV practical expedient and therefore have not been categorized within the fair value hierarchy. Overseas deposits The Company’s share of a portfolio of Lloyd’s overseas deposits are managed centrally by Lloyd’s and invested according to local regulatory requirements. The composition of the portfolio varies and the deposits are made across the market. The fair value of the deposits is based on the portfolio level reporting that is provided by Lloyd’s. The fair value of these investments are measured using the NAV practical expedient and therefore have not been categorized within the fair value hierarchy. Mutual funds Mutual funds consist of an investment fund which invests in various quoted investments. The fair value of units in the mutual fund is based on the NAV of the fund as reported by the fund manager. The mutual fund has daily liquidity which allows us to redeem our holdings at the applicable NAV in the near term. As such, the Company has classified this investment as Level 2. (c) Level 3 investments The following table presents a reconciliation of the beginning and ending balances for all investments measured at fair value on a recurring basis using Level 3 inputs during the three and nine months ended September 30, 2017 and 2016 : Three Months Ended September 30, 2017 Bank Loans Catastrophe Bonds Fixed Income Investment Funds Asset Backed Securities Total Level 3 investments, beginning of period $ 224,172 $ 68,025 $ 16,400 $ 35,921 $ 344,518 Purchases 31,312 — — — 31,312 Sales — — — (71 ) (71 ) Settlements (29,796 ) (1,000 ) 486 — (30,310 ) Change in net unrealized (losses) gains (1,787 ) 1,684 — 137 34 Level 3 investments, end of period $ 223,901 $ 68,709 $ 16,886 $ 35,987 $ 345,483 Three Months Ended September 30, 2016 Bank Loans Catastrophe Bonds Asset Backed Securities Total Level 3 investments, beginning of period $ 243,148 $ 37,518 $ 12,383 $ 293,049 Purchases 21,256 — 11,513 32,769 Sales (12,388 ) — — (12,388 ) Change in net unrealized gains 484 517 — 1,001 Level 3 investments, end of period $ 252,500 $ 38,035 $ 23,896 $ 314,431 Nine Months Ended September 30, 2017 Bank Loans Catastrophe Bonds Fixed Income Investment Funds Asset Backed Securities Total Level 3 investments—beginning of period $ 246,496 $ 48,375 $ 12,168 $ 23,931 $ 330,970 Purchases 71,245 66,091 3,432 11,053 151,821 Sales — — — (124 ) (124 ) Settlements (91,799 ) (49,996 ) 1,286 — (140,509 ) Net realized gains — 3,350 — — 3,350 Change in net unrealized (losses) gains (2,041 ) 889 — 1,127 (25 ) Level 3 investments—end of period $ 223,901 $ 68,709 $ 16,886 $ 35,987 $ 345,483 Nine Months Ended September 30, 2016 Bank Loans Catastrophe Bonds Asset Backed Securities Total Level 3 investments—beginning of period $ 232,337 $ 13,500 $ — $ 245,837 Purchases 72,244 23,272 23,896 119,412 Sales (14,777 ) — — (14,777 ) Settlements (34,033 ) (125 ) — (34,158 ) Change in net unrealized (losses) gains (3,271 ) 1,388 — (1,883 ) Level 3 investments—end of period $ 252,500 $ 38,035 $ 23,896 $ 314,431 There have not been any transfers into or out of Level 3 during the three and nine months ended September 30, 2017 or 2016 . (d) Financial instruments not carried at fair value ASC Topic 825 “Financial Instruments” is also applicable to disclosures of financial instruments not carried at fair value, except for certain financial instruments, including insurance contracts and investments in affiliates. The carrying values of cash and cash equivalents, restricted cash, accrued investment income, other assets, net payable for investments purchased and accounts payable and accrued expenses approximated their fair values at September 30, 2017 , due to their respective short maturities. As these financial instruments are not actively traded, their respective fair values are classified within Level 2. |
Variable interest entities
Variable interest entities | 9 Months Ended |
Sep. 30, 2017 | |
Variable Interest Entities Disclosure [Abstract] | |
Variable interest entities | Variable interest entities The Company consolidates all VOEs in which it has a controlling financial interest and all VIEs in which it is considered to be the primary beneficiary. The Company’s VIEs are primarily entities in the AlphaCat segment. (a) Consolidated VIEs AlphaCat sidecars Beginning on May 25, 2011, the Company joined with other investors in capitalizing a series of sidecars for the purpose of investing in collateralized reinsurance and retrocessional contracts. Certain of these sidecars deployed their capital through transactions entered into by AlphaCat Reinsurance Ltd. (“AlphaCat Re”). Each of these entities return capital once the risk period expires and all losses have been paid out. The AlphaCat sidecars are VIEs and are consolidated by the Company as the primary beneficiary. The Company’s maximum exposure to any of the sidecars is the amount of capital invested at any given time. AlphaCat ILS funds The AlphaCat ILS funds received third party subscriptions beginning on December 17, 2012 . The Company and third party investors invest in the AlphaCat ILS funds for the purpose of investing in instruments with returns linked to property catastrophe reinsurance, retrocession and ILS contracts. The AlphaCat ILS funds have varying risk profiles and are categorized by the expected loss of the fund. Expected loss represents the average annual loss over the set of simulation scenarios divided by the total limit. Lower risk ILS funds are defined as having a maximum permitted portfolio expected loss of less than 7% , whereas higher risk ILS funds have a maximum permitted portfolio expected loss of greater than 7% . The AlphaCat ILS funds primarily deploy their capital through transactions entered into by AlphaCat Re and AlphaCat Master Fund Ltd. (“AlphaCat Master Fund”). All of the AlphaCat ILS funds are VIEs and were consolidated by the Company as the primary beneficiary through May 31, 2017. However, on June 1, 2017, the Company redeemed its investment in one of the lower risk AlphaCat ILS funds. As a result, the Company was no longer deemed to be the primary beneficiary and therefore this fund was deconsolidated effective June 1, 2017. The deconsolidation resulted in a loss of $402 which is included in the Consolidated Statements of Comprehensive Income as other insurance related income for the nine months ended September 30, 2017 . The Company’s maximum exposure to any of the funds is the amount of capital invested at any given time and any remaining capital commitments. Refer to Note 15 , “Commitments and contingencies,” for further details. AlphaCat Re and AlphaCat Master Fund The Company utilizes AlphaCat Re and AlphaCat Master Fund (collectively the “master funds”), both market facing entities, for the purpose of writing collateralized reinsurance and investing in capital markets products, respectively, on behalf of certain entities within the AlphaCat segment and direct third party investors. AlphaCat Re enters into transactions on behalf of the AlphaCat sidecars and ILS funds (collectively the “feeder funds”) and direct third party investors, whereas AlphaCat Master Fund only enters into transactions on behalf of certain AlphaCat ILS funds. All of the risks and rewards of the underlying transactions are allocated to the feeder funds and direct third party investors using variable funding notes. The master funds are VIEs and are consolidated by the Company as the primary beneficiary. Notes Payable to AlphaCat Investors The master funds issue variable funding notes to the feeder funds, and direct to third party investors, in order to write collateralized reinsurance and invest in capital markets products on their behalf. The Company’s investments in the feeder funds, together with investments made by third parties in the feeder funds and on a direct basis, are provided as consideration for the notes to the master funds. The duration of the underlying collateralized reinsurance contracts and capital market products is typically twelve months ; however, the variable funding notes do not have a stated maturity date or principal amount since repayment is dependent on the settlement and income or loss of the underlying transactions. Therefore, the notes are subsequently redeemed as the underlying transactions are settled. The income or loss generated by the underlying transactions is then transferred to the feeder funds and direct third party investors via the variable funding notes. Any notes issued by the master funds to the consolidated feeder funds are eliminated on consolidation and only variable funding notes issued by AlphaCat Re to direct third party investors and non-consolidated feeder funds remain on the Consolidated Balance Sheets as notes payable to AlphaCat investors with the related income or loss included in the Consolidated Statements of Income and Comprehensive Income as (income) attributable to AlphaCat investors. To the extent that the income has not been returned to the investors, it is included in accounts payable and accrued expenses in the Consolidated Balance Sheets. During 2017 and 2016, one of the AlphaCat ILS funds (the “Fund”) issued both common shares and structured notes to the Company and other third party investors in order to capitalize the fund. The Fund deploys its capital through AlphaCat Re; therefore, the structured notes do not have a stated maturity date or principal amount since repayment is dependent on the settlement and income or loss of the variable funding notes with AlphaCat Re. The structured notes rank senior to the common shares of the Fund and earn an interest rate of 7% (2016: 8% ) per annum, payable on a cumulative basis in arrears. As the Fund is consolidated by the Company, the structured notes issued to the Company are eliminated on consolidation and only the structured notes issued to third party investors remain on the Consolidated Balance Sheets as notes payable to AlphaCat investors with any related interest included in the Consolidated Statements of Income and Comprehensive Income as (income) attributable to AlphaCat investors. To the extent that the accrued interest on the structured notes has not been returned to the investors, it is included in accounts payable and accrued expenses in the Consolidated Balance Sheets. The following tables present a reconciliation of the beginning and ending notes payable to AlphaCat investors for the three and nine months ended September 30, 2017 and 2016 : Three Months Ended September 30, 2017 Variable Funding Notes Structured Notes Total Notes payable to AlphaCat investors, beginning of period $ 893,959 $ 172,200 $ 1,066,159 Issuance of notes payable to AlphaCat investors 59,530 — 59,530 Redemption of notes payable to AlphaCat investors (18,627 ) — (18,627 ) Foreign exchange losses 556 — 556 Notes payable to AlphaCat investors, end of period $ 935,418 $ 172,200 $ 1,107,618 Three Months Ended September 30, 2016 Variable Funding Notes Structured Notes Total Notes payable to AlphaCat investors, beginning of period $ 276,656 $ 94,326 $ 370,982 Issuance of notes payable to AlphaCat investors 13,808 — 13,808 Redemption of notes payable to AlphaCat investors (12,028 ) — (12,028 ) Foreign exchange gains (32 ) — (32 ) Notes payable to AlphaCat investors, end of period $ 278,404 $ 94,326 $ 372,730 Nine Months Ended September 30, 2017 Variable Funding Notes Structured Notes Total Notes payable to AlphaCat investors, beginning of period $ 278,202 $ — $ 278,202 Notes payable to AlphaCat investors recognized on deconsolidation of AlphaCat ILS fund 423,269 — 423,269 Issuance of notes payable to AlphaCat investors 601,407 172,200 773,607 Redemption of notes payable to AlphaCat investors (367,733 ) — (367,733 ) Foreign exchange losses 273 — 273 Notes payable to AlphaCat investors, end of period $ 935,418 $ 172,200 $ 1,107,618 Nine Months Ended September 30, 2016 Variable Funding Notes Structured Notes Total Notes payable to AlphaCat investors, beginning of period $ 75,493 $ — $ 75,493 Issuance of notes payable to AlphaCat investors 311,913 94,326 406,239 Redemption of notes payable to AlphaCat investors (109,712 ) — (109,712 ) Foreign exchange losses 710 — 710 Notes payable to AlphaCat investors, end of period $ 278,404 $ 94,326 $ 372,730 As at December 31, 2016 , $1,000 of the structured notes redeemed during the year were payable to AlphaCat investors and included in accounts payable and accrued expenses. The loss attributable to AlphaCat investors for the three and nine months ended September 30, 2017 was $74,130 and $54,797 ( 2016 : income of $5,564 and $16,278 ), with $9,737 included in accounts payable and accrued expenses as at September 30, 2017 (December 31, 2016 : $17,068 ). BetaCat ILS funds The BetaCat ILS funds invest exclusively in catastrophe bonds (principal-at-risk variable rate notes and other event-linked securities, being referred to collectively as “Cat Bonds”) focused on property and casualty risk and issued under Rule 144A of the Securities Act of 1933, as amended, following a passive buy-and-hold investment strategy. Two of the funds are VIEs, one of which is consolidated by the Company as the primary beneficiary. The remaining fund is a VOE and is consolidated by the Company as it owns all of the voting equity interests. The Company’s maximum exposure to any of the funds is the amount of capital invested at any given time. The following table presents the total assets and total liabilities of the Company’s consolidated VIEs, excluding intercompany eliminations, as at September 30, 2017 and December 31, 2016 : September 30, 2017 December 31, 2016 Total Assets Total Liabilities Total Assets Total Liabilities AlphaCat sidecars $ 30,598 $ 3,708 $ 40,041 $ 3,206 AlphaCat ILS funds - Lower Risk (a) 1,019,072 234,192 1,498,276 42,457 AlphaCat ILS funds - Higher Risk (a) 947,135 541,466 972,633 381,332 AlphaCat Re and AlphaCat Master Fund 3,427,625 3,427,455 2,510,415 2,510,245 BetaCat ILS funds 144,766 291 82,471 30,663 (a) Lower risk AlphaCat ILS funds have a maximum permitted portfolio expected loss of less than 7%, whereas higher risk AlphaCat ILS funds have a maximum permitted portfolio expected loss of greater than 7%. Expected loss represents the average annual loss over the set of simulation scenarios divided by the total limit. Assets of consolidated VIEs can only be used to settle obligations and liabilities of the consolidated VIEs and do not have recourse to the general credit of the Company. Investments held by these entities are presented separately in Note 4 , “ Investments ,” as non-managed investments. (b) Non-Consolidated VIEs The Company invests in private equity and other investment vehicles as part of the Company’s investment portfolio. The activities of these VIEs are generally limited to holding investments and the Company’s involvement in these entities is passive in nature. The Company’s maximum exposure to the VIEs is the amount of capital invested at any given time, and the Company does not have the power to direct the activities which most significantly impact the VIEs economic performance. The Company is therefore not the primary beneficiary of these VIEs. |
Noncontrolling interest
Noncontrolling interest | 9 Months Ended |
Sep. 30, 2017 | |
Noncontrolling Interest [Abstract] | |
Noncontrolling interest | Noncontrolling interests Investors in certain of the AlphaCat and BetaCat ILS funds have rights that enable them, subject to certain limitations, to redeem their shares. The third party equity is therefore recorded in the Company’s Consolidated Balance Sheets as redeemable noncontrolling interests. When and if a redemption notice is received, the fair value of the redemption is reclassified to a liability. The AlphaCat sidecars and one of the AlphaCat ILS funds have no shareholder redemption rights. Therefore, the third party equity is recorded in the Company’s Consolidated Balance Sheets as noncontrolling interests. The following tables present a reconciliation of the beginning and ending balances of redeemable noncontrolling interests and noncontrolling interests for the three and nine months ended September 30, 2017 and 2016 : Redeemable noncontrolling interests Noncontrolling interests Total Three Months Ended September 30, Three Months Ended September 30, Three Months Ended September 30, 2017 2016 2017 2016 2017 2016 Balance, beginning of period $ 1,251,660 $ 1,532,283 $ 415,658 $ 212,154 $ 1,667,318 $ 1,744,437 Issuance of shares 26,999 700 — — 26,999 700 (Loss) income attributable to noncontrolling interests (140,781 ) 26,597 (235,585 ) 10,842 (376,366 ) 37,439 Redemption of shares / distributions (3,998 ) — (101,126 ) — (105,124 ) — Balance, end of period $ 1,133,880 $ 1,559,580 $ 78,947 $ 222,996 $ 1,212,827 $ 1,782,576 Redeemable noncontrolling interests Noncontrolling interests Total Nine Months Ended September 30, Nine Months Ended September 30, Nine Months Ended September 30, 2017 2016 2017 2016 2017 2016 Balance, beginning of period $ 1,528,001 $ 1,111,714 $ 165,977 $ 154,662 $ 1,693,978 $ 1,266,376 Issuance of shares 237,199 381,950 258,300 171,674 495,499 553,624 Adjustment to noncontrolling interests as a result of deconsolidation (459,021 ) — — — (459,021 ) — (Loss) income attributable to noncontrolling interests (86,296 ) 72,400 (203,848 ) 23,763 (290,144 ) 96,163 Redemption of shares / distributions (86,003 ) (6,484 ) (141,482 ) (127,103 ) (227,485 ) (133,587 ) Balance, end of period $ 1,133,880 $ 1,559,580 $ 78,947 $ 222,996 $ 1,212,827 $ 1,782,576 As at September 30, 2017 , redemptions of $nil and distributions of $nil (December 31, 2016 : $71,530 and $16,144 ) were payable to redeemable noncontrolling interests and noncontrolling interests, respectively. These amounts are classified within accounts payable and accrued expenses on the Company’s Consolidated Balance Sheets. |
Derivative instruments
Derivative instruments | 9 Months Ended |
Sep. 30, 2017 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Derivative instruments | Derivative instruments The Company enters into derivative instruments for risk management purposes, specifically to hedge unmatched foreign currency exposures, interest rate exposures and to shorten the duration of the Company’s fixed maturities portfolio. (a) Derivatives not designated as hedging instruments The following table summarizes information on the classification and amount of the fair value of derivatives not designated as hedging instruments for accounting purposes within the Company’s Consolidated Balance Sheets as at September 30, 2017 and December 31, 2016 : September 30, 2017 December 31, 2016 Derivatives not designated as hedging instruments Notional Exposure Asset Derivative at Fair Value (a) Liability Derivative at Fair Value (a) Notional Exposure Asset Derivative at Fair Value (a) Liability Derivative at Fair Value (a) Foreign currency forward contracts $ 267,206 $ 1,522 $ 1,379 $ 181,375 $ 2,351 $ 3,421 Interest rate swap contracts $ 200,000 $ 440 $ 1,607 $ — $ — $ — (a) Asset and liability derivatives are classified within other assets and accounts payable and accrued expenses, respectively, within the Company’s consolidated balance sheets. The following table summarizes information on the classification and net impact on earnings, recognized in the Company’s Consolidated Statements of Income and Comprehensive Income relating to the foreign currency forward and interest rate swap contracts that were not designated as hedging instruments for accounting purposes during the three and nine months ended September 30, 2017 and 2016 : Derivatives not designated as hedging instruments Classification of (losses) gains recognized in earnings Three Months Ended September 30, Nine Months Ended September 30, 2017 2016 2017 2016 Foreign currency forward contracts Foreign exchange (losses) gains $ (1,927 ) $ 1,326 $ (7,999 ) $ 209 Foreign currency forward contracts Other loss $ — $ (155 ) $ (979 ) $ (35 ) Interest rate swap contracts Change in unrealized (losses) gains on investments $ (848 ) $ 566 $ (1,167 ) $ 566 (b) Derivatives designated as hedging instruments The following table summarizes information on the classification and amount of the fair value of derivatives designated as hedging instruments for accounting purposes on the Consolidated Balance Sheets as at September 30, 2017 and December 31, 2016 : September 30, 2017 December 31, 2016 Derivatives designated as hedging instruments Notional Exposure Asset Derivative at Fair Value (a) Liability Derivative at Fair Value (a) Notional Exposure Asset Derivative at Fair Value (a) Liability Derivative at Fair Value (a) Interest rate swap contracts $ 552,263 $ 20 $ 1,347 $ 552,263 $ 20 $ 1,479 (a) Asset and liability derivatives are classified within other assets and accounts payable and accrued expenses, respectively, within the Company’s consolidated balance sheets. Derivative instruments designated as a cash flow hedge The Company designates its interest rate derivative instruments as cash flow hedges for accounting purposes and formally and contemporaneously documents all relationships between the hedging instruments and hedged items and links the derivative instruments to specific assets and liabilities. The Company assesses the effectiveness of the hedges, both at inception and on an on-going basis and determines whether the hedges are highly effective in offsetting changes in fair value of the linked hedged items. The Company currently applies the long haul method when assessing the hedge’s effectiveness. The following table provides the total impact on other comprehensive income (loss) and earnings relating to the derivative instruments formally designated as cash flow hedges along with the impact of the related hedged items for the three and nine months ended September 30, 2017 and 2016 : Three Months Ended September 30, Nine Months Ended September 30, Interest rate swap contracts 2017 2016 2017 2016 Amount of effective portion recognized in other comprehensive income $ 1,918 $ 3,155 $ 6,294 $ 9,505 Amount of effective portion subsequently reclassified to earnings $ (1,931 ) $ (2,717 ) $ (6,261 ) $ (8,373 ) Amount of ineffective portion excluded from effectiveness testing $ 13 $ (438 ) $ (33 ) $ (1,132 ) The above balances relate to interest payments and have therefore been classified as finance expenses in the Consolidated Statements of Income and Comprehensive Income. (c) Classification within the fair value hierarchy As described in Note 5 , “ Fair value measurements ,” under U.S. GAAP, a company must determine the appropriate level in the fair value hierarchy for each fair value measurement. The assumptions used within the valuation of the Company’s derivative instruments are observable in the marketplace, can be derived from observable data or are supported by observable levels at which other similar transactions are executed in the marketplace. Accordingly, these derivatives were classified within Level 2 of the fair value hierarchy. (d) Balance sheet offsetting There was no balance sheet offsetting activity as at September 30, 2017 or December 31, 2016 . The Company currently provides cash collateral as security for interest rate swap contracts. The Company does not provide cash collateral or financial instruments as security for foreign currency forward contracts. Our derivative instruments are generally traded under International Swaps and Derivatives Association master netting agreements, which establish terms that apply to all transactions. On a periodic basis, the amounts receivable from or payable to the counterparties are settled in cash. The Company has not elected to settle multiple transactions with an individual counterparty on a net basis. |
Reserve for losses and loss exp
Reserve for losses and loss expenses | 9 Months Ended |
Sep. 30, 2017 | |
Liability for Future Policy Benefits and Unpaid Claims and Claims Adjustment Expense [Abstract] | |
Reserve for losses and loss expenses | Reserve for losses and loss expenses Reserves for losses and loss expenses are based in part upon the estimation of case reserves from broker, insured and ceding company reported data. The Company also uses statistical and actuarial methods to estimate ultimate expected losses and loss expenses, from which incurred but not reported losses (“IBNR”) can be calculated. The period of time from the occurrence of a loss to the reporting of a loss to the Company and to the settlement of the Company’s liability may be several months or years. During this period, additional facts and trends may be revealed. As these factors become apparent, reserves will be adjusted, sometimes requiring an increase or decrease in the overall reserves of the Company, and at other times requiring a reallocation of incurred but not reported reserves to specific case reserves. These estimates are reviewed and adjusted regularly, and such adjustments, if any, are reflected in earnings in the period in which they become known. While management believes that it has made a reasonable estimate of ultimate losses, there can be no assurances that ultimate losses and loss expenses will not exceed this estimate. The following table summarizes the total reserve for losses and loss expenses as at September 30, 2017 and December 31, 2016 : September 30, 2017 December 31, 2016 Case reserves $ 1,271,580 $ 1,237,772 IBNR 3,664,057 1,757,423 Total reserve for losses and loss expenses $ 4,935,637 $ 2,995,195 The following table represents an analysis of paid and unpaid losses and loss expenses incurred and a reconciliation of the beginning and ending unpaid losses and loss expenses for the three and nine months ended September 30, 2017 and 2016 : Three Months Ended September 30, Nine Months Ended September 30, 2017 2016 2017 2016 Reserve for losses and loss expenses, beginning of period $ 3,305,191 $ 3,122,717 $ 2,995,195 $ 2,996,567 Loss reserves recoverable (600,207 ) (442,987 ) (430,421 ) (350,586 ) Net reserves for losses and loss expenses, beginning of period 2,704,984 2,679,730 2,564,774 2,645,981 Net reserves acquired (a) — — 23,753 — Increase (decrease) in net reserves for losses and loss expenses in respect of losses occurring in: Current year 1,329,666 311,279 1,999,921 959,376 Prior years (75,064 ) (52,885 ) (179,585 ) (169,405 ) Total net incurred losses and loss expenses 1,254,602 258,394 1,820,336 789,971 Less net losses and loss expenses paid in respect of losses occurring in: Current year (191,612 ) (178,707 ) (242,068 ) (240,362 ) Prior years (181,094 ) (166,539 ) (612,448 ) (596,618 ) Total net paid losses (372,706 ) (345,246 ) (854,516 ) (836,980 ) Foreign exchange losses (gains) 13,741 (1,500 ) 46,274 (7,594 ) Net reserve for losses and loss expenses, end of period 3,600,621 2,591,378 3,600,621 2,591,378 Loss reserves recoverable 1,335,016 444,609 1,335,016 444,609 Reserve for losses and loss expenses, end of period $ 4,935,637 $ 3,035,987 $ 4,935,637 $ 3,035,987 (a) Equals net reserves acquired of $42,575 less net reserves commuted at closing of $18,822 . Incurred losses and loss expenses comprise: Three Months Ended September 30, Nine Months Ended September 30, 2017 2016 2017 2016 Gross losses and loss expenses $ 2,104,914 $ 284,413 $ 2,866,722 $ 952,129 Reinsurance recoverable (850,312 ) (26,019 ) (1,046,386 ) (162,158 ) Net incurred losses and loss expenses $ 1,254,602 $ 258,394 $ 1,820,336 $ 789,971 The net favorable development on prior years by segment and line of business for the three and nine months ended September 30, 2017 and 2016 was as follows: Three Months Ended September 30, 2017 Property Marine Specialty Liability Total Validus Re $ (26,372 ) $ (7,105 ) $ (14,660 ) $ — $ (48,137 ) Talbot (8,752 ) (2,737 ) (12,125 ) — (23,614 ) Western World 464 — — (526 ) (62 ) AlphaCat (1,471 ) — (1,780 ) — (3,251 ) Net favorable development $ (36,131 ) $ (9,842 ) $ (28,565 ) $ (526 ) $ (75,064 ) The net favorable loss reserve development on prior accident years of $75.1 million during the three months ended September 30, 2017 included favorable development on loss events and attritional losses of $16.1 million and $58.9 million , respectively. Three Months Ended September 30, 2016 Property Marine Specialty Liability Total Validus Re $ (19,736 ) $ (8,504 ) $ (4,793 ) $ — $ (33,033 ) Talbot (2,429 ) (4,547 ) (11,715 ) — (18,691 ) Western World (553 ) — — (327 ) (880 ) AlphaCat (265 ) — (16 ) — (281 ) Net favorable development $ (22,983 ) $ (13,051 ) $ (16,524 ) $ (327 ) $ (52,885 ) The net favorable loss reserve development on prior accident years of $52.9 million during the three months ended September 30, 2016 included favorable development on loss events and attritional losses of $20.3 million and $32.6 million , respectively. Nine Months Ended September 30, 2017 Property Marine Specialty Liability Total Validus Re $ (30,614 ) $ (38,847 ) $ (30,555 ) $ — $ (100,016 ) Talbot (19,980 ) (35,789 ) (12,535 ) — (68,304 ) Western World (2,838 ) — — 2,094 (744 ) AlphaCat (8,963 ) — (1,558 ) — (10,521 ) Net (favorable) adverse development $ (62,395 ) $ (74,636 ) $ (44,648 ) $ 2,094 $ (179,585 ) The net favorable loss reserve development on prior accident years of $179.6 million during the nine months ended September 30, 2017 included favorable development on loss events and attritional losses of $31.5 million and $148.0 million , respectively. Nine Months Ended September 30, 2016 Property Marine Specialty Liability Total Validus Re $ (52,036 ) $ (14,967 ) $ (22,591 ) $ — $ (89,594 ) Talbot (30,969 ) (10,511 ) (28,259 ) — (69,739 ) Western World (2,576 ) — — (5,888 ) (8,464 ) AlphaCat (742 ) — (866 ) — (1,608 ) Net favorable development $ (86,323 ) $ (25,478 ) $ (51,716 ) $ (5,888 ) $ (169,405 ) The net favorable development on prior accident years of $169.4 million during the nine months ended September 30, 2016 included favorable development on loss events and attritional losses of $9.0 million and $160.4 million , respectively. |
Reinsurance
Reinsurance | 9 Months Ended |
Sep. 30, 2017 | |
Reinsurance Disclosures [Abstract] | |
Reinsurance | Reinsurance The Company’s reinsurance balances recoverable at September 30, 2017 and December 31, 2016 were as follows: September 30, 2017 December 31, 2016 Loss reserves recoverable on unpaid: Case reserves $ 207,368 $ 165,328 IBNR 1,127,648 265,093 Total loss reserves recoverable 1,335,016 430,421 Paid losses recoverable 77,730 35,247 Total reinsurance balances recoverable $ 1,412,746 $ 465,668 The Company enters into reinsurance and retrocession agreements in order to mitigate its accumulation of loss, reduce its liability on individual risks, enable it to underwrite policies with higher limits and increase its aggregate capacity. The cession of insurance and reinsurance does not legally discharge the Company from its primary liability for the full amount of the policies, and the Company is required to pay the loss and bear collection risk if the reinsurer fails to meet its obligations under the reinsurance or retrocession agreement. Amounts recoverable from reinsurers are estimated in a manner consistent with the underlying liabilities. Credit risk The Company evaluates the financial condition of its reinsurers and monitors concentration of credit risk arising from its exposure to individual reinsurers. The reinsurance program is generally placed with reinsurers whose rating, at the time of placement, was A- or better as rated by Standard & Poor’s or the equivalent with other rating agencies. Exposure to a single reinsurer is also controlled with restrictions dependent on rating. As at September 30, 2017 , $1,400,430 or 99.1% ( December 31, 2016 : $461,369 or 99.1% ) of the Company’s reinsurance balances recoverable were either fully collateralized or recoverable from reinsurers rated A- or better. Reinsurance balances recoverable by reinsurer as at September 30, 2017 and December 31, 2016 were as follows: September 30, 2017 December 31, 2016 Reinsurance Recoverable % of Total Reinsurance Recoverable % of Total Top 10 reinsurers $ 1,208,003 85.5 % $ 395,308 84.9 % Other reinsurers’ balances > $1 million 198,774 14.1 % 66,944 14.4 % Other reinsurers’ balances < $1 million 5,969 0.4 % 3,416 0.7 % Total $ 1,412,746 100.0 % $ 465,668 100.0 % The following tables show the reinsurance balances recoverable due from, and the ratings associated with, the Company’s top ten reinsurers as at September 30, 2017 and December 31, 2016 : September 30, 2017 Top 10 Reinsurers Rating Reinsurance Recoverable % of Total Fully collateralized reinsurers NR $ 564,714 40.0 % Munich Re AA- 164,131 11.6 % Everest Re A+ 95,759 6.8 % Lloyd's Syndicates A+ 94,845 6.7 % Swiss Re AA- 81,921 5.8 % Hannover Re AA- 62,715 4.4 % Federal Crop Insurance Corporation (a) 49,503 3.5 % Qatar Insurance Company A 38,061 2.7 % Transatlantic Re A+ 29,795 2.1 % XL Catlin A+ 26,559 1.9 % Total $ 1,208,003 85.5 % (a) The Company participates in a crop reinsurance program sponsored by the U.S. federal government. The Company remains obligated for amounts ceded in the event that its reinsurers or retrocessionaires do not meet their obligations, except for amounts ceded to the U.S. federal government in the agriculture line of business. December 31, 2016 Top 10 Reinsurers Rating Reinsurance Recoverable % of Total Lloyd's Syndicates A+ $ 84,419 18.2 % Swiss Re AA- 84,044 18.1 % Fully collateralized reinsurers NR 83,088 17.8 % Hannover Re AA- 50,603 10.9 % Everest Re A+ 36,912 7.9 % Munich Re AA- 18,214 3.9 % Transatlantic Re A+ 10,593 2.3 % Hamilton Re A- 10,343 2.2 % Toa Re A+ 9,510 2.0 % National Indemnity Company AA+ 7,582 1.6 % Total $ 395,308 84.9 % At September 30, 2017 and December 31, 2016 , the provision for uncollectible reinsurance relating to reinsurance balances recoverable was $8,326 and $5,153 , respectively. To estimate this provision for uncollectible reinsurance, reinsurance balances recoverable are first allocated to applicable reinsurers. This determination is based on a process rather than an estimate, although an element of judgment is applied, especially in relation to ceded IBNR. The Company then uses default factors to determine the portion of a reinsurer’s balance deemed to be uncollectible. Default factors require considerable judgment and are determined in part using the current rating, or rating equivalent, of each reinsurer as well as other key considerations and assumptions. |
Share capital
Share capital | 9 Months Ended |
Sep. 30, 2017 | |
Stockholders' Equity Note [Abstract] | |
Share capital | Share capital The Company is authorized to issue up to an aggregate of 571,428,571 common and preferred shares with a par value of $0.175 per share. (a) Preferred shares On June 12, 2017, the Company issued 10,000 shares of its 5.800% Non-Cumulative Preferred Shares, Series B (the “Series B Preferred Shares”) (equivalent to 10,000,000 Depositary Shares, each of which represents a 1/1,000th interest in a Series B Preferred Share), $0.175 par value and $25,000 liquidation preference per share (equivalent to $25 per Depositary Share). The Series B Preferred Shares were registered and sold under the Securities Act of 1933, as amended, and were issued at a price to the public of $25,000 per share (equivalent to $25 per Depositary Share). After underwriting discounts and expenses, the Company received net proceeds of $241,686 which was used for general corporate purposes. The Depositary Shares, representing the Series B Preferred Shares, are traded on the New York Stock Exchange (“NYSE”) under the symbol “VRPRB.” The Series B Preferred Shares have no stated maturity date and are redeemable, in whole or in part, at the Company’s option on and after June 21, 2022, at a redemption price of $25,000 per Series B Preferred Share (equivalent to $25 per Depository Share), plus declared and unpaid dividends. The Company may also redeem all, but not less than all, of the Series B Preferred Shares before the redemption date at a redemption price of $26,000 per share (equivalent to $26 per Depository Share), plus declared and unpaid dividends, if the Company is required to submit a proposal to the holders of the Series B Preferred Shares concerning an amalgamation, consolidation, merger or other similar corporate transaction or change in Bermuda law. The Series B Preferred Shares may also be redeemed before the redemption date at a redemption price of $25,000 per Series B Preferred Share (equivalent to $25 per Depository Share), plus declared and unpaid dividends, in whole, if there is a certain change in tax law, or in whole or in part, in the case of a capital disqualification event. However, no redemption may occur prior to June 21, 2027 unless the Company has sufficient funds in order to meet the Bermuda Monetary Authority’s (“the BMA”) Enhanced Capital Requirements (“ECR”) and the BMA approves of the redemption, or the Company replaces the capital represented by the Series B Preferred Shares with capital having equal or better capital treatment as the Series B Preferred Shares under the ECR. Dividends on the Series B Preferred Shares, when, as and if declared by the Company’s Board of Directors or a duly authorized committee thereof, will accrue and be payable on the liquidation preference amount from the original issue date, on a non-cumulative basis, quarterly in arrears on each dividend payment date at an annual rate of 5.800% . The Company will be restricted from paying dividends on and repurchasing its common shares, unless certain dividend payments are made on the Series B Preferred Shares. Upon any voluntary or involuntary liquidation, dissolution or winding up of the Company, holders of the Series B Preferred Shares and any parity shares are entitled to receive out of our assets available for distribution to shareholders, before any distribution is made to holders of common shares or other junior shares, a liquidating distribution in the amount of $25,000 per Series B Preferred Share (equivalent to $25 per Depositary Share) plus declared and unpaid dividends. Distributions will be made pro rata in accordance with the respective aggregate liquidation preferences of the Series B Preferred Shares and any parity shares and only to the extent of our assets, if any, that are available after satisfaction of all liabilities to creditors. Holders of the Series B Preferred Shares have no voting rights, except with respect to certain fundamental changes in the terms of the Series B Preferred Shares and in the case of certain dividend non-payments or as otherwise required by Bermuda law or the Company’s bye-laws. On June 13, 2016, the Company issued 6,000 shares of its 5.875% Non-Cumulative Preferred Shares, Series A (the “Series A Preferred Shares”) (equivalent to 6,000,000 Depositary Shares, each of which represents a 1/1,000th interest in a Series A Preferred Share), $0.175 par value and $25,000 liquidation preference per share (equivalent to $25 per Depositary Share). Holders of the Series A Preferred Shares have no voting rights, except with respect to certain fundamental changes in the terms of the Series A Preferred Shares and in the case of certain dividend non-payments or as otherwise required by Bermuda law or the Company’s bye-laws. The following table is a summary of the preferred share activity during the nine months ended September 30, 2017 and 2016 : Nine Months Ended September 30, 2017 2016 Preferred shares issued and outstanding, beginning of period 6,000 — Preferred shares issued 10,000 6,000 Preferred shares issued and outstanding, end of period 16,000 6,000 The Company had 6,000 Series A Preferred Shares and 10,000 Series B Preferred Shares issued and outstanding as at September 30, 2017 and 6,000 Series A Preferred Shares issued and outstanding as at December 31, 2016. (b) Common Shares The holders of common shares are entitled to receive dividends and are allocated one vote per share , provided that, if the controlled shares of any shareholder or group of related shareholders constitute more than 9.09 percent of the outstanding common shares of the Company, their voting power will be reduced to 9.09 percent. The Company may from time to time repurchase its securities, including common shares, Junior Subordinated Deferrable Debentures and Senior Notes. On February 3, 2015, the Board of Directors of the Company approved an increase in the Company’s common share repurchase authorization to $750,000 . This amount is in addition to the $2,274,401 of common shares repurchased by the Company through February 3, 2015 under its previously authorized share repurchase programs. The Company has repurchased 80,860,661 common shares for an aggregate purchase price of $2,722,749 from the inception of its share repurchase program to September 30, 2017 . The Company had $301,652 remaining under its authorized share repurchase program as of September 30, 2017 . The Company expects the purchases under its share repurchase program to be made from time to time in the open market or in privately negotiated transactions. The timing, form and amount of the share repurchases under the program will depend on a variety of factors, including market conditions, the Company’s capital position relative to internal and rating agency targets, legal requirements and other factors. The repurchase program may be modified, extended or terminated by the Board of Directors at any time. The following table is a summary of the common share activity during the nine months ended September 30, 2017 and 2016 : Nine Months Ended September 30, 2017 2016 Common shares issued, beginning of period 161,279,976 160,570,772 Restricted share awards vested, net of shares withheld 619,046 608,024 Restricted share units vested, net of shares withheld 15,454 18,486 Options exercised — 27,983 Performance share awards vested, net of shares withheld 42,410 48,088 Common shares issued, end of period 161,956,886 161,273,353 Treasury shares, end of period (82,499,633 ) (81,830,323 ) Common shares outstanding, end of period 79,457,253 79,443,030 (c) Dividends On August 9, 2017 , the Company announced a quarterly cash dividend of $0.38 ( 2016 : $0.35 ) per common share and cash dividends of $0.3671875 ( 2016 : $0.3753472 ) and $0.3423611 per depositary share on its outstanding Series A and Series B Preferred Shares, respectively. The common share dividend was paid on September 29, 2017 to holders of record on September 15, 2017 . The preferred share dividends were paid on September 15, 2017 to shareholders of record on September 1, 2017. On May 10, 2017, the Company announced a quarterly cash dividend of $0.38 (2016: $0.35 ) per common share and a cash dividend of $0.3671875 per depositary share on its outstanding Series A Preferred Shares. The common share dividend was paid on June 30, 2017 to holders of record on June 15, 2017. The preferred share dividend was paid on June 15, 2017 to holders of record on June 1, 2017. On February 9, 2017, the Company announced a quarterly cash dividend of $0.38 (2016: $0.35 ) per common share and a cash dividend of $0.3671875 per depositary share on its outstanding Series A Preferred Shares. The common share dividend was paid on March 31, 2017 to holders of record on March 15, 2017. The preferred share dividend was paid on March 15, 2017 to holders of record on March 1, 2017. |
Stock plans
Stock plans | 9 Months Ended |
Sep. 30, 2017 | |
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |
Stock plans | Stock plans (a) Long Term Incentive Plan The Company’s Amended and Restated 2005 Long Term Incentive Plan (“LTIP”) provides for grants to employees of options, stock appreciation rights (“SARs”), restricted shares, restricted share units, performance shares, dividend equivalents or other share-based awards. The total number of shares reserved for issuance under the LTIP are 2,753,292 shares of which 701,617 shares remain available for issuance at September 30, 2017 . The LTIP is administered by the Compensation Committee of the Board of Directors. No SARs have been granted to date. Grant prices are established at the fair market value of the Company’s common shares at the date of grant. i. Options Options may be exercised for voting common shares upon vesting. Outstanding options have a life of 10 years and vest either pro rata or at the end of the required service period from the date of grant. Fair value of the option awards at the date of grant is determined using the Black-Scholes option-pricing model. Expected volatility is based on stock price volatility of comparable publicly-traded companies. The Company used the simplified method consistent with U.S. GAAP authoritative guidance on stock compensation expenses to estimate expected lives for options granted during the period as historical exercise data was not available and the options met the requirement as set out in the guidance. The Company has not granted any stock option awards since September 4, 2009. These stock option awards were fully amortized during the year ended December 31, 2012. Activity with respect to options for the nine months ended September 30, 2017 and 2016 was as follows: Nine Months Ended September 30, 2017 2016 Options Weighted Average Grant Date Fair Value Weighted Average Grant Date Exercise Price Options Weighted Average Grant Date Fair Value Weighted Average Grant Date Exercise Price Options outstanding, beginning of period 26,136 $ 6.78 $ 23.48 65,401 $ 7.74 $ 20.17 Options exercised — — — (35,351 ) 8.16 17.82 Options outstanding, end of period 26,136 $ 6.78 $ 23.48 30,050 $ 7.24 $ 22.93 ii. Restricted share awards Restricted shares granted under the LTIP vest either pro rata or at the end of the required service period and contain certain restrictions during the vesting period, relating to, among other things, forfeiture in the event of termination of employment and transferability. The Company recognized share compensation expenses in respect of restricted share awards during the three and nine months ended September 30, 2017 of $7,814 ( 2016 : $9,159 ) and $26,603 ( 2016 : $27,805 ), respectively. The expenses represent the proportionate accrual of the fair value of each grant based on the remaining vesting period. Activity with respect to unvested restricted share awards for the nine months ended September 30, 2017 and 2016 was as follows: Nine Months Ended September 30, 2017 2016 Restricted Share Awards Weighted Average Grant Date Fair Value Restricted Share Awards Weighted Average Grant Date Fair Value Restricted share awards outstanding, beginning of period 2,469,982 $ 40.89 2,739,446 $ 38.25 Restricted share awards granted 508,186 53.25 559,516 48.78 Restricted share awards vested (828,800 ) 41.25 (789,547 ) 37.36 Restricted share awards forfeited (53,775 ) 43.38 (33,070 ) 40.25 Restricted share awards outstanding, end of period 2,095,593 $ 43.69 2,476,345 $ 40.88 At September 30, 2017 , there were $57,065 ( December 31, 2016 : $58,804 ) of total unrecognized share compensation expenses in respect of restricted share awards that are expected to be recognized over a weighted-average period of 2.4 years ( December 31, 2016 : 2.3 years ). iii. Restricted share units Restricted share units under the LTIP vest either ratably or at the end of the required service period and contain certain restrictions during the vesting period, relating to, among other things, forfeiture in the event of termination of employment and transferability. The Company recognized share compensation expenses in respect of restricted share units during the three and nine months ended September 30, 2017 of $340 ( 2016 : $290 ) and $982 ( 2016 : $978 ), respectively. The expenses represent the proportionate accrual of the fair value of each grant based on the remaining vesting period. Activity with respect to unvested restricted share units for the nine months ended September 30, 2017 and 2016 was as follows: Nine Months Ended September 30, 2017 2016 Restricted Share Units Weighted Average Grant Date Fair Value Restricted Share Units Weighted Average Grant Date Fair Value Restricted share units outstanding, beginning of period 112,808 $ 40.95 114,337 $ 38.47 Restricted share units granted 12,236 53.40 21,609 48.83 Restricted share units vested (18,748 ) 41.91 (23,982 ) 38.18 Restricted share units issued in lieu of cash dividends 2,260 41.42 2,436 39.10 Restricted share units forfeited — — (8,338 ) 44.34 Restricted share units outstanding, end of period 108,556 $ 42.20 106,062 $ 40.20 At September 30, 2017 , there were $2,233 ( December 31, 2016 : $2,542 ) of total unrecognized share compensation expenses in respect of restricted share units that are expected to be recognized over a weighted-average period of 2.5 years ( December 31, 2016 : 2.6 years ). iv. Performance share awards The performance share awards contain a performance based component. The performance component relates to the compounded growth in the Dividend Adjusted Diluted Book Value per Share (“DBVPS”) over a three -year period relative to the Company’s peer group. For performance share awards granted during the period, the grant date DBVPS is based on the DBVPS at the end of the most recent financial reporting year. The Dividend Adjusted Performance Period End DBVPS will be the DBVPS three years after the grant date DBVPS. The fair value estimate earns over the requisite attribution period and the estimate will be reassessed at the end of each performance period which will reflect any adjustments in the Consolidated Statements of Income and Comprehensive Income in the period in which they are determined. The Company recognized share compensation expenses in respect of performance share awards during the three and nine months ended September 30, 2017 of $1,289 ( 2016 : $1,052 ) and $2,495 ( 2016 : $3,682 ), respectively. Activity with respect to unvested performance share awards for the nine months ended September 30, 2017 and 2016 was as follows: Nine Months Ended September 30, 2017 2016 Performance Share Awards Weighted Average Grant Date Fair Value Performance Share Awards Weighted Average Grant Date Fair Value Performance share awards outstanding, beginning of period 285,820 $ 44.53 172,594 $ 40.70 Performance share awards granted 107,209 53.40 125,290 48.75 Performance share awards vested (52,639 ) 37.33 (57,581 ) 36.11 Performance share awards conversion adjustment (26,322 ) 36.82 45,517 36.82 Performance share awards outstanding, end of period 314,068 $ 49.37 285,820 $ 44.53 At September 30, 2017 , there were $9,031 ( December 31, 2016 : $6,902 ) of total unrecognized share compensation expenses in respect of performance share awards that are expected to be recognized over a weighted-average period of 2.1 years ( December 31, 2016 : 2.1 years ). (b) Total share compensation expenses The breakdown of share compensation expenses by award type for the periods indicated was as follows: Three Months Ended September 30, Nine Months Ended September 30, 2017 2016 2017 2016 Restricted share awards $ 7,814 $ 9,159 $ 26,603 $ 27,805 Restricted share units 340 290 982 978 Performance share awards 1,289 1,052 2,495 3,682 Total $ 9,443 $ 10,501 $ 30,080 $ 32,465 |
Debt and financing arrangements
Debt and financing arrangements | 9 Months Ended |
Sep. 30, 2017 | |
Debt Disclosure [Abstract] | |
Debt and financing arrangements | Debt and financing arrangements The Company’s financing structure is comprised of debentures and senior notes payable along with credit and other facilities. (a) Senior notes and junior subordinated deferrable debentures The Company’s outstanding debentures and senior notes payable as at September 30, 2017 and December 31, 2016 were as follows: September 30, 2017 December 31, 2016 Deferrable debentures 2006 Junior Subordinated $ 150,000 $ 150,000 2007 Junior Subordinated 139,800 139,800 Flagstone 2006 Junior Subordinated 135,360 133,676 Flagstone 2007 Junior Subordinated 113,750 113,750 Total debentures payable 538,910 537,226 2010 Senior notes payable 250,000 250,000 Less: Unamortized debt issuance costs (4,487 ) (4,638 ) Total senior notes payable 245,513 245,362 Total debentures and senior notes payable $ 784,423 $ 782,588 The following table summarizes the key terms of the Company’s senior notes and junior subordinated deferrable debentures: Description Issuance date Issued Maturity date Interest Rate as at Interest payments due Issuance Date September 30, 2017 2006 Junior Subordinated Deferrable Debentures June 15, 2006 $ 150,000 June 15, 2036 9.069 % (a) 5.831 % (e) Quarterly Flagstone 2006 Junior Subordinated Deferrable Debentures August 23, 2006 $ 135,360 September 15, 2036 3.540 % (b) 6.463 % (e) Quarterly 2007 Junior Subordinated Deferrable Debentures June 21, 2007 $ 200,000 June 15, 2037 8.480 % (c) 5.180 % (e) Quarterly Flagstone 2007 Junior Subordinated Deferrable Debentures June 8, 2007 $ 100,000 July 30, 2037 3.000 % (b) 5.900 % (e) Quarterly Flagstone 2007 Junior Subordinated Deferrable Debentures September 20, 2007 $ 25,000 September 15, 2037 3.100 % (b) 5.983 % (e) Quarterly 2010 Senior Notes due 2040 January 26, 2010 $ 250,000 January 26, 2040 8.875 % (d) 8.875 % (d) Semi-annually in arrears (a) Fixed interest rate for 5 years , floating interest rate of three-month LIBOR plus 3.550% thereafter, reset quarterly. (b) Floating interest rate of three-month LIBOR plus amount stated, reset quarterly. (c) Fixed interest rate for 5 years , floating interest rate of three-month LIBOR plus 2.950% thereafter, reset quarterly. (d) Fixed interest rate. (e) Fixed interest rate as a result of interest rate swap contracts entered into by the Company. Future payments of principal of $250,000 and $538,910 on the 2010 Senior Notes and the debentures, respectively, are expected to be made after 2022. (b) Credit and other facilities The Company’s outstanding credit facilities as at September 30, 2017 and December 31, 2016 were as follows: September 30, 2017 Commitment Outstanding (a) Drawn (b) Cash and investments pledged as collateral Credit facilities $85,000 syndicated unsecured letter of credit facility $ 85,000 $ — $ — $ — $300,000 syndicated secured letter of credit facility 300,000 89,449 — 108,265 $24,000 secured bi-lateral letter of credit facility 24,000 5,767 — 22,342 $25,000 IPC bi-lateral facility 25,000 7,755 — — $236,000 Flagstone bi-lateral facility 236,000 90,390 — 134,482 $65,000 unsecured revolving credit facility 65,000 65,000 65,000 — $100,000 unsecured revolving credit facility 100,000 100,000 100,000 — Total credit facilities $ 835,000 $ 358,361 $ 165,000 $ 265,089 (a) Indicates utilization of commitment amount, not drawn borrowings. (b) Represents drawn borrowings included in accounts payable and accrued expenses. December 31, 2016 Commitment Outstanding (a) Drawn (b) Cash and investments pledged as collateral Credit facilities $85,000 syndicated unsecured letter of credit facility $ 85,000 $ — $ — $ — $300,000 syndicated secured letter of credit facility 300,000 121,428 — 157,597 $24,000 secured bi-lateral letter of credit facility 24,000 4,553 — 48,097 $20,000 AlphaCat Re secured letter of credit facility (c) 20,000 20,000 — 20,032 $25,000 IPC bi-lateral facility 25,000 8,807 — — $236,000 Flagstone bi-lateral facility 236,000 156,375 — 216,458 Total credit facilities $ 690,000 $ 311,163 $ — $ 442,184 (a) Indicates utilization of commitment amount, not drawn borrowings. (b) Represents drawn borrowings. (c) The Company terminated its AlphaCat Re secured letter of credit facility on January 6, 2017. On August 7, 2017, the Company and Validus Reinsurance, Ltd. entered into a $65,000 unsecured revolving credit facility with Barclays Bank PLC, as the lender (the “Barclays Unsecured Revolving Facility”) expiring August 6, 2018. Loans under the Barclays Unsecured Revolving Facility will be available for the general corporate and working capital purposes of the Company. Borrowings under the Barclays Unsecured Revolving Facility bear interest at the base rate (the higher of (i) the prime rate quoted in the Wall Street Journal, (ii) the federal reserve bank effective rate plus 0.50% , and (iii) the adjusted LIBOR rate plus 1.0% ) or the adjusted LIBOR rate applicable to such loans, plus an applicable rate. Also on August 7, 2017, the Company and Validus Reinsurance, Ltd. entered into a $100,000 unsecured revolving credit facility with HSBC Bank USA, National Association, as the lender (the “HSBC Unsecured Revolving Facility” and together with the Barclays Unsecured Revolving Facility, the “Credit Facilities”) expiring December 31, 2019. Loans under the HSBC Unsecured Revolving Facility will be available for the general corporate and working capital purposes of the Company. Borrowings under the HSBC Unsecured Revolving Facility bear interest at the base rate (the higher of (i) the prime rate announced by HSBC Bank USA, National Association, (ii) the higher of the federal reserve bank effective rate the overnight bank funding rate plus 0.50% , or (iii) the adjusted LIBOR rate plus 1.0% ). The Credit Facilities contain covenants that include, among other things (i) the requirement that the Company initially maintain a minimum level of consolidated net worth of at least $2,789,131 and, commencing with the end of the fiscal quarter ending September 30, 2017, to be increased quarterly by an amount equal to 25% of the Company’s consolidated net income (if positive) for such quarter plus 50% of the aggregate increases in the consolidated shareholders’ equity of the Company during such fiscal quarter by reason of the issuance and sale of common equity interests of the Company, including upon any conversion of debt securities of the Company into such equity interests, (ii) the requirement that the Company maintain at all times a consolidated total debt to consolidated total capital ratio not greater than 0.35:1.00 , and (iii) the requirement that Validus Reinsurance, Ltd. and any certain other material insurance subsidiaries maintain a financial strength rating by A.M. Best of not less than “B++” (Fair). In addition, the Credit Facilities contain customary negative covenants applicable to the Company and its subsidiaries, including limitations on the ability to pay dividends and other payments in respect of equity interests at any time that the Company is otherwise in default with respect to certain provisions under the respective Credit Facilities, limitations on the ability to incur liens, sell assets, merge or consolidate with others, enter into transactions with affiliates, and limitations on the ability of its subsidiaries to incur indebtedness. The Credit Facilities also contain customary affirmative covenants, representations and warranties and events of default for credit facilities of its type. As of September 30, 2017 and December 31, 2016 , the Company was in compliance with all covenants and restrictions under its credit and other facilities. (c) Finance expenses Finance expenses consist of interest on the junior subordinated deferrable debentures and senior notes, the amortization of debt offering costs, credit facility fees, bank charges, AlphaCat financing fees and other charges as follows: Three Months Ended September 30, Nine Months Ended September 30, 2017 2016 2017 2016 2006 Junior Subordinated Deferrable Debentures $ 2,235 $ 2,135 $ 6,633 $ 6,557 2007 Junior Subordinated Deferrable Debentures 1,851 1,851 5,492 5,512 Flagstone 2006 Junior Subordinated Deferrable Debentures 2,272 2,271 6,741 6,760 Flagstone 2007 Junior Subordinated Deferrable Debentures 1,775 1,784 5,249 5,317 2010 Senior Notes due 2040 5,597 5,597 16,792 16,791 Credit facilities 575 463 1,196 1,359 Bank and other charges 183 276 465 489 AlphaCat fees (a) 35 144 107 1,105 Total finance expenses $ 14,523 $ 14,521 $ 42,675 $ 43,890 (a) Includes finance expenses incurred by AlphaCat Managers Ltd. in relation to fund raising for the AlphaCat sidecars, the AlphaCat ILS funds and AlphaCat direct. |
Accumulated other comprehensive
Accumulated other comprehensive loss | 9 Months Ended |
Sep. 30, 2017 | |
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] | |
Accumulated other comprehensive loss | Accumulated other comprehensive loss The changes in accumulated other comprehensive loss, by component for the three and nine months ended September 30, 2017 and 2016 was as follows: Three Months Ended September 30, 2017 Foreign currency translation adjustment Minimum pension liability Cash flow hedge Total Balance, net of tax, beginning of period $ (20,188 ) $ 1,102 $ (838 ) $ (19,924 ) Other comprehensive income, net of tax 1,481 — 13 1,494 Balance, net of tax, end of period $ (18,707 ) $ 1,102 $ (825 ) $ (18,430 ) Three Months Ended September 30, 2016 Foreign currency translation adjustment Minimum pension liability Cash flow hedge Total Balance, net of tax, beginning of period $ (17,149 ) $ 730 $ (1,763 ) $ (18,182 ) Other comprehensive loss, net of tax (1,370 ) (1,101 ) (439 ) (2,910 ) Balance, net of tax, end of period $ (18,519 ) $ (371 ) $ (2,202 ) $ (21,092 ) Nine Months Ended September 30, 2017 Foreign currency translation adjustment Minimum pension liability Cash flow hedge Total Balance, net of tax, beginning of period $ (22,274 ) $ (150 ) $ (792 ) $ (23,216 ) Other comprehensive income (loss), net of tax 3,567 1,252 (33 ) 4,786 Balance, net of tax, end of period $ (18,707 ) $ 1,102 $ (825 ) $ (18,430 ) Nine Months Ended September 30, 2016 Foreign currency translation adjustment Minimum pension liability Cash flow hedge Total Balance, net of tax, beginning of period $ (11,834 ) $ 334 $ (1,069 ) $ (12,569 ) Other comprehensive loss, net of tax (6,685 ) (705 ) (1,133 ) (8,523 ) Balance, net of tax, end of period $ (18,519 ) $ (371 ) $ (2,202 ) $ (21,092 ) |
Commitments and contingencies
Commitments and contingencies | 9 Months Ended |
Sep. 30, 2017 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and contingencies | Commitments and contingencies (a) Funds at Lloyd’s Talbot operates in Lloyd’s through a corporate member, Talbot 2002 Underwriting Capital Ltd (“T02”), which is the sole participant in Syndicate 1183. Lloyd’s sets T02’s required capital annually based on Syndicate 1183’s business plan, rating environment and reserving environment together with input arising from Lloyd’s discussions with, inter alia, regulatory and rating agencies. Such capital, called Funds at Lloyd’s (“FAL”), comprises cash and investments. The Company provided FAL in the amount of $583,600 for the 2017 underwriting year ( 2016 underwriting year: $617,000 ). The amounts which are provided as FAL are not available for distribution to the Company for the payment of dividends. Talbot’s corporate member may also be required to maintain funds under the control of Lloyd’s in excess of its capital requirement and such funds also may not be available for distribution to the Company for the payment of dividends. (b) Lloyd’s Central Fund Whenever a member of Lloyd’s is unable to pay its debts to policyholders, such debts may be payable by the Lloyd’s Central Fund. If Lloyd’s determines that the Central Fund needs to be increased, it has the power to assess premium levies on current Lloyd’s members up to 3% of a member’s underwriting capacity in any one year. The Company does not believe that any assessment is likely in the foreseeable future and has not provided any allowance for such an assessment. However, based on the Company’s 2017 underwriting capacity at Lloyd’s of £600,000 , at the September 30, 2017 exchange rate of £1 equals $1.34 and assuming the maximum 3% assessment, the Company would be assessed approximately $24,120 . (c) Marketing Services Agreement (“MSA”) On May 1, 2017, the Company entered into a MSA with Archer Daniels Midland (“ADM”). Under this agreement, ADM agrees to provide marketing services via its own distribution channels for an annual fee of $2,000 for a period of seven years , with an option for the Company to extend for an additional three years . For the three and nine months ended September 30, 2017 , the Company had incurred fees in relation to the MSA of $500 and $833 , respectively. (d) Unfunded investment commitments As at September 30, 2017 and December 31, 2016 , the Company had total unfunded investment commitments related to the following: Unfunded investment commitments September 30, 2017 December 31, 2016 Fixed maturity investments (a) $ 21,959 $ 28,499 Other investments (b) 101,082 156,134 Investments in investment affiliates (c) 87,372 64,071 AlphaCat ILS Fund — 10,000 Total unfunded investment commitments $ 210,413 $ 258,704 (a) The Company has an outstanding commitment to participate in certain secured loan facilities through participation agreements with an established loan originator. (b) The Company’s total capital commitments related to other investments as at September 30, 2017 was $313,000 ( December 31, 2016 : $308,000 ). (c) Refer to Note 4 (c), “Investments in Investment Affiliates.” |
Related party transactions
Related party transactions | 9 Months Ended |
Sep. 30, 2017 | |
Related Party Transactions [Abstract] | |
Related party transactions | Related party transactions The transactions listed below are classified as related party transactions as principals and/or directors of each counterparty are members of the Company’s board of directors. (a) Aquiline Capital Partners LLC (“Aquiline Capital”) Group Ark Insurance Subsequent to July 2016, Aquiline Capital ceased to be shareholders of Group Ark Insurance Holdings Ltd. (“Group Ark”). Christopher E. Watson, a director of the Company and senior principal of Aquiline Capital, continues to serve as a director of Group Ark. Pursuant to reinsurance agreements with a subsidiary of Group Ark, the Company recognized gross premiums written during the three and nine months ended September 30, 2016 of $1,096 and $3,067 , respectively. The Company also recognized reinsurance premiums ceded during the three and nine months ended September 30, 2016 of $41 and $41 , respectively. Earned premium adjustments were recorded during the three and nine months ended September 30, 2016 of $1,276 and $2,275 , respectively. As at December 31, 2016 the Company had recorded premiums receivable and loss reserves recoverable of $292 and $798 , respectively. Wellington Pursuant to reinsurance agreements with a subsidiary of Wellington Insurance Company (“Wellington”), during the three and nine months ended September 30, 2017 the Company recognized gross premiums written of $78 and $4,196 ( 2016 : $nil and $nil ), respectively, and earned premium adjustments of $943 and $3,480 ( 2016 : $nil and $nil ), respectively. As at September 30, 2017 and December 31, 2016 the Company had recorded premiums receivable of $468 and $666 , respectively. Aquiline Capital are shareholders of Wellington and Christopher E. Watson, a director of the Company and senior principal of Aquiline Capital, serves as a director of Wellington. Aquiline II, Aquiline III and Aquiline Tech The Company had, as of September 30, 2017 and December 31, 2016 , investments in Aquiline II, III and Tech with a total value of $92,079 and $100,431 and outstanding unfunded commitments of $87,372 and $64,071 , respectively. For the three and nine months ended September 30, 2017 , the Company incurred $106 and $592 ( 2016 : $520 and $1,535 ), respectively, in partnership fees associated with these investments. Jeffrey W. Greenberg and Christopher E. Watson, directors of the Company, serve as managing principal and senior principal, respectively, of Aquiline Capital. Additional information related to Aquiline II, III and Tech is disclosed in Note 4 (c), “Investments in Investment Affiliates.” (b) Other Certain shareholders of the Company and their affiliates, as well as employers of entities associated with directors or officers have purchased insurance and/or reinsurance from the Company in the ordinary course of business. The Company believes these transactions were settled for arm’s length consideration. |
Earnings per share
Earnings per share | 9 Months Ended |
Sep. 30, 2017 | |
Earnings Per Share [Abstract] | |
Earnings per common share | Earnings per common share The following table sets forth the computation of basic earnings per common share and earnings per diluted common share for the three and nine months ended September 30, 2017 and 2016 : Three Months Ended September 30, Nine Months Ended September 30, 2017 2016 2017 2016 Basic (loss) earnings per common share Net (loss) income (attributable) available to Validus common shareholders $ (250,446 ) $ 89,844 $ (54,790 ) $ 351,617 Weighted average number of common shares outstanding 78,994,335 80,134,394 79,132,856 81,635,496 Basic (loss) earnings per share (attributable) available to Validus common shareholders $ (3.17 ) $ 1.12 $ (0.69 ) $ 4.31 (Loss) earnings per diluted common share Net (loss) income (attributable) available to Validus common shareholders $ (250,446 ) $ 89,844 $ (54,790 ) $ 351,617 Weighted average number of common shares outstanding 78,994,335 80,134,394 79,132,856 81,635,496 Share equivalents: Stock options — 26,705 — 32,126 Unvested restricted shares — 1,083,457 — 1,271,002 Weighted average number of diluted common shares outstanding 78,994,335 81,244,556 79,132,856 82,938,624 (Loss) earnings per diluted share (attributable) available to Validus common shareholders $ (3.17 ) $ 1.11 $ (0.69 ) $ 4.24 Earnings per diluted common share assumes the exercise of all dilutive stock options and restricted stock grants. Due to the net loss incurred during the three and nine months ended September 30, 2017, share equivalents were not included in the computation of diluted loss per share due to their anti-dilutive effect. Share equivalents that would result in the issuance of common shares of 19,808 and 175,690 were outstanding for the three and nine months ended September 30, 2016, respectively, but were not included in the computation of earnings per diluted common share because the effect would be anti-dilutive. |
Segment information
Segment information | 9 Months Ended |
Sep. 30, 2017 | |
Segment Reporting [Abstract] | |
Segment information | Segment information The Company conducts its operations worldwide through four operating segments, which have been determined under ASC Topic 280 “Segment Reporting” to be Validus Re, Talbot, Western World and AlphaCat. For segmental reporting purposes, the results of CRS have been included in the results of the Western World segment as of May 1, 2017, the date of acquisition. The Company’s operating segments are strategic business units that offer different products and services. They are managed and have capital allocated separately because each segment undertakes different strategies. A description of each of the Company’s operating segments and its Corporate and Investments function is as follows: Validus Re Segment The Validus Re segment is focused primarily on treaty reinsurance. The primary lines in which the segment conducts business are property, marine and specialty which includes agriculture, aerospace and aviation, financial lines of business, nuclear, terrorism, life, accident & health, workers’ compensation, crisis management, contingency, technical lines, composite, trade credit and casualty. Talbot Segment The Talbot segment is focused on a wide range of marine and energy, political lines, commercial property, financial lines, contingency, accident & health and aviation classes of business on an insurance or facultative reinsurance basis and principally property, aerospace and marine classes of business on a treaty reinsurance basis. Western World Segment The Western World segment is focused on providing commercial insurance products on a surplus lines and specialty admitted basis. Western World specializes in underwriting classes of business that are not easily placed in the standard insurance market due to their complexity, high hazard, or unusual nature; including general liability, property and professional liability, homeowners, commercial package and agriculture classes of business. AlphaCat Segment The AlphaCat segment leverages the Company’s underwriting and analytical expertise and earns management and performance fees from the Company and other third party investors primarily through the AlphaCat ILS funds and sidecars. Corporate and Investments The Company has a corporate and investments function (“Corporate and Investments”), which includes the activities of the parent company, and which carries out certain functions for the group, including investment management. Corporate and Investments includes investment income on a managed basis and other non-segment expenses, predominantly general and administrative, stock compensation, finance and transaction expenses. Transaction expenses are primarily comprised of legal, financial advisory and audit related services incurred in connection with the acquisition of CRS. Corporate and Investments also includes the activities of certain key executives such as the Chief Executive Officer and Chief Financial Officer. For reporting purposes, Corporate and Investments is reflected separately; however, it is not considered an operating segment under these circumstances. Other reconciling items include, but are not limited to, the elimination of certain inter segment revenues and expenses and other items that are not allocated to the operating segments. The following tables summarize the results of our operating segments and “Corporate and Investments”: Three Months Ended September 30, Nine Months Ended September 30, Validus Re Segment Information 2017 2016 2017 2016 Underwriting revenues Gross premiums written $ 153,890 $ 94,741 $ 1,071,409 $ 1,072,219 Reinsurance premiums ceded (40,988 ) (15,967 ) (161,188 ) (111,658 ) Net premiums written 112,902 78,774 910,221 960,561 Change in unearned premiums 154,145 149,705 (184,155 ) (241,129 ) Net premiums earned 267,047 228,479 726,066 719,432 Other insurance related income (loss) 68 58 204 (107 ) Total underwriting revenues 267,115 228,537 726,270 719,325 Underwriting deductions Losses and loss expenses 347,484 98,425 538,323 313,432 Policy acquisition costs 45,422 42,837 133,836 127,660 General and administrative expenses 12,444 17,528 48,550 52,579 Share compensation expenses 2,606 2,695 7,746 8,371 Total underwriting deductions 407,956 161,485 728,455 502,042 Underwriting (loss) income $ (140,841 ) $ 67,052 $ (2,185 ) $ 217,283 Selected ratios Ratio of net to gross premiums written 73.4 % 83.1 % 85.0 % 89.6 % Losses and loss expense ratio 130.1 % 43.1 % 74.1 % 43.6 % Policy acquisition cost ratio 17.0 % 18.7 % 18.4 % 17.7 % General and administrative expense ratio (a) 5.7 % 8.9 % 7.8 % 8.5 % Expense ratio 22.7 % 27.6 % 26.2 % 26.2 % Combined ratio 152.8 % 70.7 % 100.3 % 69.8 % (a) The general and administrative expense ratio includes share compensation expenses. Three Months Ended September 30, Nine Months Ended September 30, Talbot Segment Information 2017 2016 2017 2016 Underwriting revenues Gross premiums written $ 192,883 $ 189,674 $ 702,535 $ 752,058 Reinsurance premiums ceded (36,462 ) (22,877 ) (154,263 ) (137,496 ) Net premiums written 156,421 166,797 548,272 614,562 Change in unearned premiums 23,191 32,258 18,279 (7,166 ) Net premiums earned 179,612 199,055 566,551 607,396 Other insurance related income 692 99 1,512 389 Total underwriting revenues 180,304 199,154 568,063 607,785 Underwriting deductions Losses and loss expenses 178,440 109,860 378,241 319,271 Policy acquisition costs 41,493 46,488 129,074 134,444 General and administrative expenses 23,069 32,333 97,094 109,929 Share compensation expenses 2,310 3,163 8,292 9,955 Total underwriting deductions 245,312 191,844 612,701 573,599 Underwriting (loss) income $ (65,008 ) $ 7,310 $ (44,638 ) $ 34,186 Selected ratios Ratio of net to gross premiums written 81.1 % 87.9 % 78.0 % 81.7 % Losses and loss expense ratio 99.3 % 55.2 % 66.8 % 52.6 % Policy acquisition cost ratio 23.1 % 23.4 % 22.8 % 22.1 % General and administrative expense ratio (a) 14.2 % 17.8 % 18.5 % 19.7 % Expense ratio 37.3 % 41.2 % 41.3 % 41.8 % Combined ratio 136.6 % 96.4 % 108.1 % 94.4 % (a) The general and administrative expense ratio includes share compensation expenses. Three Months Ended September 30, Nine Months Ended September 30, Western World Segment Information 2017 2016 2017 2016 Underwriting revenues Gross premiums written $ 156,517 $ 85,260 $ 459,628 $ 236,190 Reinsurance premiums ceded (43,207 ) (6,202 ) (72,005 ) (15,347 ) Net premiums written 113,310 79,058 387,623 220,843 Change in unearned premiums 61,603 (8,260 ) 15,256 (22,890 ) Net premiums earned 174,913 70,798 402,879 197,953 Other insurance related income 662 219 1,566 696 Total underwriting revenues 175,575 71,017 404,445 198,649 Underwriting deductions Losses and loss expenses 157,709 45,748 329,642 129,623 Policy acquisition costs 20,721 17,094 60,187 46,704 General and administrative expenses 21,553 10,171 50,623 33,704 Share compensation expenses 354 702 1,655 1,825 Total underwriting deductions 200,337 73,715 442,107 211,856 Underwriting (loss) $ (24,762 ) $ (2,698 ) $ (37,662 ) $ (13,207 ) Selected ratios Ratio of net to gross premiums written 72.4 % 92.7 % 84.3 % 93.5 % Losses and loss expense ratio 90.2 % 64.6 % 81.8 % 65.5 % Policy acquisition cost ratio 11.8 % 24.1 % 14.9 % 23.6 % General and administrative expense ratio (a) 12.5 % 15.4 % 13.0 % 17.9 % Expense ratio 24.3 % 39.5 % 27.9 % 41.5 % Combined ratio 114.5 % 104.1 % 109.7 % 107.0 % (a) The general and administrative expense ratio includes share compensation expenses. Three Months Ended September 30, Nine Months Ended September 30, AlphaCat Segment Information 2017 2016 2017 2016 Fee revenues Third party $ 5,095 $ 7,025 $ 15,288 $ 14,843 Related party 457 1,373 1,732 2,592 Total fee revenues 5,552 8,398 17,020 17,435 Expenses General and administrative expenses 2,929 3,324 10,322 7,557 Share compensation expenses 183 (107 ) 348 167 Finance expenses 32 31 107 914 Tax (benefit) expense (65 ) — 69 — Foreign exchange losses 7 5 7 17 Total expenses 3,086 3,253 10,853 8,655 Income before investments from AlphaCat Funds and Sidecars 2,466 5,145 6,167 8,780 Investment (loss) income from AlphaCat Funds and Sidecars (a) AlphaCat Sidecars 201 (72 ) 68 593 AlphaCat ILS Funds - Lower Risk (b) (7,553 ) 2,321 (4,063 ) 6,903 AlphaCat ILS Funds - Higher Risk (b) (21,816 ) 2,479 (16,849 ) 5,607 BetaCat ILS Funds (922 ) 1,303 (291 ) 2,979 PaCRe — — — (23 ) Validus’ share of investment (loss) income from AlphaCat Funds and Sidecars (30,090 ) 6,031 (21,135 ) 16,059 Validus’ share of AlphaCat segment (loss) income $ (27,624 ) $ 11,176 $ (14,968 ) $ 24,839 Supplemental information Gross premiums written AlphaCat Sidecars $ — $ (112 ) $ 66 $ (178 ) AlphaCat ILS Funds - Lower Risk (b) 10,979 2,049 117,519 112,241 AlphaCat ILS Funds - Higher Risk (b) 16,275 1,797 153,483 140,127 AlphaCat Direct (c) (41 ) 679 26,753 18,476 Total gross premiums written $ 27,213 $ 4,413 $ 297,821 $ 270,666 (a) The investment (loss) income from the AlphaCat funds and sidecars is based on equity accounting. (b) Lower risk AlphaCat ILS funds have a maximum permitted portfolio expected loss of less than 7%, whereas higher risk AlphaCat ILS funds have a maximum permitted portfolio expected loss of greater than 7%. Expected loss represents the average annual loss over the set of simulation scenarios divided by the total limit. (c) AlphaCat Direct includes direct investments from third party investors in AlphaCat Re. Three Months Ended September 30, Nine Months Ended September 30, Corporate and Investments 2017 2016 2017 2016 Managed investments Managed net investment income (a) $ 37,091 $ 41,071 $ 111,346 $ 105,843 Net realized gains on managed investments (a) 903 4,080 280 5,514 Change in net unrealized gains on managed investments (a) 941 4,652 31,232 81,782 Income (loss) from investment affiliates 1,011 453 15,665 (4,249 ) Total managed investment return 39,946 50,256 158,523 188,890 Corporate expenses General and administrative expenses 9,539 18,221 45,563 52,276 Share compensation expenses 3,990 4,048 12,039 12,147 Finance expenses (a) 14,449 14,317 42,462 42,637 Dividends on preferred shares 5,627 2,252 10,033 2,252 Tax (benefit) expense (a) (2,567 ) 1,830 (7,237 ) 1,418 Total Corporate expenses 31,038 40,668 102,860 110,730 Other items Foreign exchange (losses) (a) (1,495 ) (1,067 ) (7,715 ) 11,628 Other income (loss) 35 (1,529 ) 303 (773 ) Transaction expenses — — (4,427 ) — Total other items (1,460 ) (2,596 ) (11,839 ) 10,855 Total Corporate and Investments $ 7,448 $ 6,992 $ 43,824 $ 89,015 (a) These items exclude the components which are included in Validus’ share of AlphaCat and amounts which are consolidated from VIEs. The following tables reconcile the results of our operating segments along with our corporate and investments function to the Consolidated results of the Company for the periods indicated: Three Months Ended September 30, 2017 Validus Re Segment Talbot Segment Western World Segment AlphaCat Segment and Consolidated VIEs Corporate and Investments Eliminations Total Underwriting revenues Gross premiums written $ 153,890 $ 192,883 $ 156,517 $ 27,213 $ — $ (6,647 ) $ 523,856 Reinsurance premiums ceded (40,988 ) (36,462 ) (43,207 ) (2,850 ) — 6,647 (116,860 ) Net premiums written 112,902 156,421 113,310 24,363 — — 406,996 Change in unearned premiums 154,145 23,191 61,603 77,273 — — 316,212 Net premiums earned 267,047 179,612 174,913 101,636 — — 723,208 Other insurance related income 68 692 662 6,083 — (3,969 ) 3,536 Total underwriting revenues 267,115 180,304 175,575 107,719 — (3,969 ) 726,744 Underwriting deductions Losses and loss expenses 347,484 178,440 157,709 570,969 — — 1,254,602 Policy acquisition costs 45,422 41,493 20,721 8,314 — (360 ) 115,590 General and administrative expenses 12,444 23,069 21,553 7,687 9,539 (3,950 ) 70,342 Share compensation expenses 2,606 2,310 354 183 3,990 — 9,443 Total underwriting deductions 407,956 245,312 200,337 587,153 13,529 (4,310 ) 1,449,977 Underwriting (loss) $ (140,841 ) $ (65,008 ) $ (24,762 ) $ (479,434 ) $ (13,529 ) $ 341 $ (723,233 ) Net investment return (a) — — — 1,232 39,946 — 41,178 Other items (b) — — — 82 (18,969 ) — (18,887 ) Loss attributable to AlphaCat investors — — — 74,130 — — 74,130 Net loss attributable to noncontrolling interest — — — 376,366 — — 376,366 Segmental (loss) $ (140,841 ) $ (65,008 ) $ (24,762 ) $ (27,624 ) $ 7,448 $ 341 Net loss attributable to Validus common shareholders $ (250,446 ) (a) Net investment return includes net investment income, net realized and change in net unrealized gains (losses) on investments and income (loss) from investment affiliates. (b) Other items includes finance expenses, transaction expenses, dividends on preferred shares, tax benefit (expense), foreign exchange gains (losses), income (loss) from operating affiliate and other income (loss). Three Months Ended September 30, 2016 Validus Re Segment Talbot Segment Western World Segment AlphaCat Segment and Consolidated VIEs Corporate and Investments Eliminations Total Underwriting revenues Gross premiums written $ 94,741 $ 189,674 $ 85,260 $ 4,413 $ — $ (1,670 ) $ 372,418 Reinsurance premiums ceded (15,967 ) (22,877 ) (6,202 ) (1,630 ) — 1,670 (45,006 ) Net premiums written 78,774 166,797 79,058 2,783 — — 327,412 Change in unearned premiums 149,705 32,258 (8,260 ) 62,660 — — 236,363 Net premiums earned 228,479 199,055 70,798 65,443 — — 563,775 Other insurance related income 58 99 219 8,656 — (8,113 ) 919 Total underwriting revenues 228,537 199,154 71,017 74,099 — (8,113 ) 564,694 Underwriting deductions Losses and loss expenses 98,425 109,860 45,748 4,361 — — 258,394 Policy acquisition costs 42,837 46,488 17,094 7,075 — (60 ) 113,434 General and administrative expenses 17,528 32,333 10,171 12,255 18,221 (8,065 ) 82,443 Share compensation expenses 2,695 3,163 702 (107 ) 4,048 — 10,501 Total underwriting deductions 161,485 191,844 73,715 23,584 22,269 (8,125 ) 464,772 Underwriting income (loss) $ 67,052 $ 7,310 $ (2,698 ) $ 50,515 $ (22,269 ) $ 12 $ 99,922 Net investment return (a) — — — 3,567 50,256 — 53,823 Other items (b) — — — 97 (20,995 ) — (20,898 ) (Income) attributable to AlphaCat investors — — — (5,564 ) — — (5,564 ) Net (income) attributable to noncontrolling interest — — — (37,439 ) — — (37,439 ) Segmental income (loss) $ 67,052 $ 7,310 $ (2,698 ) $ 11,176 $ 6,992 $ 12 Net income available to Validus common shareholders $ 89,844 (a) Net investment return includes net investment income, net realized and change in net unrealized gains (losses) on investments and income (loss) from investment affiliates. (b) Other items includes finance expenses, transaction expenses, dividends on preferred shares, tax benefit (expense), foreign exchange gains (losses), income (loss) from operating affiliate and other income (loss). Nine Months Ended September 30, 2017 Validus Re Segment Talbot Segment Western World Segment AlphaCat Segment and Consolidated VIEs Corporate and Investments Eliminations Total Underwriting revenues Gross premiums written $ 1,071,409 $ 702,535 $ 459,628 $ 297,821 $ — $ (23,778 ) $ 2,507,615 Reinsurance premiums ceded (161,188 ) (154,263 ) (72,005 ) (9,510 ) — 23,778 (373,188 ) Net premiums written 910,221 548,272 387,623 288,311 — — 2,134,427 Change in unearned premiums (184,155 ) 18,279 15,256 (54,196 ) — — (204,816 ) Net premiums earned 726,066 566,551 402,879 234,115 — — 1,929,611 Other insurance related income 204 1,512 1,566 17,118 — (14,463 ) 5,937 Total underwriting revenues 726,270 568,063 404,445 251,233 — (14,463 ) 1,935,548 Underwriting deductions Losses and loss expenses 538,323 378,241 329,642 574,130 — — 1,820,336 Policy acquisition costs 133,836 129,074 60,187 22,380 — (991 ) 344,486 General and administrative expenses 48,550 97,094 50,623 27,096 45,563 (14,311 ) 254,615 Share compensation expenses 7,746 8,292 1,655 348 12,039 — 30,080 Total underwriting deductions 728,455 612,701 442,107 623,954 57,602 (15,302 ) 2,449,517 Underwriting (loss) $ (2,185 ) $ (44,638 ) $ (37,662 ) $ (372,721 ) $ (57,602 ) $ 839 $ (513,969 ) Net investment return (a) — — — 12,543 158,523 — 171,066 Other items (b) — — — 269 (57,097 ) — (56,828 ) Loss attributable to AlphaCat investors — — — 54,797 — — 54,797 Net loss attributable to noncontrolling interest — — — 290,144 — — 290,144 Segmental (loss) $ (2,185 ) $ (44,638 ) $ (37,662 ) $ (14,968 ) $ 43,824 $ 839 Net loss attributable to Validus common shareholders $ (54,790 ) (a) Net investment return includes net investment income, net realized and change in net unrealized gains (losses) on investments and income (loss) from investment affiliates. (b) Other items includes finance expenses, transaction expenses, dividends on preferred shares, tax benefit (expense), foreign exchange gains (losses), income (loss) from operating affiliate and other income (loss). Nine Months Ended September 30, 2016 Validus Re Segment Talbot Segment Western World Segment AlphaCat Segment and Consolidated VIEs Corporate and Investments Eliminations Total Underwriting revenues Gross premiums written $ 1,072,219 $ 752,058 $ 236,190 $ 270,666 $ — $ (21,882 ) $ 2,309,251 Reinsurance premiums ceded (111,658 ) (137,496 ) (15,347 ) (6,451 ) — 21,882 (249,070 ) Net premiums written 960,561 614,562 220,843 264,215 — — 2,060,181 Change in unearned premiums (241,129 ) (7,166 ) (22,890 ) (80,230 ) — — (351,415 ) Net premiums earned 719,432 607,396 197,953 183,985 — — 1,708,766 Other insurance related (loss) income (107 ) 389 696 17,722 — (16,300 ) 2,400 Total underwriting revenues 719,325 607,785 198,649 201,707 — (16,300 ) 1,711,166 Underwriting deductions Losses and loss expenses 313,432 319,271 129,623 27,645 — — 789,971 Policy acquisition costs 127,660 134,444 46,704 19,762 — 23 328,593 General and administrative expenses 52,579 109,929 33,704 26,272 52,276 (16,421 ) 258,339 Share compensation expenses 8,371 9,955 1,825 167 12,147 — 32,465 Total underwriting deductions 502,042 573,599 211,856 73,846 64,423 (16,398 ) 1,409,368 Underwriting income (loss) $ 217,283 $ 34,186 $ (13,207 ) $ 127,861 $ (64,423 ) $ 98 $ 301,798 Net investment return (a) — — — 10,558 188,890 (597 ) 198,851 Other items (b) — — — (1,139 ) (35,452 ) — (36,591 ) (Income) attributable to AlphaCat investors — — — (16,278 ) — — (16,278 ) Net (income) attributable to noncontrolling interest — — — (96,163 ) — — (96,163 ) Segmental income (loss) $ 217,283 $ 34,186 $ (13,207 ) $ 24,839 $ 89,015 $ (499 ) Net income available to Validus common shareholders $ 351,617 (a) Net investment return includes net investment income, net realized and change in net unrealized gains (losses) on investments and income (loss) from investment affiliates. (b) Other items includes finance expenses, transaction expenses, dividends on preferred shares, tax benefit (expense), foreign exchange gains (losses), income (loss) from operating affiliate and other income (loss). The Company’s exposures are generally diversified across geographic zones. The following tables set forth the gross premiums written by operating segment allocated to the territory of coverage exposure for the periods indicated: Gross Premiums Written Three Months Ended September 30, 2017 Validus Re Talbot Western World AlphaCat Eliminations Total % United States $ 59,838 $ 24,584 $ 156,517 $ 18,440 $ (6,300 ) $ 253,079 48.3 % Worldwide excluding United States (a) 7,198 43,136 — 712 76 51,122 9.8 % Australia and New Zealand (450 ) 3,696 — — 9 3,255 0.6 % Europe 4,744 5,372 — 149 62 10,327 2.0 % Latin America and Caribbean 19,430 20,726 — — (454 ) 39,702 7.6 % Japan 436 1,165 — — — 1,601 0.3 % Canada 24 1,820 — 458 (6 ) 2,296 0.4 % Rest of the world (b) 1,447 21,478 — — 57 22,982 4.4 % Sub-total, non United States 32,829 97,393 — 1,319 (256 ) 131,285 25.1 % Worldwide including United States (a) 33,724 16,293 — 4,993 (91 ) 54,919 10.5 % Other locations non-specific (c) 27,499 54,613 — 2,461 — 84,573 16.1 % Total $ 153,890 $ 192,883 $ 156,517 $ 27,213 $ (6,647 ) $ 523,856 100.0 % Gross Premiums Written Three Months Ended September 30, 2016 Validus Re Talbot Western World AlphaCat Eliminations Total % United States $ 31,345 $ 19,937 $ 85,260 $ 1,837 $ (76 ) $ 138,303 37.1 % Worldwide excluding United States (a) 4,145 40,058 — (288 ) (39 ) 43,876 11.7 % Australia and New Zealand 57 3,238 — — 6 3,301 0.9 % Europe 4,536 4,957 — — 40 9,533 2.6 % Latin America and Caribbean 17,036 25,173 — — (793 ) 41,416 11.1 % Japan (33 ) 997 — — 7 971 0.3 % Canada 149 2,015 — — (42 ) 2,122 0.6 % Rest of the world (b) 2,360 19,166 — — 66 21,592 5.8 % Sub-total, non United States 28,250 95,604 — (288 ) (755 ) 122,811 33.0 % Worldwide including United States (a) 22,399 12,771 — 2,872 (838 ) 37,204 10.0 % Other locations non-specific (c) 12,747 61,362 — (8 ) (1 ) 74,100 19.9 % Total $ 94,741 $ 189,674 $ 85,260 $ 4,413 $ (1,670 ) $ 372,418 100.0 % Gross Premiums Written Nine Months Ended September 30, 2017 Validus Re Talbot Western World AlphaCat Eliminations Total % United States $ 374,018 $ 88,139 $ 459,628 $ 116,691 $ (10,623 ) $ 1,027,853 41.0 % Worldwide excluding United States (a) 45,803 110,094 — 8,617 (463 ) 164,051 6.6 % Australia and New Zealand 3,745 8,726 — 2,003 (101 ) 14,373 0.6 % Europe 35,108 22,944 — 600 (368 ) 58,284 2.2 % Latin America and Caribbean 40,646 69,703 — 46 (4,737 ) 105,658 4.2 % Japan 40,902 6,371 — 3,855 (36 ) 51,092 2.0 % Canada 4,894 4,068 — 588 (55 ) 9,495 0.4 % Rest of the world (b) 20,229 67,918 — — (1,520 ) 86,627 3.5 % Sub-total, non United States 191,327 289,824 — 15,709 (7,280 ) 489,580 19.5 % Worldwide including United States (a) 189,669 74,385 — 158,239 (5,875 ) 416,418 16.6 % Other locations non-specific (c) 316,395 250,187 — 7,182 — 573,764 22.9 % Total $ 1,071,409 $ 702,535 $ 459,628 $ 297,821 $ (23,778 ) $ 2,507,615 100.0 % Gross Premiums Written Nine Months Ended September 30, 2016 Validus Re Talbot Western World AlphaCat Eliminations Total % United States $ 455,826 $ 85,182 $ 236,190 $ 64,566 $ (1,631 ) $ 840,133 36.4 % Worldwide excluding United States (a) 51,384 105,590 — 22,219 (650 ) 178,543 7.8 % Australia and New Zealand 6,906 7,613 — 4,949 (107 ) 19,361 0.8 % Europe 30,270 25,673 — 3,306 (668 ) 58,581 2.5 % Latin America and Caribbean 36,610 76,577 — — (6,330 ) 106,857 4.6 % Japan 39,892 5,579 — 3,221 (24 ) 48,668 2.1 % Canada 3,646 5,577 — 223 (129 ) 9,317 0.4 % Rest of the world (b) 22,307 76,456 — — (2,276 ) 96,487 4.2 % Sub-total, non United States 191,015 303,065 — 33,918 (10,184 ) 517,814 22.4 % Worldwide including United States (a) 169,737 75,423 — 170,639 (10,052 ) 405,747 17.6 % Other locations non-specific (c) 255,641 288,388 — 1,543 (15 ) 545,557 23.6 % Total $ 1,072,219 $ 752,058 $ 236,190 $ 270,666 $ (21,882 ) $ 2,309,251 100.1 % (a) Represents risks in two or more geographic zones. (b) Represents risks in one geographic zone. (c) The Other locations non-specific category refers to business for which an analysis of exposure by geographic zone is not applicable since these exposures can span multiple geographic areas and, in some instances, are not fixed locations. |
Subsequent events
Subsequent events | 9 Months Ended |
Sep. 30, 2017 | |
Subsequent Events [Abstract] | |
Subsequent events | Subsequent events California Wildfires The California Wildfires were a series of wildfires that burned across Northern California in October 2017 causing widespread residential and commercial property damage across a number of counties. The Company is presently reviewing its exposure based on in-force contracts and preliminary loss information from clients and anticipates that the California Wildfires will likely be a notable loss event. Dividends On November 1, 2017, the Company announced a quarterly cash dividend of $0.38 per common share, payable on December 29, 2017 to shareholders of record on December 15, 2017. The Company also announced a quarterly cash dividend of $0.3671875 and $0.3625000 per depository share on the outstanding Series A and Series B Preferred Shares, respectively. The Series A and Series B Preferred Share dividends are payable on December 15, 2017 to shareholders of record on December 1, 2017. |
Significant accounting policies
Significant accounting policies (Policies) | 9 Months Ended |
Sep. 30, 2017 | |
Accounting Policies [Abstract] | |
Basis of preparation | These unaudited Consolidated Financial Statements (the “Consolidated Financial Statements”) have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 in Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In addition, the year-end balance sheet data was derived from audited financial statements but does not include all disclosures required by U.S. GAAP. This Quarterly Report on Form 10-Q should be read in conjunction with the financial statements and related notes included in Validus Holdings, Ltd.’s (the “Company”) Annual Report on Form 10-K for the year ended December 31, 2016 , as filed with the U.S. Securities and Exchange Commission (the “SEC”). In the opinion of management, these unaudited Consolidated Financial Statements reflect all adjustments (including normal recurring adjustments) considered necessary for a fair statement of the Company’s financial position and results of operations as at the end of and for the periods presented. All significant intercompany accounts and transactions have been eliminated. The results of operations for any interim period are not necessarily indicative of the results for a full year. |
Use of estimates | The preparation of these financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. While management believes that the amounts included in the Consolidated Financial Statements reflect its best estimates and assumptions, actual results could differ materially from those estimates. The Company’s principal estimates include: • reserve for losses and loss expenses; • premium estimates for business written on a line slip or proportional basis; • the valuation of goodwill and intangible assets; • reinsurance recoverable balances including the provision for uncollectible amounts; and • investment valuation of financial assets. |
Consolidating voting interest entities and variable interest entities | The Company consolidates in these Consolidated Financial Statements the results of operations and financial position of all voting interest entities (“VOE”) in which the Company has a controlling financial interest and all variable interest entities (“VIE”) in which the Company is considered to be the primary beneficiary. The consolidation assessment, including the determination as to whether an entity qualifies as a VIE or VOE, depends on the facts and circumstances surrounding each entity. |
Business combination (Tables)
Business combination (Tables) | 9 Months Ended |
Sep. 30, 2017 | |
Business Combinations [Abstract] | |
Schedule of fair value of net assets acquired | The fair value of net assets acquired, including GAAP adjustments, are summarized as follows: Total purchase price $ 185,576 Assets acquired Cash and cash equivalents $ 1,653 Premiums receivable 564,453 Prepaid reinsurance premiums 227,157 Other assets 157,146 Assets acquired 950,409 Liabilities acquired Reinsurance balances payable $ 294,201 Unearned premiums 406,649 Net loss reserves 42,575 Other liabilities 122,715 Liabilities acquired 866,140 Excess purchase price $ 101,307 Goodwill and other intangible assets acquired Intangible asset - Distribution channels $ 52,898 Intangible asset - Brand name 9,568 Intangible asset - Technology 1,455 Total intangible assets 63,921 Goodwill 30,943 Deferred tax arising on Goodwill 6,443 Total goodwill and intangible assets $ 101,307 |
Reconciliation of goodwill and intangible assets | The following tables reconcile the carrying amount of goodwill and intangible assets from December 31, 2016 to September 30, 2017 : Goodwill Nine Months Ended September 30, 2017 Talbot Western World Total Balance at December 31, 2016 $ 20,393 $ 176,365 $ 196,758 Additions — 30,943 30,943 Balance at September 30, 2017 $ 20,393 $ 207,308 $ 227,701 Intangible assets Nine Months Ended September 30, 2017 Talbot Western World Total Balance at December 31, 2016 $ 93,924 $ 21,668 $ 115,592 Additions — 63,921 63,921 Amortization (2,081 ) (4,034 ) (6,115 ) Balance at September 30, 2017 $ 91,843 $ 81,555 $ 173,398 Intangible assets Nine Months Ended September 30, 2017 With a Finite Life With an Indefinite Life Total Balance at December 31, 2016 $ 11,424 $ 104,168 $ 115,592 Additions 63,921 — 63,921 Amortization (6,115 ) — (6,115 ) Balance at September 30, 2017 $ 69,230 $ 104,168 $ 173,398 |
Supplemental pro forma information | The following selected unaudited information has been provided to present a summary of the results of CRS that have been included in the Consolidated Financial Statements for the three and nine months ended September 30, 2017 . Three Months Ended September 30, 2017 Nine Months Ended September 30, 2017 Net premiums written $ 32,852 $ 39,840 Net premiums earned $ 98,757 $ 148,801 Total underwriting deductions $ 84,826 $ 129,606 Underwriting income, before general and administrative expenses $ 13,931 $ 19,195 |
Investments (Tables)
Investments (Tables) | 9 Months Ended |
Sep. 30, 2017 | |
Investments [Abstract] | |
Amortized cost (or cost), gross unrealized gains and (losses) and fair value of investments | The amortized cost (or cost) and fair value of the Company’s investments as at September 30, 2017 and December 31, 2016 were as follows: September 30, 2017 December 31, 2016 Amortized Amortized Fair Value Managed investments U.S. government and government agency $ 598,607 $ 595,694 $ 809,392 $ 804,126 Non-U.S. government and government agency 288,296 290,538 245,651 240,791 U.S. states, municipalities and political subdivisions 205,880 206,667 271,742 271,830 Agency residential mortgage-backed securities 830,542 828,400 684,490 679,595 Non-agency residential mortgage-backed securities 38,806 38,993 15,858 15,477 U.S. corporate 1,457,073 1,466,739 1,540,036 1,534,508 Non-U.S. corporate 390,519 392,242 418,520 410,227 Bank loans 471,855 464,464 579,121 570,399 Asset-backed securities 520,594 522,524 528,563 526,814 Commercial mortgage-backed securities 315,585 314,221 333,740 330,932 Total fixed maturities 5,117,757 5,120,482 5,427,113 5,384,699 Short-term investments 258,339 258,646 228,574 228,386 Other investments Fund of hedge funds — — 1,457 955 Hedge funds 11,292 19,233 11,292 17,381 Private equity investments 88,299 107,230 66,383 82,627 Fixed income investment funds 282,707 285,034 247,967 249,275 Overseas deposits 55,775 55,775 50,106 50,106 Mutual funds 1,918 4,028 2,925 5,368 Total other investments 439,991 471,300 380,130 405,712 Investments in investment affiliates (a) 60,228 92,079 84,840 100,431 Total managed investments $ 5,876,315 $ 5,942,507 $ 6,120,657 $ 6,119,228 Non-managed investments Catastrophe bonds $ 303,789 $ 299,484 $ 157,486 $ 158,331 Short-term investments 2,734,600 2,734,600 2,567,784 2,567,784 Total non-managed investments 3,038,389 3,034,084 2,725,270 2,726,115 Total investments $ 8,914,704 $ 8,976,591 $ 8,845,927 $ 8,845,343 (a) The Company’s investments in investment affiliates have been treated as equity method investments with the corresponding gains and losses recorded in income as “Income (loss) from investment affiliates.” |
Investment ratings on fixed maturities | The following table sets forth certain information regarding the investment ratings of the Company’s fixed maturity investments as at September 30, 2017 and December 31, 2016 . September 30, 2017 December 31, 2016 Fair Value % of Total Fair Value % of Total Managed fixed maturities AAA $ 2,349,803 43.3 % $ 2,405,597 43.4 % AA 437,215 8.1 % 538,289 9.7 % A 1,060,849 19.6 % 1,081,949 19.5 % BBB 752,808 13.9 % 740,861 13.4 % Total investment grade managed fixed maturities 4,600,675 84.9 % 4,766,696 86.0 % BB 177,667 3.2 % 213,568 3.9 % B 156,590 2.9 % 177,737 3.2 % CCC 5,286 0.1 % 13,371 0.2 % NR 180,264 3.4 % 213,327 3.8 % Total non-investment grade fixed maturities 519,807 9.6 % 618,003 11.1 % Total managed fixed maturities $ 5,120,482 94.5 % $ 5,384,699 97.1 % Non-managed catastrophe bonds AAA $ 1,650 0.0 % $ — 0.0 % Total investment grade non-managed fixed maturities 1,650 0.0 % — 0.0 % BB 28,031 0.5 % 29,731 0.6 % B 2,755 0.1 % 4,524 0.1 % NR 267,048 4.9 % 124,076 2.2 % Total non-investment grade non-managed fixed maturities 297,834 5.5 % 158,331 2.9 % Total non-managed fixed maturities 299,484 5.5 % 158,331 2.9 % Total fixed maturities $ 5,419,966 100.0 % $ 5,543,030 100.0 % |
Fixed maturities investments by contractual maturity | The amortized cost and fair value amounts for the Company’s fixed maturity investments held at September 30, 2017 and December 31, 2016 are shown below by contractual maturity. Actual maturity may differ from contractual maturity because certain borrowers may have the right to call or prepay certain obligations with or without call or prepayment penalties. September 30, 2017 December 31, 2016 Amortized Cost Fair Value Amortized Cost Fair Value Managed fixed maturities Due in one year or less $ 279,069 $ 278,118 $ 350,733 $ 346,161 Due after one year through five years 2,418,737 2,416,963 2,954,856 2,933,146 Due after five years through ten years 534,922 535,538 430,365 426,647 Due after ten years 179,502 185,725 128,508 125,927 3,412,230 3,416,344 3,864,462 3,831,881 Asset-backed and mortgage-backed securities 1,705,527 1,704,138 1,562,651 1,552,818 Total managed fixed maturities $ 5,117,757 $ 5,120,482 $ 5,427,113 $ 5,384,699 Non-managed catastrophe bonds Due in one year or less $ 88,949 $ 88,202 $ 43,664 $ 45,418 Due after one year through five years 209,340 206,117 112,572 111,656 Due after five years through ten years 5,500 5,165 1,250 1,257 Total non-managed fixed maturities 303,789 299,484 157,486 158,331 Total fixed maturities $ 5,421,546 $ 5,419,966 $ 5,584,599 $ 5,543,030 |
Other investments | The following tables set forth certain information regarding the Company’s other investment portfolio as at September 30, 2017 and December 31, 2016 : September 30, 2017 Fair Value Investments with redemption restrictions Investments without redemption restrictions Redemption frequency (a) Redemption notice period (a) Hedge funds 19,233 19,233 — Private equity investments 107,230 107,230 — Fixed income investment funds 285,034 249,999 35,035 Daily Daily to 2 days Overseas deposits 55,775 55,775 — Mutual funds 4,028 — 4,028 Daily Daily Total other investments $ 471,300 $ 432,237 $ 39,063 December 31, 2016 Fair Value Investments with redemption restrictions Investments without redemption restrictions Redemption frequency (a) Redemption notice period (a) Fund of hedge funds $ 955 $ 955 $ — Hedge funds 17,381 17,381 — Private equity investments 82,627 82,627 — Fixed income investment funds 249,275 218,333 30,942 Daily 2 days Overseas deposits 50,106 50,106 — Mutual funds 5,368 — 5,368 Daily Daily Total other investments $ 405,712 $ 369,402 $ 36,310 (a) The redemption frequency and notice periods only apply to investments without redemption restrictions. |
Reconciliation of beginning and ending investment in affiliate balances | The following table presents a reconciliation of the Company’s beginning and ending investments in investment affiliates for the three and nine months ended September 30, 2017 and 2016 : Three Months Ended September 30, Nine Months Ended September 30, 2017 2016 2017 2016 Investments in investment affiliates, beginning of period $ 103,377 $ 99,278 $ 100,431 $ 87,673 Net capital (distributions) contributions (12,309 ) — (24,017 ) 16,307 Income (loss) from investment affiliates 1,011 453 15,665 (4,249 ) Investments in investment affiliates, end of period $ 92,079 $ 99,731 $ 92,079 $ 99,731 |
Schedule of equity method investments | The following table presents the Company’s investments in investment affiliates as at September 30, 2017 and December 31, 2016 : September 30, 2017 Investment at cost Voting ownership % Equity ownership % Carrying value Aquiline II $ 33,349 — % 8.1 % $ 50,695 Aquiline III 24,737 — % 9.0 % 39,530 Aquiline Tech 2,142 — % 10.6 % 1,854 Total investments in investment affiliates $ 60,228 $ 92,079 December 31, 2016 Investment at cost Voting ownership % Equity ownership % Carrying value Aquiline II $ 46,871 — % 8.1 % $ 61,999 Aquiline III 37,969 — % 9.0 % 38,432 Total investments in investment affiliates $ 84,840 $ 100,431 |
Net investment income | Net investment income was derived from the following sources: Three Months Ended September 30, Nine Months Ended September 30, 2017 2016 2017 2016 Managed investments Fixed maturities and short-term investments $ 30,823 $ 30,572 $ 93,706 $ 89,210 Other investments 7,391 11,768 21,832 20,666 Cash and cash equivalents and restricted cash 1,230 891 2,556 2,136 Securities lending income 3 22 23 39 Total gross investment income 39,447 43,253 118,117 112,051 Investment expenses (2,356 ) (2,182 ) (6,771 ) (6,208 ) Total managed net investment income $ 37,091 $ 41,071 $ 111,346 $ 105,843 Non managed investments Fixed maturities and short-term investments $ 3,941 $ 1,970 $ 11,501 $ 5,242 Restricted cash, cash and cash equivalents 3,426 473 6,066 1,147 Total non-managed net investment income 7,367 2,443 17,567 6,389 Total net investment income $ 44,458 $ 43,514 $ 128,913 $ 112,232 |
Analysis of net realized gains and the change in net unrealized gains (losses) on investments | The following table sets forth an analysis of net realized gains and the change in net unrealized (losses) gains on investments: Three Months Ended September 30, Nine Months Ended September 30, 2017 2016 2017 2016 Managed fixed maturities, short-term and other investments Gross realized gains $ 5,170 $ 4,544 $ 13,035 $ 11,067 Gross realized (losses) (4,267 ) (464 ) (12,755 ) (5,553 ) Net realized gains on investments 903 4,080 280 5,514 Change in net unrealized gains on investments 941 4,652 31,232 81,782 Total net realized and change in net unrealized gains on managed investments $ 1,844 $ 8,732 $ 31,512 $ 87,296 Non-managed fixed maturities and short-term investments Gross realized gains $ 3 $ 317 $ 1,736 $ 1,032 Gross realized (losses) — — — (9 ) Net realized gains on investments 3 317 1,736 1,023 Change in net unrealized (losses) gains on investments (6,138 ) 807 (6,760 ) 2,549 Total net realized and change in net unrealized (losses) gains on non-managed investments (6,135 ) 1,124 (5,024 ) 3,572 Total net realized and change in net unrealized (losses) gains on total investments $ (4,291 ) $ 9,856 $ 26,488 $ 90,868 |
Fair value measurements (Tables
Fair value measurements (Tables) | 9 Months Ended |
Sep. 30, 2017 | |
Fair Value Disclosures [Abstract] | |
Fair value hierarchy - allocation of investments | At September 30, 2017 , the Company’s investments were allocated between Levels 1, 2 and 3 as follows: Level 1 Level 2 Level 3 Fair value based on NAV practical expedient (a) Total Managed investments U.S. government and government agency $ — $ 595,694 $ — $ — $ 595,694 Non-U.S. government and government agency — 290,538 — — 290,538 U.S. states, municipalities and political subdivisions — 206,667 — — 206,667 Agency residential mortgage-backed securities — 828,400 — — 828,400 Non-agency residential mortgage-backed securities — 38,993 — — 38,993 U.S. corporate — 1,466,739 — — 1,466,739 Non-U.S. corporate — 392,242 — — 392,242 Bank loans — 240,563 223,901 — 464,464 Asset-backed securities — 486,537 35,987 — 522,524 Commercial mortgage-backed securities — 314,221 — — 314,221 Total fixed maturities — 4,860,594 259,888 — 5,120,482 Short-term investments 251,578 7,068 — — 258,646 Other investments Hedge funds — — — 19,233 19,233 Private equity investments — — — 107,230 107,230 Fixed income investment funds — 35,145 16,886 233,003 285,034 Overseas deposits — — — 55,775 55,775 Mutual funds — 4,028 — — 4,028 Total other investments — 39,173 16,886 415,241 471,300 Investments in investment affiliates (b) — — — — 92,079 Total managed investments $ 251,578 $ 4,906,835 $ 276,774 $ 415,241 $ 5,942,507 Non-managed investments Catastrophe bonds $ — $ 230,775 $ 68,709 $ — $ 299,484 Short-term investments 2,734,600 — — — 2,734,600 Total non-managed investments 2,734,600 230,775 68,709 — 3,034,084 Total investments $ 2,986,178 $ 5,137,610 $ 345,483 $ 415,241 $ 8,976,591 (a) In accordance with ASC Topic 820 “Fair Value Measurements,” investments measured at fair value using the net asset value (“NAV”) per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy. (b) In accordance with ASC Topic 825 “Financial Instruments,” the Company’s investments in investment affiliates have not been classified in the fair value hierarchy. At December 31, 2016 , the Company’s investments were allocated between Levels 1, 2 and 3 as follows: Level 1 Level 2 Level 3 Fair value based on NAV practical expedient (a) Total Managed investments U.S. government and government agency $ — $ 804,126 $ — $ — $ 804,126 Non-U.S. government and government agency — 240,791 — — 240,791 U.S. states, municipalities and political subdivisions — 271,830 — — 271,830 Agency residential mortgage-backed securities — 679,595 — — 679,595 Non-agency residential mortgage-backed securities — 15,477 — — 15,477 U.S. corporate — 1,534,508 — — 1,534,508 Non-U.S. corporate — 410,227 — — 410,227 Bank loans — 323,903 246,496 — 570,399 Asset-backed securities — 502,883 23,931 — 526,814 Commercial mortgage-backed securities — 330,932 — — 330,932 Total fixed maturities — 5,114,272 270,427 — 5,384,699 Short-term investments 209,651 18,735 — — 228,386 Other investments Fund of hedge funds — — — 955 955 Hedge funds — — — 17,381 17,381 Private equity investments — — — 82,627 82,627 Fixed income investment funds — 30,941 12,168 206,166 249,275 Overseas deposits — — — 50,106 50,106 Mutual funds — 5,368 — — 5,368 Total other investments — 36,309 12,168 357,235 405,712 Investments in investment affiliates (b) — — — — 100,431 Total managed investments $ 209,651 $ 5,169,316 $ 282,595 $ 357,235 $ 6,119,228 Non-managed investments Catastrophe bonds $ — $ 109,956 $ 48,375 $ — $ 158,331 Short-term investments 2,567,784 — — — 2,567,784 Total non-managed investments 2,567,784 109,956 48,375 — 2,726,115 Total investments $ 2,777,435 $ 5,279,272 $ 330,970 $ 357,235 $ 8,845,343 (a) In accordance with ASC Topic 820 “Fair Value Measurements,” investments measured at fair value using the net asset value (“NAV”) per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy. (b) In accordance with ASC Topic 825 “Financial Instruments,” the Company’s investments in investment affiliates have not been classified in the fair value hierarchy. |
Reconciliation of beginning and ending balances for all Level 3 investments measured at fair value on recurring basis | The following table presents a reconciliation of the beginning and ending balances for all investments measured at fair value on a recurring basis using Level 3 inputs during the three and nine months ended September 30, 2017 and 2016 : Three Months Ended September 30, 2017 Bank Loans Catastrophe Bonds Fixed Income Investment Funds Asset Backed Securities Total Level 3 investments, beginning of period $ 224,172 $ 68,025 $ 16,400 $ 35,921 $ 344,518 Purchases 31,312 — — — 31,312 Sales — — — (71 ) (71 ) Settlements (29,796 ) (1,000 ) 486 — (30,310 ) Change in net unrealized (losses) gains (1,787 ) 1,684 — 137 34 Level 3 investments, end of period $ 223,901 $ 68,709 $ 16,886 $ 35,987 $ 345,483 Three Months Ended September 30, 2016 Bank Loans Catastrophe Bonds Asset Backed Securities Total Level 3 investments, beginning of period $ 243,148 $ 37,518 $ 12,383 $ 293,049 Purchases 21,256 — 11,513 32,769 Sales (12,388 ) — — (12,388 ) Change in net unrealized gains 484 517 — 1,001 Level 3 investments, end of period $ 252,500 $ 38,035 $ 23,896 $ 314,431 Nine Months Ended September 30, 2017 Bank Loans Catastrophe Bonds Fixed Income Investment Funds Asset Backed Securities Total Level 3 investments—beginning of period $ 246,496 $ 48,375 $ 12,168 $ 23,931 $ 330,970 Purchases 71,245 66,091 3,432 11,053 151,821 Sales — — — (124 ) (124 ) Settlements (91,799 ) (49,996 ) 1,286 — (140,509 ) Net realized gains — 3,350 — — 3,350 Change in net unrealized (losses) gains (2,041 ) 889 — 1,127 (25 ) Level 3 investments—end of period $ 223,901 $ 68,709 $ 16,886 $ 35,987 $ 345,483 Nine Months Ended September 30, 2016 Bank Loans Catastrophe Bonds Asset Backed Securities Total Level 3 investments—beginning of period $ 232,337 $ 13,500 $ — $ 245,837 Purchases 72,244 23,272 23,896 119,412 Sales (14,777 ) — — (14,777 ) Settlements (34,033 ) (125 ) — (34,158 ) Change in net unrealized (losses) gains (3,271 ) 1,388 — (1,883 ) Level 3 investments—end of period $ 252,500 $ 38,035 $ 23,896 $ 314,431 |
Variable interest entities (Tab
Variable interest entities (Tables) | 9 Months Ended |
Sep. 30, 2017 | |
Variable Interest Entities Disclosure [Abstract] | |
Summary of notes payable to variable interest entities | The following tables present a reconciliation of the beginning and ending notes payable to AlphaCat investors for the three and nine months ended September 30, 2017 and 2016 : Three Months Ended September 30, 2017 Variable Funding Notes Structured Notes Total Notes payable to AlphaCat investors, beginning of period $ 893,959 $ 172,200 $ 1,066,159 Issuance of notes payable to AlphaCat investors 59,530 — 59,530 Redemption of notes payable to AlphaCat investors (18,627 ) — (18,627 ) Foreign exchange losses 556 — 556 Notes payable to AlphaCat investors, end of period $ 935,418 $ 172,200 $ 1,107,618 Three Months Ended September 30, 2016 Variable Funding Notes Structured Notes Total Notes payable to AlphaCat investors, beginning of period $ 276,656 $ 94,326 $ 370,982 Issuance of notes payable to AlphaCat investors 13,808 — 13,808 Redemption of notes payable to AlphaCat investors (12,028 ) — (12,028 ) Foreign exchange gains (32 ) — (32 ) Notes payable to AlphaCat investors, end of period $ 278,404 $ 94,326 $ 372,730 Nine Months Ended September 30, 2017 Variable Funding Notes Structured Notes Total Notes payable to AlphaCat investors, beginning of period $ 278,202 $ — $ 278,202 Notes payable to AlphaCat investors recognized on deconsolidation of AlphaCat ILS fund 423,269 — 423,269 Issuance of notes payable to AlphaCat investors 601,407 172,200 773,607 Redemption of notes payable to AlphaCat investors (367,733 ) — (367,733 ) Foreign exchange losses 273 — 273 Notes payable to AlphaCat investors, end of period $ 935,418 $ 172,200 $ 1,107,618 Nine Months Ended September 30, 2016 Variable Funding Notes Structured Notes Total Notes payable to AlphaCat investors, beginning of period $ 75,493 $ — $ 75,493 Issuance of notes payable to AlphaCat investors 311,913 94,326 406,239 Redemption of notes payable to AlphaCat investors (109,712 ) — (109,712 ) Foreign exchange losses 710 — 710 Notes payable to AlphaCat investors, end of period $ 278,404 $ 94,326 $ 372,730 |
Total assets and liabilities of the Company's consolidated VIEs | The following table presents the total assets and total liabilities of the Company’s consolidated VIEs, excluding intercompany eliminations, as at September 30, 2017 and December 31, 2016 : September 30, 2017 December 31, 2016 Total Assets Total Liabilities Total Assets Total Liabilities AlphaCat sidecars $ 30,598 $ 3,708 $ 40,041 $ 3,206 AlphaCat ILS funds - Lower Risk (a) 1,019,072 234,192 1,498,276 42,457 AlphaCat ILS funds - Higher Risk (a) 947,135 541,466 972,633 381,332 AlphaCat Re and AlphaCat Master Fund 3,427,625 3,427,455 2,510,415 2,510,245 BetaCat ILS funds 144,766 291 82,471 30,663 (a) Lower risk AlphaCat ILS funds have a maximum permitted portfolio expected loss of less than 7%, whereas higher risk AlphaCat ILS funds have a maximum permitted portfolio expected loss of greater than 7%. Expected loss represents the average annual loss over the set of simulation scenarios divided by the total limit. |
Noncontrolling interest (Tables
Noncontrolling interest (Tables) | 9 Months Ended |
Sep. 30, 2017 | |
Noncontrolling Interest [Abstract] | |
Reconciliation of beginning and ending balances of noncontrolling interest and redeemable noncontrolling interest | The following tables present a reconciliation of the beginning and ending balances of redeemable noncontrolling interests and noncontrolling interests for the three and nine months ended September 30, 2017 and 2016 : Redeemable noncontrolling interests Noncontrolling interests Total Three Months Ended September 30, Three Months Ended September 30, Three Months Ended September 30, 2017 2016 2017 2016 2017 2016 Balance, beginning of period $ 1,251,660 $ 1,532,283 $ 415,658 $ 212,154 $ 1,667,318 $ 1,744,437 Issuance of shares 26,999 700 — — 26,999 700 (Loss) income attributable to noncontrolling interests (140,781 ) 26,597 (235,585 ) 10,842 (376,366 ) 37,439 Redemption of shares / distributions (3,998 ) — (101,126 ) — (105,124 ) — Balance, end of period $ 1,133,880 $ 1,559,580 $ 78,947 $ 222,996 $ 1,212,827 $ 1,782,576 Redeemable noncontrolling interests Noncontrolling interests Total Nine Months Ended September 30, Nine Months Ended September 30, Nine Months Ended September 30, 2017 2016 2017 2016 2017 2016 Balance, beginning of period $ 1,528,001 $ 1,111,714 $ 165,977 $ 154,662 $ 1,693,978 $ 1,266,376 Issuance of shares 237,199 381,950 258,300 171,674 495,499 553,624 Adjustment to noncontrolling interests as a result of deconsolidation (459,021 ) — — — (459,021 ) — (Loss) income attributable to noncontrolling interests (86,296 ) 72,400 (203,848 ) 23,763 (290,144 ) 96,163 Redemption of shares / distributions (86,003 ) (6,484 ) (141,482 ) (127,103 ) (227,485 ) (133,587 ) Balance, end of period $ 1,133,880 $ 1,559,580 $ 78,947 $ 222,996 $ 1,212,827 $ 1,782,576 |
Derivative instruments (Tables)
Derivative instruments (Tables) | 9 Months Ended |
Sep. 30, 2017 | |
Derivative [Line Items] | |
Location and amount of gains and losses related to derivative instruments reported on in the comprehensive income and earnings | The following table provides the total impact on other comprehensive income (loss) and earnings relating to the derivative instruments formally designated as cash flow hedges along with the impact of the related hedged items for the three and nine months ended September 30, 2017 and 2016 : Three Months Ended September 30, Nine Months Ended September 30, Interest rate swap contracts 2017 2016 2017 2016 Amount of effective portion recognized in other comprehensive income $ 1,918 $ 3,155 $ 6,294 $ 9,505 Amount of effective portion subsequently reclassified to earnings $ (1,931 ) $ (2,717 ) $ (6,261 ) $ (8,373 ) Amount of ineffective portion excluded from effectiveness testing $ 13 $ (438 ) $ (33 ) $ (1,132 ) |
Not designated as hedging instruments | |
Derivative [Line Items] | |
Location and fair value amount of derivative instruments reported on the balance sheet | The following table summarizes information on the classification and amount of the fair value of derivatives not designated as hedging instruments for accounting purposes within the Company’s Consolidated Balance Sheets as at September 30, 2017 and December 31, 2016 : September 30, 2017 December 31, 2016 Derivatives not designated as hedging instruments Notional Exposure Asset Derivative at Fair Value (a) Liability Derivative at Fair Value (a) Notional Exposure Asset Derivative at Fair Value (a) Liability Derivative at Fair Value (a) Foreign currency forward contracts $ 267,206 $ 1,522 $ 1,379 $ 181,375 $ 2,351 $ 3,421 Interest rate swap contracts $ 200,000 $ 440 $ 1,607 $ — $ — $ — (a) Asset and liability derivatives are classified within other assets and accounts payable and accrued expenses, respectively, within the Company’s consolidated balance sheets. |
Location and amount of gains and losses related to derivative instruments reported on in the income statement | The following table summarizes information on the classification and net impact on earnings, recognized in the Company’s Consolidated Statements of Income and Comprehensive Income relating to the foreign currency forward and interest rate swap contracts that were not designated as hedging instruments for accounting purposes during the three and nine months ended September 30, 2017 and 2016 : Derivatives not designated as hedging instruments Classification of (losses) gains recognized in earnings Three Months Ended September 30, Nine Months Ended September 30, 2017 2016 2017 2016 Foreign currency forward contracts Foreign exchange (losses) gains $ (1,927 ) $ 1,326 $ (7,999 ) $ 209 Foreign currency forward contracts Other loss $ — $ (155 ) $ (979 ) $ (35 ) Interest rate swap contracts Change in unrealized (losses) gains on investments $ (848 ) $ 566 $ (1,167 ) $ 566 |
Designated as hedging instruments | |
Derivative [Line Items] | |
Location and fair value amount of derivative instruments reported on the balance sheet | The following table summarizes information on the classification and amount of the fair value of derivatives designated as hedging instruments for accounting purposes on the Consolidated Balance Sheets as at September 30, 2017 and December 31, 2016 : September 30, 2017 December 31, 2016 Derivatives designated as hedging instruments Notional Exposure Asset Derivative at Fair Value (a) Liability Derivative at Fair Value (a) Notional Exposure Asset Derivative at Fair Value (a) Liability Derivative at Fair Value (a) Interest rate swap contracts $ 552,263 $ 20 $ 1,347 $ 552,263 $ 20 $ 1,479 (a) Asset and liability derivatives are classified within other assets and accounts payable and accrued expenses, respectively, within the Company’s consolidated balance sheets. |
Reserve for losses and loss e33
Reserve for losses and loss expenses (Tables) | 9 Months Ended |
Sep. 30, 2017 | |
Liability for Future Policy Benefits and Unpaid Claims and Claims Adjustment Expense [Abstract] | |
Summary of reserve for losses and loss expenses | The following table summarizes the total reserve for losses and loss expenses as at September 30, 2017 and December 31, 2016 : September 30, 2017 December 31, 2016 Case reserves $ 1,271,580 $ 1,237,772 IBNR 3,664,057 1,757,423 Total reserve for losses and loss expenses $ 4,935,637 $ 2,995,195 |
Reserve for losses and loss expenses | The following table represents an analysis of paid and unpaid losses and loss expenses incurred and a reconciliation of the beginning and ending unpaid losses and loss expenses for the three and nine months ended September 30, 2017 and 2016 : Three Months Ended September 30, Nine Months Ended September 30, 2017 2016 2017 2016 Reserve for losses and loss expenses, beginning of period $ 3,305,191 $ 3,122,717 $ 2,995,195 $ 2,996,567 Loss reserves recoverable (600,207 ) (442,987 ) (430,421 ) (350,586 ) Net reserves for losses and loss expenses, beginning of period 2,704,984 2,679,730 2,564,774 2,645,981 Net reserves acquired (a) — — 23,753 — Increase (decrease) in net reserves for losses and loss expenses in respect of losses occurring in: Current year 1,329,666 311,279 1,999,921 959,376 Prior years (75,064 ) (52,885 ) (179,585 ) (169,405 ) Total net incurred losses and loss expenses 1,254,602 258,394 1,820,336 789,971 Less net losses and loss expenses paid in respect of losses occurring in: Current year (191,612 ) (178,707 ) (242,068 ) (240,362 ) Prior years (181,094 ) (166,539 ) (612,448 ) (596,618 ) Total net paid losses (372,706 ) (345,246 ) (854,516 ) (836,980 ) Foreign exchange losses (gains) 13,741 (1,500 ) 46,274 (7,594 ) Net reserve for losses and loss expenses, end of period 3,600,621 2,591,378 3,600,621 2,591,378 Loss reserves recoverable 1,335,016 444,609 1,335,016 444,609 Reserve for losses and loss expenses, end of period $ 4,935,637 $ 3,035,987 $ 4,935,637 $ 3,035,987 (a) Equals net reserves acquired of $42,575 less net reserves commuted at closing of $18,822 . Incurred losses and loss expenses comprise: Three Months Ended September 30, Nine Months Ended September 30, 2017 2016 2017 2016 Gross losses and loss expenses $ 2,104,914 $ 284,413 $ 2,866,722 $ 952,129 Reinsurance recoverable (850,312 ) (26,019 ) (1,046,386 ) (162,158 ) Net incurred losses and loss expenses $ 1,254,602 $ 258,394 $ 1,820,336 $ 789,971 |
Prior year development by segment and line of business | The net favorable development on prior years by segment and line of business for the three and nine months ended September 30, 2017 and 2016 was as follows: Three Months Ended September 30, 2017 Property Marine Specialty Liability Total Validus Re $ (26,372 ) $ (7,105 ) $ (14,660 ) $ — $ (48,137 ) Talbot (8,752 ) (2,737 ) (12,125 ) — (23,614 ) Western World 464 — — (526 ) (62 ) AlphaCat (1,471 ) — (1,780 ) — (3,251 ) Net favorable development $ (36,131 ) $ (9,842 ) $ (28,565 ) $ (526 ) $ (75,064 ) The net favorable loss reserve development on prior accident years of $75.1 million during the three months ended September 30, 2017 included favorable development on loss events and attritional losses of $16.1 million and $58.9 million , respectively. Three Months Ended September 30, 2016 Property Marine Specialty Liability Total Validus Re $ (19,736 ) $ (8,504 ) $ (4,793 ) $ — $ (33,033 ) Talbot (2,429 ) (4,547 ) (11,715 ) — (18,691 ) Western World (553 ) — — (327 ) (880 ) AlphaCat (265 ) — (16 ) — (281 ) Net favorable development $ (22,983 ) $ (13,051 ) $ (16,524 ) $ (327 ) $ (52,885 ) The net favorable loss reserve development on prior accident years of $52.9 million during the three months ended September 30, 2016 included favorable development on loss events and attritional losses of $20.3 million and $32.6 million , respectively. Nine Months Ended September 30, 2017 Property Marine Specialty Liability Total Validus Re $ (30,614 ) $ (38,847 ) $ (30,555 ) $ — $ (100,016 ) Talbot (19,980 ) (35,789 ) (12,535 ) — (68,304 ) Western World (2,838 ) — — 2,094 (744 ) AlphaCat (8,963 ) — (1,558 ) — (10,521 ) Net (favorable) adverse development $ (62,395 ) $ (74,636 ) $ (44,648 ) $ 2,094 $ (179,585 ) The net favorable loss reserve development on prior accident years of $179.6 million during the nine months ended September 30, 2017 included favorable development on loss events and attritional losses of $31.5 million and $148.0 million , respectively. Nine Months Ended September 30, 2016 Property Marine Specialty Liability Total Validus Re $ (52,036 ) $ (14,967 ) $ (22,591 ) $ — $ (89,594 ) Talbot (30,969 ) (10,511 ) (28,259 ) — (69,739 ) Western World (2,576 ) — — (5,888 ) (8,464 ) AlphaCat (742 ) — (866 ) — (1,608 ) Net favorable development $ (86,323 ) $ (25,478 ) $ (51,716 ) $ (5,888 ) $ (169,405 ) The net favorable development on prior accident years of $169.4 million during the nine months ended September 30, 2016 |
Reinsurance (Tables)
Reinsurance (Tables) | 9 Months Ended |
Sep. 30, 2017 | |
Reinsurance Disclosures [Abstract] | |
Schedule of reinsurance recoverable | The Company’s reinsurance balances recoverable at September 30, 2017 and December 31, 2016 were as follows: September 30, 2017 December 31, 2016 Loss reserves recoverable on unpaid: Case reserves $ 207,368 $ 165,328 IBNR 1,127,648 265,093 Total loss reserves recoverable 1,335,016 430,421 Paid losses recoverable 77,730 35,247 Total reinsurance balances recoverable $ 1,412,746 $ 465,668 |
Reinsurance recoverables by reinsurer | Reinsurance balances recoverable by reinsurer as at September 30, 2017 and December 31, 2016 were as follows: September 30, 2017 December 31, 2016 Reinsurance Recoverable % of Total Reinsurance Recoverable % of Total Top 10 reinsurers $ 1,208,003 85.5 % $ 395,308 84.9 % Other reinsurers’ balances > $1 million 198,774 14.1 % 66,944 14.4 % Other reinsurers’ balances < $1 million 5,969 0.4 % 3,416 0.7 % Total $ 1,412,746 100.0 % $ 465,668 100.0 % The following tables show the reinsurance balances recoverable due from, and the ratings associated with, the Company’s top ten reinsurers as at September 30, 2017 and December 31, 2016 : September 30, 2017 Top 10 Reinsurers Rating Reinsurance Recoverable % of Total Fully collateralized reinsurers NR $ 564,714 40.0 % Munich Re AA- 164,131 11.6 % Everest Re A+ 95,759 6.8 % Lloyd's Syndicates A+ 94,845 6.7 % Swiss Re AA- 81,921 5.8 % Hannover Re AA- 62,715 4.4 % Federal Crop Insurance Corporation (a) 49,503 3.5 % Qatar Insurance Company A 38,061 2.7 % Transatlantic Re A+ 29,795 2.1 % XL Catlin A+ 26,559 1.9 % Total $ 1,208,003 85.5 % (a) The Company participates in a crop reinsurance program sponsored by the U.S. federal government. The Company remains obligated for amounts ceded in the event that its reinsurers or retrocessionaires do not meet their obligations, except for amounts ceded to the U.S. federal government in the agriculture line of business. December 31, 2016 Top 10 Reinsurers Rating Reinsurance Recoverable % of Total Lloyd's Syndicates A+ $ 84,419 18.2 % Swiss Re AA- 84,044 18.1 % Fully collateralized reinsurers NR 83,088 17.8 % Hannover Re AA- 50,603 10.9 % Everest Re A+ 36,912 7.9 % Munich Re AA- 18,214 3.9 % Transatlantic Re A+ 10,593 2.3 % Hamilton Re A- 10,343 2.2 % Toa Re A+ 9,510 2.0 % National Indemnity Company AA+ 7,582 1.6 % Total $ 395,308 84.9 % |
Share capital (Tables)
Share capital (Tables) | 9 Months Ended |
Sep. 30, 2017 | |
Stockholders' Equity Note [Abstract] | |
Summary of preferred shares issued and outstanding | The following table is a summary of the preferred share activity during the nine months ended September 30, 2017 and 2016 : Nine Months Ended September 30, 2017 2016 Preferred shares issued and outstanding, beginning of period 6,000 — Preferred shares issued 10,000 6,000 Preferred shares issued and outstanding, end of period 16,000 6,000 |
Summary of common shares issued and outstanding | The following table is a summary of the common share activity during the nine months ended September 30, 2017 and 2016 : Nine Months Ended September 30, 2017 2016 Common shares issued, beginning of period 161,279,976 160,570,772 Restricted share awards vested, net of shares withheld 619,046 608,024 Restricted share units vested, net of shares withheld 15,454 18,486 Options exercised — 27,983 Performance share awards vested, net of shares withheld 42,410 48,088 Common shares issued, end of period 161,956,886 161,273,353 Treasury shares, end of period (82,499,633 ) (81,830,323 ) Common shares outstanding, end of period 79,457,253 79,443,030 |
Stock plans (Tables)
Stock plans (Tables) | 9 Months Ended |
Sep. 30, 2017 | |
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |
Options, activity during the period | Activity with respect to options for the nine months ended September 30, 2017 and 2016 was as follows: Nine Months Ended September 30, 2017 2016 Options Weighted Average Grant Date Fair Value Weighted Average Grant Date Exercise Price Options Weighted Average Grant Date Fair Value Weighted Average Grant Date Exercise Price Options outstanding, beginning of period 26,136 $ 6.78 $ 23.48 65,401 $ 7.74 $ 20.17 Options exercised — — — (35,351 ) 8.16 17.82 Options outstanding, end of period 26,136 $ 6.78 $ 23.48 30,050 $ 7.24 $ 22.93 |
Restricted shares awards, activity during the period | Activity with respect to unvested restricted share awards for the nine months ended September 30, 2017 and 2016 was as follows: Nine Months Ended September 30, 2017 2016 Restricted Share Awards Weighted Average Grant Date Fair Value Restricted Share Awards Weighted Average Grant Date Fair Value Restricted share awards outstanding, beginning of period 2,469,982 $ 40.89 2,739,446 $ 38.25 Restricted share awards granted 508,186 53.25 559,516 48.78 Restricted share awards vested (828,800 ) 41.25 (789,547 ) 37.36 Restricted share awards forfeited (53,775 ) 43.38 (33,070 ) 40.25 Restricted share awards outstanding, end of period 2,095,593 $ 43.69 2,476,345 $ 40.88 |
Restricted share units, activity during the period | Activity with respect to unvested restricted share units for the nine months ended September 30, 2017 and 2016 was as follows: Nine Months Ended September 30, 2017 2016 Restricted Share Units Weighted Average Grant Date Fair Value Restricted Share Units Weighted Average Grant Date Fair Value Restricted share units outstanding, beginning of period 112,808 $ 40.95 114,337 $ 38.47 Restricted share units granted 12,236 53.40 21,609 48.83 Restricted share units vested (18,748 ) 41.91 (23,982 ) 38.18 Restricted share units issued in lieu of cash dividends 2,260 41.42 2,436 39.10 Restricted share units forfeited — — (8,338 ) 44.34 Restricted share units outstanding, end of period 108,556 $ 42.20 106,062 $ 40.20 |
Performance share awards, activity during the period | Activity with respect to unvested performance share awards for the nine months ended September 30, 2017 and 2016 was as follows: Nine Months Ended September 30, 2017 2016 Performance Share Awards Weighted Average Grant Date Fair Value Performance Share Awards Weighted Average Grant Date Fair Value Performance share awards outstanding, beginning of period 285,820 $ 44.53 172,594 $ 40.70 Performance share awards granted 107,209 53.40 125,290 48.75 Performance share awards vested (52,639 ) 37.33 (57,581 ) 36.11 Performance share awards conversion adjustment (26,322 ) 36.82 45,517 36.82 Performance share awards outstanding, end of period 314,068 $ 49.37 285,820 $ 44.53 |
Total share compensation expenses | The breakdown of share compensation expenses by award type for the periods indicated was as follows: Three Months Ended September 30, Nine Months Ended September 30, 2017 2016 2017 2016 Restricted share awards $ 7,814 $ 9,159 $ 26,603 $ 27,805 Restricted share units 340 290 982 978 Performance share awards 1,289 1,052 2,495 3,682 Total $ 9,443 $ 10,501 $ 30,080 $ 32,465 |
Debt and financing arrangemen37
Debt and financing arrangements (Tables) | 9 Months Ended |
Sep. 30, 2017 | |
Debt Disclosure [Abstract] | |
Summary of outstanding debentures and senior notes payable | The Company’s outstanding debentures and senior notes payable as at September 30, 2017 and December 31, 2016 were as follows: September 30, 2017 December 31, 2016 Deferrable debentures 2006 Junior Subordinated $ 150,000 $ 150,000 2007 Junior Subordinated 139,800 139,800 Flagstone 2006 Junior Subordinated 135,360 133,676 Flagstone 2007 Junior Subordinated 113,750 113,750 Total debentures payable 538,910 537,226 2010 Senior notes payable 250,000 250,000 Less: Unamortized debt issuance costs (4,487 ) (4,638 ) Total senior notes payable 245,513 245,362 Total debentures and senior notes payable $ 784,423 $ 782,588 |
Summary of key terms of debentures and senior notes | The following table summarizes the key terms of the Company’s senior notes and junior subordinated deferrable debentures: Description Issuance date Issued Maturity date Interest Rate as at Interest payments due Issuance Date September 30, 2017 2006 Junior Subordinated Deferrable Debentures June 15, 2006 $ 150,000 June 15, 2036 9.069 % (a) 5.831 % (e) Quarterly Flagstone 2006 Junior Subordinated Deferrable Debentures August 23, 2006 $ 135,360 September 15, 2036 3.540 % (b) 6.463 % (e) Quarterly 2007 Junior Subordinated Deferrable Debentures June 21, 2007 $ 200,000 June 15, 2037 8.480 % (c) 5.180 % (e) Quarterly Flagstone 2007 Junior Subordinated Deferrable Debentures June 8, 2007 $ 100,000 July 30, 2037 3.000 % (b) 5.900 % (e) Quarterly Flagstone 2007 Junior Subordinated Deferrable Debentures September 20, 2007 $ 25,000 September 15, 2037 3.100 % (b) 5.983 % (e) Quarterly 2010 Senior Notes due 2040 January 26, 2010 $ 250,000 January 26, 2040 8.875 % (d) 8.875 % (d) Semi-annually in arrears (a) Fixed interest rate for 5 years , floating interest rate of three-month LIBOR plus 3.550% thereafter, reset quarterly. (b) Floating interest rate of three-month LIBOR plus amount stated, reset quarterly. (c) Fixed interest rate for 5 years , floating interest rate of three-month LIBOR plus 2.950% thereafter, reset quarterly. (d) Fixed interest rate. (e) Fixed interest rate as a result of interest rate swap contracts entered into by the Company. |
Summary of outstanding credit and other facilities | The Company’s outstanding credit facilities as at September 30, 2017 and December 31, 2016 were as follows: September 30, 2017 Commitment Outstanding (a) Drawn (b) Cash and investments pledged as collateral Credit facilities $85,000 syndicated unsecured letter of credit facility $ 85,000 $ — $ — $ — $300,000 syndicated secured letter of credit facility 300,000 89,449 — 108,265 $24,000 secured bi-lateral letter of credit facility 24,000 5,767 — 22,342 $25,000 IPC bi-lateral facility 25,000 7,755 — — $236,000 Flagstone bi-lateral facility 236,000 90,390 — 134,482 $65,000 unsecured revolving credit facility 65,000 65,000 65,000 — $100,000 unsecured revolving credit facility 100,000 100,000 100,000 — Total credit facilities $ 835,000 $ 358,361 $ 165,000 $ 265,089 (a) Indicates utilization of commitment amount, not drawn borrowings. (b) Represents drawn borrowings included in accounts payable and accrued expenses. December 31, 2016 Commitment Outstanding (a) Drawn (b) Cash and investments pledged as collateral Credit facilities $85,000 syndicated unsecured letter of credit facility $ 85,000 $ — $ — $ — $300,000 syndicated secured letter of credit facility 300,000 121,428 — 157,597 $24,000 secured bi-lateral letter of credit facility 24,000 4,553 — 48,097 $20,000 AlphaCat Re secured letter of credit facility (c) 20,000 20,000 — 20,032 $25,000 IPC bi-lateral facility 25,000 8,807 — — $236,000 Flagstone bi-lateral facility 236,000 156,375 — 216,458 Total credit facilities $ 690,000 $ 311,163 $ — $ 442,184 (a) Indicates utilization of commitment amount, not drawn borrowings. (b) Represents drawn borrowings. (c) The Company terminated its AlphaCat Re secured letter of credit facility on January 6, 2017. |
Components of finance expenses | Finance expenses consist of interest on the junior subordinated deferrable debentures and senior notes, the amortization of debt offering costs, credit facility fees, bank charges, AlphaCat financing fees and other charges as follows: Three Months Ended September 30, Nine Months Ended September 30, 2017 2016 2017 2016 2006 Junior Subordinated Deferrable Debentures $ 2,235 $ 2,135 $ 6,633 $ 6,557 2007 Junior Subordinated Deferrable Debentures 1,851 1,851 5,492 5,512 Flagstone 2006 Junior Subordinated Deferrable Debentures 2,272 2,271 6,741 6,760 Flagstone 2007 Junior Subordinated Deferrable Debentures 1,775 1,784 5,249 5,317 2010 Senior Notes due 2040 5,597 5,597 16,792 16,791 Credit facilities 575 463 1,196 1,359 Bank and other charges 183 276 465 489 AlphaCat fees (a) 35 144 107 1,105 Total finance expenses $ 14,523 $ 14,521 $ 42,675 $ 43,890 (a) Includes finance expenses incurred by AlphaCat Managers Ltd. in relation to fund raising for the AlphaCat sidecars, the AlphaCat ILS funds and AlphaCat direct. |
Accumulated other comprehensi38
Accumulated other comprehensive loss (Tables) | 9 Months Ended |
Sep. 30, 2017 | |
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] | |
Schedule of changes in accumulated other comprehensive loss | The changes in accumulated other comprehensive loss, by component for the three and nine months ended September 30, 2017 and 2016 was as follows: Three Months Ended September 30, 2017 Foreign currency translation adjustment Minimum pension liability Cash flow hedge Total Balance, net of tax, beginning of period $ (20,188 ) $ 1,102 $ (838 ) $ (19,924 ) Other comprehensive income, net of tax 1,481 — 13 1,494 Balance, net of tax, end of period $ (18,707 ) $ 1,102 $ (825 ) $ (18,430 ) Three Months Ended September 30, 2016 Foreign currency translation adjustment Minimum pension liability Cash flow hedge Total Balance, net of tax, beginning of period $ (17,149 ) $ 730 $ (1,763 ) $ (18,182 ) Other comprehensive loss, net of tax (1,370 ) (1,101 ) (439 ) (2,910 ) Balance, net of tax, end of period $ (18,519 ) $ (371 ) $ (2,202 ) $ (21,092 ) Nine Months Ended September 30, 2017 Foreign currency translation adjustment Minimum pension liability Cash flow hedge Total Balance, net of tax, beginning of period $ (22,274 ) $ (150 ) $ (792 ) $ (23,216 ) Other comprehensive income (loss), net of tax 3,567 1,252 (33 ) 4,786 Balance, net of tax, end of period $ (18,707 ) $ 1,102 $ (825 ) $ (18,430 ) Nine Months Ended September 30, 2016 Foreign currency translation adjustment Minimum pension liability Cash flow hedge Total Balance, net of tax, beginning of period $ (11,834 ) $ 334 $ (1,069 ) $ (12,569 ) Other comprehensive loss, net of tax (6,685 ) (705 ) (1,133 ) (8,523 ) Balance, net of tax, end of period $ (18,519 ) $ (371 ) $ (2,202 ) $ (21,092 ) |
Commitments and contingencies (
Commitments and contingencies (Tables) | 9 Months Ended |
Sep. 30, 2017 | |
Commitments and Contingencies Disclosure [Abstract] | |
Unfunded investment commitments | As at September 30, 2017 and December 31, 2016 , the Company had total unfunded investment commitments related to the following: Unfunded investment commitments September 30, 2017 December 31, 2016 Fixed maturity investments (a) $ 21,959 $ 28,499 Other investments (b) 101,082 156,134 Investments in investment affiliates (c) 87,372 64,071 AlphaCat ILS Fund — 10,000 Total unfunded investment commitments $ 210,413 $ 258,704 (a) The Company has an outstanding commitment to participate in certain secured loan facilities through participation agreements with an established loan originator. (b) The Company’s total capital commitments related to other investments as at September 30, 2017 was $313,000 ( December 31, 2016 : $308,000 ). (c) Refer to Note 4 (c), “Investments in Investment Affiliates.” |
Earnings per share (Tables)
Earnings per share (Tables) | 9 Months Ended |
Sep. 30, 2017 | |
Earnings Per Share [Abstract] | |
Computation of basic and diluted earnings per share | The following table sets forth the computation of basic earnings per common share and earnings per diluted common share for the three and nine months ended September 30, 2017 and 2016 : Three Months Ended September 30, Nine Months Ended September 30, 2017 2016 2017 2016 Basic (loss) earnings per common share Net (loss) income (attributable) available to Validus common shareholders $ (250,446 ) $ 89,844 $ (54,790 ) $ 351,617 Weighted average number of common shares outstanding 78,994,335 80,134,394 79,132,856 81,635,496 Basic (loss) earnings per share (attributable) available to Validus common shareholders $ (3.17 ) $ 1.12 $ (0.69 ) $ 4.31 (Loss) earnings per diluted common share Net (loss) income (attributable) available to Validus common shareholders $ (250,446 ) $ 89,844 $ (54,790 ) $ 351,617 Weighted average number of common shares outstanding 78,994,335 80,134,394 79,132,856 81,635,496 Share equivalents: Stock options — 26,705 — 32,126 Unvested restricted shares — 1,083,457 — 1,271,002 Weighted average number of diluted common shares outstanding 78,994,335 81,244,556 79,132,856 82,938,624 (Loss) earnings per diluted share (attributable) available to Validus common shareholders $ (3.17 ) $ 1.11 $ (0.69 ) $ 4.24 |
Segment information (Tables)
Segment information (Tables) | 9 Months Ended |
Sep. 30, 2017 | |
Segment Reporting [Abstract] | |
Summary of results of operating segments and Corporate and Investments | The following tables summarize the results of our operating segments and “Corporate and Investments”: Three Months Ended September 30, Nine Months Ended September 30, Validus Re Segment Information 2017 2016 2017 2016 Underwriting revenues Gross premiums written $ 153,890 $ 94,741 $ 1,071,409 $ 1,072,219 Reinsurance premiums ceded (40,988 ) (15,967 ) (161,188 ) (111,658 ) Net premiums written 112,902 78,774 910,221 960,561 Change in unearned premiums 154,145 149,705 (184,155 ) (241,129 ) Net premiums earned 267,047 228,479 726,066 719,432 Other insurance related income (loss) 68 58 204 (107 ) Total underwriting revenues 267,115 228,537 726,270 719,325 Underwriting deductions Losses and loss expenses 347,484 98,425 538,323 313,432 Policy acquisition costs 45,422 42,837 133,836 127,660 General and administrative expenses 12,444 17,528 48,550 52,579 Share compensation expenses 2,606 2,695 7,746 8,371 Total underwriting deductions 407,956 161,485 728,455 502,042 Underwriting (loss) income $ (140,841 ) $ 67,052 $ (2,185 ) $ 217,283 Selected ratios Ratio of net to gross premiums written 73.4 % 83.1 % 85.0 % 89.6 % Losses and loss expense ratio 130.1 % 43.1 % 74.1 % 43.6 % Policy acquisition cost ratio 17.0 % 18.7 % 18.4 % 17.7 % General and administrative expense ratio (a) 5.7 % 8.9 % 7.8 % 8.5 % Expense ratio 22.7 % 27.6 % 26.2 % 26.2 % Combined ratio 152.8 % 70.7 % 100.3 % 69.8 % (a) The general and administrative expense ratio includes share compensation expenses. Three Months Ended September 30, Nine Months Ended September 30, Talbot Segment Information 2017 2016 2017 2016 Underwriting revenues Gross premiums written $ 192,883 $ 189,674 $ 702,535 $ 752,058 Reinsurance premiums ceded (36,462 ) (22,877 ) (154,263 ) (137,496 ) Net premiums written 156,421 166,797 548,272 614,562 Change in unearned premiums 23,191 32,258 18,279 (7,166 ) Net premiums earned 179,612 199,055 566,551 607,396 Other insurance related income 692 99 1,512 389 Total underwriting revenues 180,304 199,154 568,063 607,785 Underwriting deductions Losses and loss expenses 178,440 109,860 378,241 319,271 Policy acquisition costs 41,493 46,488 129,074 134,444 General and administrative expenses 23,069 32,333 97,094 109,929 Share compensation expenses 2,310 3,163 8,292 9,955 Total underwriting deductions 245,312 191,844 612,701 573,599 Underwriting (loss) income $ (65,008 ) $ 7,310 $ (44,638 ) $ 34,186 Selected ratios Ratio of net to gross premiums written 81.1 % 87.9 % 78.0 % 81.7 % Losses and loss expense ratio 99.3 % 55.2 % 66.8 % 52.6 % Policy acquisition cost ratio 23.1 % 23.4 % 22.8 % 22.1 % General and administrative expense ratio (a) 14.2 % 17.8 % 18.5 % 19.7 % Expense ratio 37.3 % 41.2 % 41.3 % 41.8 % Combined ratio 136.6 % 96.4 % 108.1 % 94.4 % (a) The general and administrative expense ratio includes share compensation expenses. Three Months Ended September 30, Nine Months Ended September 30, Western World Segment Information 2017 2016 2017 2016 Underwriting revenues Gross premiums written $ 156,517 $ 85,260 $ 459,628 $ 236,190 Reinsurance premiums ceded (43,207 ) (6,202 ) (72,005 ) (15,347 ) Net premiums written 113,310 79,058 387,623 220,843 Change in unearned premiums 61,603 (8,260 ) 15,256 (22,890 ) Net premiums earned 174,913 70,798 402,879 197,953 Other insurance related income 662 219 1,566 696 Total underwriting revenues 175,575 71,017 404,445 198,649 Underwriting deductions Losses and loss expenses 157,709 45,748 329,642 129,623 Policy acquisition costs 20,721 17,094 60,187 46,704 General and administrative expenses 21,553 10,171 50,623 33,704 Share compensation expenses 354 702 1,655 1,825 Total underwriting deductions 200,337 73,715 442,107 211,856 Underwriting (loss) $ (24,762 ) $ (2,698 ) $ (37,662 ) $ (13,207 ) Selected ratios Ratio of net to gross premiums written 72.4 % 92.7 % 84.3 % 93.5 % Losses and loss expense ratio 90.2 % 64.6 % 81.8 % 65.5 % Policy acquisition cost ratio 11.8 % 24.1 % 14.9 % 23.6 % General and administrative expense ratio (a) 12.5 % 15.4 % 13.0 % 17.9 % Expense ratio 24.3 % 39.5 % 27.9 % 41.5 % Combined ratio 114.5 % 104.1 % 109.7 % 107.0 % (a) The general and administrative expense ratio includes share compensation expenses. Three Months Ended September 30, Nine Months Ended September 30, AlphaCat Segment Information 2017 2016 2017 2016 Fee revenues Third party $ 5,095 $ 7,025 $ 15,288 $ 14,843 Related party 457 1,373 1,732 2,592 Total fee revenues 5,552 8,398 17,020 17,435 Expenses General and administrative expenses 2,929 3,324 10,322 7,557 Share compensation expenses 183 (107 ) 348 167 Finance expenses 32 31 107 914 Tax (benefit) expense (65 ) — 69 — Foreign exchange losses 7 5 7 17 Total expenses 3,086 3,253 10,853 8,655 Income before investments from AlphaCat Funds and Sidecars 2,466 5,145 6,167 8,780 Investment (loss) income from AlphaCat Funds and Sidecars (a) AlphaCat Sidecars 201 (72 ) 68 593 AlphaCat ILS Funds - Lower Risk (b) (7,553 ) 2,321 (4,063 ) 6,903 AlphaCat ILS Funds - Higher Risk (b) (21,816 ) 2,479 (16,849 ) 5,607 BetaCat ILS Funds (922 ) 1,303 (291 ) 2,979 PaCRe — — — (23 ) Validus’ share of investment (loss) income from AlphaCat Funds and Sidecars (30,090 ) 6,031 (21,135 ) 16,059 Validus’ share of AlphaCat segment (loss) income $ (27,624 ) $ 11,176 $ (14,968 ) $ 24,839 Supplemental information Gross premiums written AlphaCat Sidecars $ — $ (112 ) $ 66 $ (178 ) AlphaCat ILS Funds - Lower Risk (b) 10,979 2,049 117,519 112,241 AlphaCat ILS Funds - Higher Risk (b) 16,275 1,797 153,483 140,127 AlphaCat Direct (c) (41 ) 679 26,753 18,476 Total gross premiums written $ 27,213 $ 4,413 $ 297,821 $ 270,666 (a) The investment (loss) income from the AlphaCat funds and sidecars is based on equity accounting. (b) Lower risk AlphaCat ILS funds have a maximum permitted portfolio expected loss of less than 7%, whereas higher risk AlphaCat ILS funds have a maximum permitted portfolio expected loss of greater than 7%. Expected loss represents the average annual loss over the set of simulation scenarios divided by the total limit. (c) AlphaCat Direct includes direct investments from third party investors in AlphaCat Re. Three Months Ended September 30, Nine Months Ended September 30, Corporate and Investments 2017 2016 2017 2016 Managed investments Managed net investment income (a) $ 37,091 $ 41,071 $ 111,346 $ 105,843 Net realized gains on managed investments (a) 903 4,080 280 5,514 Change in net unrealized gains on managed investments (a) 941 4,652 31,232 81,782 Income (loss) from investment affiliates 1,011 453 15,665 (4,249 ) Total managed investment return 39,946 50,256 158,523 188,890 Corporate expenses General and administrative expenses 9,539 18,221 45,563 52,276 Share compensation expenses 3,990 4,048 12,039 12,147 Finance expenses (a) 14,449 14,317 42,462 42,637 Dividends on preferred shares 5,627 2,252 10,033 2,252 Tax (benefit) expense (a) (2,567 ) 1,830 (7,237 ) 1,418 Total Corporate expenses 31,038 40,668 102,860 110,730 Other items Foreign exchange (losses) (a) (1,495 ) (1,067 ) (7,715 ) 11,628 Other income (loss) 35 (1,529 ) 303 (773 ) Transaction expenses — — (4,427 ) — Total other items (1,460 ) (2,596 ) (11,839 ) 10,855 Total Corporate and Investments $ 7,448 $ 6,992 $ 43,824 $ 89,015 (a) These items exclude the components which are included in Validus’ share of AlphaCat and amounts which are consolidated from VIEs. The following tables reconcile the results of our operating segments along with our corporate and investments function to the Consolidated results of the Company for the periods indicated: Three Months Ended September 30, 2017 Validus Re Segment Talbot Segment Western World Segment AlphaCat Segment and Consolidated VIEs Corporate and Investments Eliminations Total Underwriting revenues Gross premiums written $ 153,890 $ 192,883 $ 156,517 $ 27,213 $ — $ (6,647 ) $ 523,856 Reinsurance premiums ceded (40,988 ) (36,462 ) (43,207 ) (2,850 ) — 6,647 (116,860 ) Net premiums written 112,902 156,421 113,310 24,363 — — 406,996 Change in unearned premiums 154,145 23,191 61,603 77,273 — — 316,212 Net premiums earned 267,047 179,612 174,913 101,636 — — 723,208 Other insurance related income 68 692 662 6,083 — (3,969 ) 3,536 Total underwriting revenues 267,115 180,304 175,575 107,719 — (3,969 ) 726,744 Underwriting deductions Losses and loss expenses 347,484 178,440 157,709 570,969 — — 1,254,602 Policy acquisition costs 45,422 41,493 20,721 8,314 — (360 ) 115,590 General and administrative expenses 12,444 23,069 21,553 7,687 9,539 (3,950 ) 70,342 Share compensation expenses 2,606 2,310 354 183 3,990 — 9,443 Total underwriting deductions 407,956 245,312 200,337 587,153 13,529 (4,310 ) 1,449,977 Underwriting (loss) $ (140,841 ) $ (65,008 ) $ (24,762 ) $ (479,434 ) $ (13,529 ) $ 341 $ (723,233 ) Net investment return (a) — — — 1,232 39,946 — 41,178 Other items (b) — — — 82 (18,969 ) — (18,887 ) Loss attributable to AlphaCat investors — — — 74,130 — — 74,130 Net loss attributable to noncontrolling interest — — — 376,366 — — 376,366 Segmental (loss) $ (140,841 ) $ (65,008 ) $ (24,762 ) $ (27,624 ) $ 7,448 $ 341 Net loss attributable to Validus common shareholders $ (250,446 ) (a) Net investment return includes net investment income, net realized and change in net unrealized gains (losses) on investments and income (loss) from investment affiliates. (b) Other items includes finance expenses, transaction expenses, dividends on preferred shares, tax benefit (expense), foreign exchange gains (losses), income (loss) from operating affiliate and other income (loss). Three Months Ended September 30, 2016 Validus Re Segment Talbot Segment Western World Segment AlphaCat Segment and Consolidated VIEs Corporate and Investments Eliminations Total Underwriting revenues Gross premiums written $ 94,741 $ 189,674 $ 85,260 $ 4,413 $ — $ (1,670 ) $ 372,418 Reinsurance premiums ceded (15,967 ) (22,877 ) (6,202 ) (1,630 ) — 1,670 (45,006 ) Net premiums written 78,774 166,797 79,058 2,783 — — 327,412 Change in unearned premiums 149,705 32,258 (8,260 ) 62,660 — — 236,363 Net premiums earned 228,479 199,055 70,798 65,443 — — 563,775 Other insurance related income 58 99 219 8,656 — (8,113 ) 919 Total underwriting revenues 228,537 199,154 71,017 74,099 — (8,113 ) 564,694 Underwriting deductions Losses and loss expenses 98,425 109,860 45,748 4,361 — — 258,394 Policy acquisition costs 42,837 46,488 17,094 7,075 — (60 ) 113,434 General and administrative expenses 17,528 32,333 10,171 12,255 18,221 (8,065 ) 82,443 Share compensation expenses 2,695 3,163 702 (107 ) 4,048 — 10,501 Total underwriting deductions 161,485 191,844 73,715 23,584 22,269 (8,125 ) 464,772 Underwriting income (loss) $ 67,052 $ 7,310 $ (2,698 ) $ 50,515 $ (22,269 ) $ 12 $ 99,922 Net investment return (a) — — — 3,567 50,256 — 53,823 Other items (b) — — — 97 (20,995 ) — (20,898 ) (Income) attributable to AlphaCat investors — — — (5,564 ) — — (5,564 ) Net (income) attributable to noncontrolling interest — — — (37,439 ) — — (37,439 ) Segmental income (loss) $ 67,052 $ 7,310 $ (2,698 ) $ 11,176 $ 6,992 $ 12 Net income available to Validus common shareholders $ 89,844 (a) Net investment return includes net investment income, net realized and change in net unrealized gains (losses) on investments and income (loss) from investment affiliates. (b) Other items includes finance expenses, transaction expenses, dividends on preferred shares, tax benefit (expense), foreign exchange gains (losses), income (loss) from operating affiliate and other income (loss). Nine Months Ended September 30, 2017 Validus Re Segment Talbot Segment Western World Segment AlphaCat Segment and Consolidated VIEs Corporate and Investments Eliminations Total Underwriting revenues Gross premiums written $ 1,071,409 $ 702,535 $ 459,628 $ 297,821 $ — $ (23,778 ) $ 2,507,615 Reinsurance premiums ceded (161,188 ) (154,263 ) (72,005 ) (9,510 ) — 23,778 (373,188 ) Net premiums written 910,221 548,272 387,623 288,311 — — 2,134,427 Change in unearned premiums (184,155 ) 18,279 15,256 (54,196 ) — — (204,816 ) Net premiums earned 726,066 566,551 402,879 234,115 — — 1,929,611 Other insurance related income 204 1,512 1,566 17,118 — (14,463 ) 5,937 Total underwriting revenues 726,270 568,063 404,445 251,233 — (14,463 ) 1,935,548 Underwriting deductions Losses and loss expenses 538,323 378,241 329,642 574,130 — — 1,820,336 Policy acquisition costs 133,836 129,074 60,187 22,380 — (991 ) 344,486 General and administrative expenses 48,550 97,094 50,623 27,096 45,563 (14,311 ) 254,615 Share compensation expenses 7,746 8,292 1,655 348 12,039 — 30,080 Total underwriting deductions 728,455 612,701 442,107 623,954 57,602 (15,302 ) 2,449,517 Underwriting (loss) $ (2,185 ) $ (44,638 ) $ (37,662 ) $ (372,721 ) $ (57,602 ) $ 839 $ (513,969 ) Net investment return (a) — — — 12,543 158,523 — 171,066 Other items (b) — — — 269 (57,097 ) — (56,828 ) Loss attributable to AlphaCat investors — — — 54,797 — — 54,797 Net loss attributable to noncontrolling interest — — — 290,144 — — 290,144 Segmental (loss) $ (2,185 ) $ (44,638 ) $ (37,662 ) $ (14,968 ) $ 43,824 $ 839 Net loss attributable to Validus common shareholders $ (54,790 ) (a) Net investment return includes net investment income, net realized and change in net unrealized gains (losses) on investments and income (loss) from investment affiliates. (b) Other items includes finance expenses, transaction expenses, dividends on preferred shares, tax benefit (expense), foreign exchange gains (losses), income (loss) from operating affiliate and other income (loss). Nine Months Ended September 30, 2016 Validus Re Segment Talbot Segment Western World Segment AlphaCat Segment and Consolidated VIEs Corporate and Investments Eliminations Total Underwriting revenues Gross premiums written $ 1,072,219 $ 752,058 $ 236,190 $ 270,666 $ — $ (21,882 ) $ 2,309,251 Reinsurance premiums ceded (111,658 ) (137,496 ) (15,347 ) (6,451 ) — 21,882 (249,070 ) Net premiums written 960,561 614,562 220,843 264,215 — — 2,060,181 Change in unearned premiums (241,129 ) (7,166 ) (22,890 ) (80,230 ) — — (351,415 ) Net premiums earned 719,432 607,396 197,953 183,985 — — 1,708,766 Other insurance related (loss) income (107 ) 389 696 17,722 — (16,300 ) 2,400 Total underwriting revenues 719,325 607,785 198,649 201,707 — (16,300 ) 1,711,166 Underwriting deductions Losses and loss expenses 313,432 319,271 129,623 27,645 — — 789,971 Policy acquisition costs 127,660 134,444 46,704 19,762 — 23 328,593 General and administrative expenses 52,579 109,929 33,704 26,272 52,276 (16,421 ) 258,339 Share compensation expenses 8,371 9,955 1,825 167 12,147 — 32,465 Total underwriting deductions 502,042 573,599 211,856 73,846 64,423 (16,398 ) 1,409,368 Underwriting income (loss) $ 217,283 $ 34,186 $ (13,207 ) $ 127,861 $ (64,423 ) $ 98 $ 301,798 Net investment return (a) — — — 10,558 188,890 (597 ) 198,851 Other items (b) — — — (1,139 ) (35,452 ) — (36,591 ) (Income) attributable to AlphaCat investors — — — (16,278 ) — — (16,278 ) Net (income) attributable to noncontrolling interest — — — (96,163 ) — — (96,163 ) Segmental income (loss) $ 217,283 $ 34,186 $ (13,207 ) $ 24,839 $ 89,015 $ (499 ) Net income available to Validus common shareholders $ 351,617 (a) Net investment return includes net investment income, net realized and change in net unrealized gains (losses) on investments and income (loss) from investment affiliates. (b) Other items includes finance expenses, transaction expenses, dividends on preferred shares, tax benefit (expense), foreign exchange gains (losses), income (loss) from operating affiliate and other income (loss). |
Gross premiums written allocated to the territory of coverage exposure | The following tables set forth the gross premiums written by operating segment allocated to the territory of coverage exposure for the periods indicated: Gross Premiums Written Three Months Ended September 30, 2017 Validus Re Talbot Western World AlphaCat Eliminations Total % United States $ 59,838 $ 24,584 $ 156,517 $ 18,440 $ (6,300 ) $ 253,079 48.3 % Worldwide excluding United States (a) 7,198 43,136 — 712 76 51,122 9.8 % Australia and New Zealand (450 ) 3,696 — — 9 3,255 0.6 % Europe 4,744 5,372 — 149 62 10,327 2.0 % Latin America and Caribbean 19,430 20,726 — — (454 ) 39,702 7.6 % Japan 436 1,165 — — — 1,601 0.3 % Canada 24 1,820 — 458 (6 ) 2,296 0.4 % Rest of the world (b) 1,447 21,478 — — 57 22,982 4.4 % Sub-total, non United States 32,829 97,393 — 1,319 (256 ) 131,285 25.1 % Worldwide including United States (a) 33,724 16,293 — 4,993 (91 ) 54,919 10.5 % Other locations non-specific (c) 27,499 54,613 — 2,461 — 84,573 16.1 % Total $ 153,890 $ 192,883 $ 156,517 $ 27,213 $ (6,647 ) $ 523,856 100.0 % Gross Premiums Written Three Months Ended September 30, 2016 Validus Re Talbot Western World AlphaCat Eliminations Total % United States $ 31,345 $ 19,937 $ 85,260 $ 1,837 $ (76 ) $ 138,303 37.1 % Worldwide excluding United States (a) 4,145 40,058 — (288 ) (39 ) 43,876 11.7 % Australia and New Zealand 57 3,238 — — 6 3,301 0.9 % Europe 4,536 4,957 — — 40 9,533 2.6 % Latin America and Caribbean 17,036 25,173 — — (793 ) 41,416 11.1 % Japan (33 ) 997 — — 7 971 0.3 % Canada 149 2,015 — — (42 ) 2,122 0.6 % Rest of the world (b) 2,360 19,166 — — 66 21,592 5.8 % Sub-total, non United States 28,250 95,604 — (288 ) (755 ) 122,811 33.0 % Worldwide including United States (a) 22,399 12,771 — 2,872 (838 ) 37,204 10.0 % Other locations non-specific (c) 12,747 61,362 — (8 ) (1 ) 74,100 19.9 % Total $ 94,741 $ 189,674 $ 85,260 $ 4,413 $ (1,670 ) $ 372,418 100.0 % Gross Premiums Written Nine Months Ended September 30, 2017 Validus Re Talbot Western World AlphaCat Eliminations Total % United States $ 374,018 $ 88,139 $ 459,628 $ 116,691 $ (10,623 ) $ 1,027,853 41.0 % Worldwide excluding United States (a) 45,803 110,094 — 8,617 (463 ) 164,051 6.6 % Australia and New Zealand 3,745 8,726 — 2,003 (101 ) 14,373 0.6 % Europe 35,108 22,944 — 600 (368 ) 58,284 2.2 % Latin America and Caribbean 40,646 69,703 — 46 (4,737 ) 105,658 4.2 % Japan 40,902 6,371 — 3,855 (36 ) 51,092 2.0 % Canada 4,894 4,068 — 588 (55 ) 9,495 0.4 % Rest of the world (b) 20,229 67,918 — — (1,520 ) 86,627 3.5 % Sub-total, non United States 191,327 289,824 — 15,709 (7,280 ) 489,580 19.5 % Worldwide including United States (a) 189,669 74,385 — 158,239 (5,875 ) 416,418 16.6 % Other locations non-specific (c) 316,395 250,187 — 7,182 — 573,764 22.9 % Total $ 1,071,409 $ 702,535 $ 459,628 $ 297,821 $ (23,778 ) $ 2,507,615 100.0 % Gross Premiums Written Nine Months Ended September 30, 2016 Validus Re Talbot Western World AlphaCat Eliminations Total % United States $ 455,826 $ 85,182 $ 236,190 $ 64,566 $ (1,631 ) $ 840,133 36.4 % Worldwide excluding United States (a) 51,384 105,590 — 22,219 (650 ) 178,543 7.8 % Australia and New Zealand 6,906 7,613 — 4,949 (107 ) 19,361 0.8 % Europe 30,270 25,673 — 3,306 (668 ) 58,581 2.5 % Latin America and Caribbean 36,610 76,577 — — (6,330 ) 106,857 4.6 % Japan 39,892 5,579 — 3,221 (24 ) 48,668 2.1 % Canada 3,646 5,577 — 223 (129 ) 9,317 0.4 % Rest of the world (b) 22,307 76,456 — — (2,276 ) 96,487 4.2 % Sub-total, non United States 191,015 303,065 — 33,918 (10,184 ) 517,814 22.4 % Worldwide including United States (a) 169,737 75,423 — 170,639 (10,052 ) 405,747 17.6 % Other locations non-specific (c) 255,641 288,388 — 1,543 (15 ) 545,557 23.6 % Total $ 1,072,219 $ 752,058 $ 236,190 $ 270,666 $ (21,882 ) $ 2,309,251 100.1 % (a) Represents risks in two or more geographic zones. (b) Represents risks in one geographic zone. (c) The Other locations non-specific category refers to business for which an analysis of exposure by geographic zone is not applicable since these exposures can span multiple geographic areas and, in some instances, are not fixed locations. |
Business combination - Fair val
Business combination - Fair value of net assets acquired (Details) $ in Thousands | May 01, 2017USD ($)StatesAgent | Sep. 30, 2017USD ($) | Sep. 30, 2016USD ($) | Sep. 30, 2017USD ($) | Sep. 30, 2016USD ($) | Dec. 31, 2016USD ($) |
Business Acquisition [Line Items] | ||||||
Transaction expenses | $ 0 | $ 0 | $ 4,427 | $ 0 | ||
Net loss reserves | 42,575 | 42,575 | ||||
Goodwill | $ 227,701 | $ 227,701 | $ 196,758 | |||
Crop Risk Services | ||||||
Business Acquisition [Line Items] | ||||||
Number of agents | Agent | 1,170 | |||||
Number of states | States | 36 | |||||
Total purchase price | $ 185,576 | |||||
Cash and cash equivalents | 1,653 | |||||
Premiums receivable | 564,453 | |||||
Prepaid reinsurance premiums | 227,157 | |||||
Other assets | 157,146 | |||||
Assets acquired | 950,409 | |||||
Reinsurance balances payable | 294,201 | |||||
Unearned premiums | 406,649 | |||||
Net loss reserves | 42,575 | |||||
Other liabilities | 122,715 | |||||
Liabilities acquired | 866,140 | |||||
Excess purchase price | 101,307 | |||||
Total intangible assets | 63,921 | |||||
Goodwill | 30,943 | |||||
Deferred tax arising on Goodwill | $ 6,443 | |||||
Crop Risk Services | Intangible asset - Distribution channels | ||||||
Business Acquisition [Line Items] | ||||||
Estimated useful life | 10 years | |||||
Total intangible assets | $ 52,898 | |||||
Crop Risk Services | Intangible asset - Brand name | ||||||
Business Acquisition [Line Items] | ||||||
Estimated useful life | 10 years | |||||
Total intangible assets | $ 9,568 | |||||
Crop Risk Services | Intangible asset - Technology | ||||||
Business Acquisition [Line Items] | ||||||
Estimated useful life | 2 years | |||||
Total intangible assets | $ 1,455 |
Business combination - Reconcil
Business combination - Reconciliation of carrying amount of goodwill and intangible assets (Details) - USD ($) $ in Thousands | 9 Months Ended | |
Sep. 30, 2017 | Sep. 30, 2016 | |
Goodwill And Other Intangible Assets [Line Items] | ||
Goodwill, beginning of period | $ 196,758 | |
Additions | 30,943 | |
Goodwill, end of period | 227,701 | |
Finite lived intangible assets, beginning of period | 11,424 | |
Indefinite lived intangible assets, beginning of period | 104,168 | |
Intangible assets, beginning of period | 115,592 | |
Additions, finite lived | 63,921 | |
Amortization | (6,115) | $ (4,248) |
Finite lived intangible assets, end of period | 69,230 | |
Indefinite lived intangible assets, end of period | 104,168 | |
Intangible assets, end of period | 173,398 | |
Talbot | ||
Goodwill And Other Intangible Assets [Line Items] | ||
Goodwill, beginning of period | 20,393 | |
Additions | 0 | |
Goodwill, end of period | 20,393 | |
Intangible assets, beginning of period | 93,924 | |
Additions, finite lived | 0 | |
Amortization | (2,081) | |
Intangible assets, end of period | 91,843 | |
Western World | ||
Goodwill And Other Intangible Assets [Line Items] | ||
Goodwill, beginning of period | 176,365 | |
Additions | 30,943 | |
Goodwill, end of period | 207,308 | |
Intangible assets, beginning of period | 21,668 | |
Additions, finite lived | 63,921 | |
Amortization | (4,034) | |
Intangible assets, end of period | $ 81,555 |
Business combination - Suppleme
Business combination - Supplemental pro forma information (Details) - Crop Risk Services - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended |
Sep. 30, 2017 | Sep. 30, 2017 | |
Business Acquisition [Line Items] | ||
Net premiums written | $ 32,852 | $ 39,840 |
Net premiums earned | 98,757 | 148,801 |
Total underwriting deductions | 84,826 | 129,606 |
Underwriting income, before general and administrative expenses | $ 13,931 | $ 19,195 |
Investments (Amortized cost or
Investments (Amortized cost or cost and fair value of investments) (Details) - USD ($) $ in Thousands | Sep. 30, 2017 | Dec. 31, 2016 | |
Amortized cost (or cost) and estimated fair value of investments | |||
Fixed maturities, at amortized cost or cost | $ 5,421,546 | $ 5,584,599 | |
Short-term investments, at amortized cost or cost | 2,992,939 | 2,796,358 | |
Other investments, at amortized cost or cost | 439,991 | 380,130 | |
Investments in investment affiliates, at cost | 60,228 | 84,840 | |
Total investments | 8,914,704 | 8,845,927 | |
Fixed maturities, at fair value | 5,419,966 | 5,543,030 | |
Short-term investments, at fair value | 2,993,246 | 2,796,170 | |
Other investments, at fair value | 471,300 | 405,712 | |
Investments in investment affiliates, at fair value | 92,079 | 100,431 | |
Total investments | 8,976,591 | 8,845,343 | |
Managed investments | |||
Amortized cost (or cost) and estimated fair value of investments | |||
Fixed maturities, at amortized cost or cost | 5,117,757 | 5,427,113 | |
Short-term investments, at amortized cost or cost | 258,339 | 228,574 | |
Other investments, at amortized cost or cost | 439,991 | 380,130 | |
Investments in investment affiliates, at cost | [1] | 60,228 | 84,840 |
Total investments | 5,876,315 | 6,120,657 | |
Fixed maturities, at fair value | 5,120,482 | 5,384,699 | |
Short-term investments, at fair value | 258,646 | 228,386 | |
Other investments, at fair value | 471,300 | 405,712 | |
Investments in investment affiliates, at fair value | [1] | 92,079 | 100,431 |
Total investments | 5,942,507 | 6,119,228 | |
Managed investments | U.S. government and government agency | |||
Amortized cost (or cost) and estimated fair value of investments | |||
Fixed maturities, at amortized cost or cost | 598,607 | 809,392 | |
Fixed maturities, at fair value | 595,694 | 804,126 | |
Managed investments | Non-U.S. government and government agency | |||
Amortized cost (or cost) and estimated fair value of investments | |||
Fixed maturities, at amortized cost or cost | 288,296 | 245,651 | |
Fixed maturities, at fair value | 290,538 | 240,791 | |
Managed investments | U.S. states, municipalities and political subdivisions | |||
Amortized cost (or cost) and estimated fair value of investments | |||
Fixed maturities, at amortized cost or cost | 205,880 | 271,742 | |
Fixed maturities, at fair value | 206,667 | 271,830 | |
Managed investments | Agency residential mortgage-backed securities | |||
Amortized cost (or cost) and estimated fair value of investments | |||
Fixed maturities, at amortized cost or cost | 830,542 | 684,490 | |
Fixed maturities, at fair value | 828,400 | 679,595 | |
Managed investments | Non-agency residential mortgage-backed securities | |||
Amortized cost (or cost) and estimated fair value of investments | |||
Fixed maturities, at amortized cost or cost | 38,806 | 15,858 | |
Fixed maturities, at fair value | 38,993 | 15,477 | |
Managed investments | U.S. corporate | |||
Amortized cost (or cost) and estimated fair value of investments | |||
Fixed maturities, at amortized cost or cost | 1,457,073 | 1,540,036 | |
Fixed maturities, at fair value | 1,466,739 | 1,534,508 | |
Managed investments | Non-U.S. corporate | |||
Amortized cost (or cost) and estimated fair value of investments | |||
Fixed maturities, at amortized cost or cost | 390,519 | 418,520 | |
Fixed maturities, at fair value | 392,242 | 410,227 | |
Managed investments | Bank loans | |||
Amortized cost (or cost) and estimated fair value of investments | |||
Fixed maturities, at amortized cost or cost | 471,855 | 579,121 | |
Fixed maturities, at fair value | 464,464 | 570,399 | |
Managed investments | Asset-backed securities | |||
Amortized cost (or cost) and estimated fair value of investments | |||
Fixed maturities, at amortized cost or cost | 520,594 | 528,563 | |
Fixed maturities, at fair value | 522,524 | 526,814 | |
Managed investments | Commercial mortgage-backed securities | |||
Amortized cost (or cost) and estimated fair value of investments | |||
Fixed maturities, at amortized cost or cost | 315,585 | 333,740 | |
Fixed maturities, at fair value | 314,221 | 330,932 | |
Managed investments | Fund of hedge funds | |||
Amortized cost (or cost) and estimated fair value of investments | |||
Other investments, at amortized cost or cost | 0 | 1,457 | |
Other investments, at fair value | 0 | 955 | |
Managed investments | Hedge funds | |||
Amortized cost (or cost) and estimated fair value of investments | |||
Other investments, at amortized cost or cost | 11,292 | 11,292 | |
Other investments, at fair value | 19,233 | 17,381 | |
Managed investments | Private equity investments | |||
Amortized cost (or cost) and estimated fair value of investments | |||
Other investments, at amortized cost or cost | 88,299 | 66,383 | |
Other investments, at fair value | 107,230 | 82,627 | |
Managed investments | Fixed income investment funds | |||
Amortized cost (or cost) and estimated fair value of investments | |||
Other investments, at amortized cost or cost | 282,707 | 247,967 | |
Other investments, at fair value | 285,034 | 249,275 | |
Managed investments | Overseas deposits | |||
Amortized cost (or cost) and estimated fair value of investments | |||
Other investments, at amortized cost or cost | 55,775 | 50,106 | |
Other investments, at fair value | 55,775 | 50,106 | |
Managed investments | Mutual funds | |||
Amortized cost (or cost) and estimated fair value of investments | |||
Other investments, at amortized cost or cost | 1,918 | 2,925 | |
Other investments, at fair value | 4,028 | 5,368 | |
Non-managed investments | |||
Amortized cost (or cost) and estimated fair value of investments | |||
Fixed maturities, at amortized cost or cost | 303,789 | 157,486 | |
Short-term investments, at amortized cost or cost | 2,734,600 | 2,567,784 | |
Total investments | 3,038,389 | 2,725,270 | |
Fixed maturities, at fair value | 299,484 | 158,331 | |
Short-term investments, at fair value | 2,734,600 | 2,567,784 | |
Total investments | 3,034,084 | 2,726,115 | |
Non-managed investments | Catastrophe bonds | |||
Amortized cost (or cost) and estimated fair value of investments | |||
Fixed maturities, at amortized cost or cost | 303,789 | 157,486 | |
Fixed maturities, at fair value | $ 299,484 | $ 158,331 | |
[1] | The Company’s investments in investment affiliates have been treated as equity method investments with the corresponding gains and losses recorded inincome as “Income (loss) from investment affiliates.” |
Investments (Fixed maturities b
Investments (Fixed maturities by investment rating) (Details) - USD ($) $ in Thousands | Sep. 30, 2017 | Dec. 31, 2016 |
Fixed Maturities | ||
Fair value | $ 5,419,966 | $ 5,543,030 |
Percentage of total | 100.00% | 100.00% |
Managed investments | ||
Fixed Maturities | ||
Fair value | $ 5,120,482 | $ 5,384,699 |
Percentage of total | 94.50% | 97.10% |
Managed investments | Total investment grade fixed maturities | ||
Fixed Maturities | ||
Fair value | $ 4,600,675 | $ 4,766,696 |
Percentage of total | 84.90% | 86.00% |
Managed investments | Total investment grade fixed maturities | AAA | ||
Fixed Maturities | ||
Fair value | $ 2,349,803 | $ 2,405,597 |
Percentage of total | 43.30% | 43.40% |
Managed investments | Total investment grade fixed maturities | AA | ||
Fixed Maturities | ||
Fair value | $ 437,215 | $ 538,289 |
Percentage of total | 8.10% | 9.70% |
Managed investments | Total investment grade fixed maturities | A rating | ||
Fixed Maturities | ||
Fair value | $ 1,060,849 | $ 1,081,949 |
Percentage of total | 19.60% | 19.50% |
Managed investments | Total investment grade fixed maturities | BBB | ||
Fixed Maturities | ||
Fair value | $ 752,808 | $ 740,861 |
Percentage of total | 13.90% | 13.40% |
Managed investments | Total non-investment grade fixed maturities | ||
Fixed Maturities | ||
Fair value | $ 519,807 | $ 618,003 |
Percentage of total | 9.60% | 11.10% |
Managed investments | Total non-investment grade fixed maturities | BB | ||
Fixed Maturities | ||
Fair value | $ 177,667 | $ 213,568 |
Percentage of total | 3.20% | 3.90% |
Managed investments | Total non-investment grade fixed maturities | B | ||
Fixed Maturities | ||
Fair value | $ 156,590 | $ 177,737 |
Percentage of total | 2.90% | 3.20% |
Managed investments | Total non-investment grade fixed maturities | CCC | ||
Fixed Maturities | ||
Fair value | $ 5,286 | $ 13,371 |
Percentage of total | 0.10% | 0.20% |
Managed investments | Total non-investment grade fixed maturities | NR | ||
Fixed Maturities | ||
Fair value | $ 180,264 | $ 213,327 |
Percentage of total | 3.40% | 3.80% |
Non-managed investments | ||
Fixed Maturities | ||
Fair value | $ 299,484 | $ 158,331 |
Percentage of total | 5.50% | 2.90% |
Non-managed investments | Total investment grade fixed maturities | ||
Fixed Maturities | ||
Fair value | $ 1,650 | $ 0 |
Percentage of total | 0.00% | 0.00% |
Non-managed investments | Total investment grade fixed maturities | BBB | ||
Fixed Maturities | ||
Fair value | $ 1,650 | $ 0 |
Percentage of total | 0.00% | 0.00% |
Non-managed investments | Total non-investment grade fixed maturities | ||
Fixed Maturities | ||
Fair value | $ 297,834 | $ 158,331 |
Percentage of total | 5.50% | 2.90% |
Non-managed investments | Total non-investment grade fixed maturities | BB | ||
Fixed Maturities | ||
Fair value | $ 28,031 | $ 29,731 |
Percentage of total | 0.50% | 0.60% |
Non-managed investments | Total non-investment grade fixed maturities | B | ||
Fixed Maturities | ||
Fair value | $ 2,755 | $ 4,524 |
Percentage of total | 0.10% | 0.10% |
Non-managed investments | Total non-investment grade fixed maturities | NR | ||
Fixed Maturities | ||
Fair value | $ 267,048 | $ 124,076 |
Percentage of total | 4.90% | 2.20% |
Investments (Maturity profile o
Investments (Maturity profile of fixed maturity investments) (Details) - USD ($) $ in Thousands | Sep. 30, 2017 | Dec. 31, 2016 |
Maturity profile | ||
Amortized cost | $ 5,421,546 | $ 5,584,599 |
Fair value | 5,419,966 | 5,543,030 |
Managed investments | ||
Maturity profile | ||
Amortized cost | 5,117,757 | 5,427,113 |
Fair value | 5,120,482 | 5,384,699 |
Managed investments | Fixed maturities trading securities allocated to contractual maturity | ||
Maturity profile | ||
Amortized cost | 3,412,230 | 3,864,462 |
Fair value | 3,416,344 | 3,831,881 |
Managed investments | Due in one year or less | Fixed maturities trading securities allocated to contractual maturity | ||
Maturity profile | ||
Amortized cost | 279,069 | 350,733 |
Fair value | 278,118 | 346,161 |
Managed investments | Due after one year through five years | Fixed maturities trading securities allocated to contractual maturity | ||
Maturity profile | ||
Amortized cost | 2,418,737 | 2,954,856 |
Fair value | 2,416,963 | 2,933,146 |
Managed investments | Due after five years through ten years | Fixed maturities trading securities allocated to contractual maturity | ||
Maturity profile | ||
Amortized cost | 534,922 | 430,365 |
Fair value | 535,538 | 426,647 |
Managed investments | Due after ten years | Fixed maturities trading securities allocated to contractual maturity | ||
Maturity profile | ||
Amortized cost | 179,502 | 128,508 |
Fair value | 185,725 | 125,927 |
Managed investments | Asset backed and mortgaged backed securities | ||
Maturity profile | ||
Amortized cost | 1,705,527 | 1,562,651 |
Fair value | 1,704,138 | 1,552,818 |
Non-managed investments | ||
Maturity profile | ||
Amortized cost | 303,789 | 157,486 |
Fair value | 299,484 | 158,331 |
Non-managed investments | Due in one year or less | ||
Maturity profile | ||
Amortized cost | 88,949 | 43,664 |
Fair value | 88,202 | 45,418 |
Non-managed investments | Due after one year through five years | ||
Maturity profile | ||
Amortized cost | 209,340 | 112,572 |
Fair value | 206,117 | 111,656 |
Non-managed investments | Due after five years through ten years | ||
Maturity profile | ||
Amortized cost | 5,500 | 1,250 |
Fair value | $ 5,165 | $ 1,257 |
Investments (Other investments)
Investments (Other investments) (Details) - USD ($) $ in Thousands | 9 Months Ended | 12 Months Ended | |
Sep. 30, 2017 | Dec. 31, 2016 | ||
Investment [Line Items] | |||
Other investments, at fair value | $ 471,300 | $ 405,712 | |
Managed investments | |||
Investment [Line Items] | |||
Other investments, at fair value | 471,300 | 405,712 | |
Managed investments | Fund of hedge funds | |||
Investment [Line Items] | |||
Other investments, at fair value | 0 | 955 | |
Managed investments | Hedge funds | |||
Investment [Line Items] | |||
Other investments, at fair value | 19,233 | 17,381 | |
Managed investments | Private equity investments | |||
Investment [Line Items] | |||
Other investments, at fair value | 107,230 | 82,627 | |
Managed investments | Fixed income investment funds | |||
Investment [Line Items] | |||
Other investments, at fair value | 285,034 | 249,275 | |
Managed investments | Overseas deposits | |||
Investment [Line Items] | |||
Other investments, at fair value | 55,775 | 50,106 | |
Managed investments | Mutual funds | |||
Investment [Line Items] | |||
Other investments, at fair value | 4,028 | 5,368 | |
Recurring | Managed investments | |||
Investment [Line Items] | |||
Other investments, at fair value | 471,300 | 405,712 | |
Recurring | Managed investments | Externally Rated or Consist of Externally Rated Securities | |||
Investment [Line Items] | |||
Other investments, at fair value | 274,651 | ||
Recurring | Managed investments | Not Externally Rated | |||
Investment [Line Items] | |||
Other investments, at fair value | 196,649 | ||
Recurring | Managed investments | Fund of hedge funds | |||
Investment [Line Items] | |||
Other investments, at fair value | 955 | ||
Recurring | Managed investments | Hedge funds | |||
Investment [Line Items] | |||
Other investments, at fair value | 19,233 | 17,381 | |
Recurring | Managed investments | Private equity investments | |||
Investment [Line Items] | |||
Other investments, at fair value | 107,230 | 82,627 | |
Recurring | Managed investments | Fixed income investment funds | |||
Investment [Line Items] | |||
Other investments, at fair value | 285,034 | 249,275 | |
Recurring | Managed investments | Overseas deposits | |||
Investment [Line Items] | |||
Other investments, at fair value | 55,775 | 50,106 | |
Recurring | Managed investments | Mutual funds | |||
Investment [Line Items] | |||
Other investments, at fair value | 4,028 | 5,368 | |
Recurring | Managed investments | Subject to redemption restriction | |||
Investment [Line Items] | |||
Other investments, at fair value | 432,237 | 369,402 | |
Recurring | Managed investments | Subject to redemption restriction | Fund of hedge funds | |||
Investment [Line Items] | |||
Other investments, at fair value | 955 | ||
Recurring | Managed investments | Subject to redemption restriction | Hedge funds | |||
Investment [Line Items] | |||
Other investments, at fair value | 19,233 | 17,381 | |
Recurring | Managed investments | Subject to redemption restriction | Private equity investments | |||
Investment [Line Items] | |||
Other investments, at fair value | 107,230 | 82,627 | |
Recurring | Managed investments | Subject to redemption restriction | Fixed income investment funds | |||
Investment [Line Items] | |||
Other investments, at fair value | 249,999 | 218,333 | |
Recurring | Managed investments | Subject to redemption restriction | Overseas deposits | |||
Investment [Line Items] | |||
Other investments, at fair value | 55,775 | 50,106 | |
Recurring | Managed investments | Subject to redemption restriction | Mutual funds | |||
Investment [Line Items] | |||
Other investments, at fair value | 0 | 0 | |
Recurring | Managed investments | Not subject to redemption restriction | |||
Investment [Line Items] | |||
Other investments, at fair value | 39,063 | 36,310 | |
Recurring | Managed investments | Not subject to redemption restriction | Fund of hedge funds | |||
Investment [Line Items] | |||
Other investments, at fair value | 0 | ||
Recurring | Managed investments | Not subject to redemption restriction | Hedge funds | |||
Investment [Line Items] | |||
Other investments, at fair value | 0 | 0 | |
Recurring | Managed investments | Not subject to redemption restriction | Private equity investments | |||
Investment [Line Items] | |||
Other investments, at fair value | 0 | 0 | |
Recurring | Managed investments | Not subject to redemption restriction | Fixed income investment funds | |||
Investment [Line Items] | |||
Other investments, at fair value | $ 35,035 | $ 30,942 | |
Redemption frequency | Daily | ||
Redemption notice period | [1] | 2 days | |
Recurring | Managed investments | Not subject to redemption restriction | Fixed income investment funds | Minimum | |||
Investment [Line Items] | |||
Redemption frequency | P1D | ||
Redemption notice period | [1] | 1 day | |
Recurring | Managed investments | Not subject to redemption restriction | Fixed income investment funds | Maximum | |||
Investment [Line Items] | |||
Redemption frequency | P2D | ||
Redemption notice period | [1] | 2 days | |
Recurring | Managed investments | Not subject to redemption restriction | Overseas deposits | |||
Investment [Line Items] | |||
Other investments, at fair value | $ 0 | $ 0 | |
Recurring | Managed investments | Not subject to redemption restriction | Mutual funds | |||
Investment [Line Items] | |||
Other investments, at fair value | $ 4,028 | $ 5,368 | |
Redemption frequency | Daily | Daily | |
Redemption notice period | [1] | 1 day | 1 day |
[1] | The redemption frequency and notice periods only apply to investments without redemption restrictions. |
Investments (Investment affilia
Investments (Investment affiliate rollforward) (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2017 | Sep. 30, 2016 | Sep. 30, 2017 | Sep. 30, 2016 | |
Schedule of Equity Method Investments [Line Items] | ||||
Investments in affiliates, beginning of period | $ 100,431 | |||
Income (loss) from investment affiliates | $ 1,011 | $ 453 | 15,665 | $ (4,249) |
Investments in affiliates, end of period | 92,079 | 92,079 | ||
Investment affiliate | ||||
Schedule of Equity Method Investments [Line Items] | ||||
Investments in affiliates, beginning of period | 103,377 | 99,278 | 100,431 | 87,673 |
Net capital (distributions) contributions | (12,309) | 0 | (24,017) | 16,307 |
Income (loss) from investment affiliates | 1,011 | 453 | 15,665 | (4,249) |
Investments in affiliates, end of period | $ 92,079 | $ 99,731 | $ 92,079 | $ 99,731 |
Investments (Investment affil50
Investments (Investment affiliate details) (Details) - USD ($) $ in Thousands | Sep. 30, 2017 | Jun. 30, 2017 | Mar. 20, 2017 | Dec. 31, 2016 | Sep. 30, 2016 | Jun. 30, 2016 | Dec. 31, 2015 |
Schedule of Equity Method Investments [Line Items] | |||||||
Investments in investment affiliates, at cost | $ 60,228 | $ 84,840 | |||||
Investments in affiliates | 92,079 | 100,431 | |||||
Aquiline Financial Services Fund II LP | |||||||
Schedule of Equity Method Investments [Line Items] | |||||||
Remaining capital commitment | 3,229 | 2,040 | |||||
Aquiline Financial Services Fund III LP | |||||||
Schedule of Equity Method Investments [Line Items] | |||||||
Remaining capital commitment | 66,285 | 62,031 | |||||
Aquiline Tech | |||||||
Schedule of Equity Method Investments [Line Items] | |||||||
Remaining capital commitment | 17,858 | $ 20,000 | |||||
Investment affiliate | |||||||
Schedule of Equity Method Investments [Line Items] | |||||||
Investments in affiliates | 92,079 | $ 103,377 | 100,431 | $ 99,731 | $ 99,278 | $ 87,673 | |
Investment affiliate | Aquiline Financial Services Fund II LP | |||||||
Schedule of Equity Method Investments [Line Items] | |||||||
Investments in investment affiliates, at cost | $ 33,349 | $ 46,871 | |||||
Voting ownership % | 0.00% | 0.00% | |||||
Equity ownership % | 8.10% | 8.10% | |||||
Investments in affiliates | $ 50,695 | $ 61,999 | |||||
Investment affiliate | Aquiline Financial Services Fund III LP | |||||||
Schedule of Equity Method Investments [Line Items] | |||||||
Investments in investment affiliates, at cost | $ 24,737 | $ 37,969 | |||||
Voting ownership % | 0.00% | 0.00% | |||||
Equity ownership % | 9.00% | 9.00% | |||||
Investments in affiliates | $ 39,530 | $ 38,432 | |||||
Investment affiliate | Aquiline Tech | |||||||
Schedule of Equity Method Investments [Line Items] | |||||||
Investments in investment affiliates, at cost | $ 2,142 | ||||||
Voting ownership % | 0.00% | ||||||
Equity ownership % | 10.60% | ||||||
Investments in affiliates | $ 1,854 |
Investments (Components of net
Investments (Components of net investment income) (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2017 | Sep. 30, 2016 | Sep. 30, 2017 | Sep. 30, 2016 | |
Net investment income | ||||
Net investment income | $ 44,458 | $ 43,514 | $ 128,913 | $ 112,232 |
Managed investments | ||||
Net investment income | ||||
Total gross investment income | 39,447 | 43,253 | 118,117 | 112,051 |
Investment expenses | (2,356) | (2,182) | (6,771) | (6,208) |
Net investment income | 37,091 | 41,071 | 111,346 | 105,843 |
Managed investments | Fixed maturities and short term investments | ||||
Net investment income | ||||
Total gross investment income | 30,823 | 30,572 | 93,706 | 89,210 |
Managed investments | Other investments | ||||
Net investment income | ||||
Total gross investment income | 7,391 | 11,768 | 21,832 | 20,666 |
Managed investments | Restricted cash, cash and cash equivalents | ||||
Net investment income | ||||
Total gross investment income | 1,230 | 891 | 2,556 | 2,136 |
Managed investments | Securities lending income | ||||
Net investment income | ||||
Total gross investment income | 3 | 22 | 23 | 39 |
Non-managed investments | ||||
Net investment income | ||||
Net investment income | 7,367 | 2,443 | 17,567 | 6,389 |
Non-managed investments | Fixed maturities and short term investments | ||||
Net investment income | ||||
Total gross investment income | 3,941 | 1,970 | 11,501 | 5,242 |
Non-managed investments | Restricted cash, cash and cash equivalents | ||||
Net investment income | ||||
Total gross investment income | $ 3,426 | $ 473 | $ 6,066 | $ 1,147 |
Investments (Realized and unrea
Investments (Realized and unrealized gains) (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2017 | Sep. 30, 2016 | Sep. 30, 2017 | Sep. 30, 2016 | |
Fixed Maturities Short Term And Other Investments And Cash Equivalents [Abstract] | ||||
Net realized gains on investments | $ 906 | $ 4,397 | $ 2,016 | $ 6,537 |
Change in net unrealized (losses) gains on investments | (5,197) | 5,459 | 24,472 | 84,331 |
Total net realized and change in net unrealized gains (losses) on investments | (4,291) | 9,856 | 26,488 | 90,868 |
Managed investments | ||||
Fixed Maturities Short Term And Other Investments And Cash Equivalents [Abstract] | ||||
Gross realized gains | 5,170 | 4,544 | 13,035 | 11,067 |
Gross realized losses | (4,267) | (464) | (12,755) | (5,553) |
Net realized gains on investments | 903 | 4,080 | 280 | 5,514 |
Change in net unrealized (losses) gains on investments | 941 | 4,652 | 31,232 | 81,782 |
Total net realized and change in net unrealized gains (losses) on investments | 1,844 | 8,732 | 31,512 | 87,296 |
Non-managed investments | ||||
Fixed Maturities Short Term And Other Investments And Cash Equivalents [Abstract] | ||||
Gross realized gains | 3 | 317 | 1,736 | 1,032 |
Gross realized losses | 0 | 0 | 0 | (9) |
Net realized gains on investments | 3 | 317 | 1,736 | 1,023 |
Change in net unrealized (losses) gains on investments | (6,138) | 807 | (6,760) | 2,549 |
Total net realized and change in net unrealized gains (losses) on investments | $ (6,135) | $ 1,124 | $ (5,024) | $ 3,572 |
Investments (Narrative) (Detail
Investments (Narrative) (Details) $ in Thousands | 9 Months Ended | |
Sep. 30, 2017USD ($)funds | Dec. 31, 2016USD ($) | |
Schedule of Trading Securities and Other Trading Assets [Line Items] | ||
Other investments, at fair value | $ 471,300 | $ 405,712 |
Cash, cash equivalents, restricted cash and investments pledged as collateral | 5,433,107 | 5,173,966 |
Investments held in trust | 5,368,025 | 5,068,092 |
Investments and cash pledged as collateral | $ 265,089 | 442,184 |
Minimum | ||
Schedule of Trading Securities and Other Trading Assets [Line Items] | ||
Remaining liquidation period | 5 years | |
Maximum | ||
Schedule of Trading Securities and Other Trading Assets [Line Items] | ||
Remaining liquidation period | 10 years | |
Managed investments | ||
Schedule of Trading Securities and Other Trading Assets [Line Items] | ||
Other investments, at fair value | $ 471,300 | 405,712 |
Recurring | Managed investments | ||
Schedule of Trading Securities and Other Trading Assets [Line Items] | ||
Other investments, at fair value | 471,300 | 405,712 |
Recurring | Managed investments | Subject to redemption restriction | ||
Schedule of Trading Securities and Other Trading Assets [Line Items] | ||
Other investments, at fair value | $ 432,237 | 369,402 |
Recurring | Managed investments | Subject to redemption restriction | Investment fund A | ||
Schedule of Trading Securities and Other Trading Assets [Line Items] | ||
Other investments number of funds | funds | 1 | |
Other investments, at fair value | $ 195,903 | $ 184,749 |
Redemption restriction period | 2 years |
Fair value measurements (Fair v
Fair value measurements (Fair value hierarchy) (Details) - USD ($) $ in Thousands | Sep. 30, 2017 | Dec. 31, 2016 | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | $ 5,419,966 | $ 5,543,030 | |
Short-term investments, at fair value | 2,993,246 | 2,796,170 | |
Other investments, at fair value | 471,300 | 405,712 | |
Investments in affiliates | 92,079 | 100,431 | |
Total investments | 8,976,591 | 8,845,343 | |
Managed investments | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 5,120,482 | 5,384,699 | |
Short-term investments, at fair value | 258,646 | 228,386 | |
Other investments, at fair value | 471,300 | 405,712 | |
Investments in affiliates | [1] | 92,079 | 100,431 |
Total investments | 5,942,507 | 6,119,228 | |
Managed investments | U.S. government and government agency | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 595,694 | 804,126 | |
Managed investments | Non-US government and government agency | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 290,538 | 240,791 | |
Managed investments | U.S. states, municipalities and political subdivisions | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 206,667 | 271,830 | |
Managed investments | Agency residential mortgage-backed securities | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 828,400 | 679,595 | |
Managed investments | Non-Agency residential mortgage-backed securities | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 38,993 | 15,477 | |
Managed investments | U.S. corporate | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 1,466,739 | 1,534,508 | |
Managed investments | Non-U.S. corporate | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 392,242 | 410,227 | |
Managed investments | Bank loans | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 464,464 | 570,399 | |
Managed investments | Asset-backed securities | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 522,524 | 526,814 | |
Managed investments | Commercial mortgage-backed securities | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 314,221 | 330,932 | |
Managed investments | Fund of hedge funds | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Other investments, at fair value | 0 | 955 | |
Managed investments | Hedge funds | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Other investments, at fair value | 19,233 | 17,381 | |
Managed investments | Private equity investments | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Other investments, at fair value | 107,230 | 82,627 | |
Managed investments | Fixed income investment funds | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Other investments, at fair value | 285,034 | 249,275 | |
Managed investments | Overseas deposits | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Other investments, at fair value | 55,775 | 50,106 | |
Managed investments | Mutual funds | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Other investments, at fair value | 4,028 | 5,368 | |
Non-managed investments | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 299,484 | 158,331 | |
Short-term investments, at fair value | 2,734,600 | 2,567,784 | |
Total investments | 3,034,084 | 2,726,115 | |
Non-managed investments | Catastrophe bonds | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 299,484 | 158,331 | |
Recurring | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Total investments | 8,976,591 | 8,845,343 | |
Recurring | Level 1 | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Total investments | 2,986,178 | 2,777,435 | |
Recurring | Level 2 | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Total investments | 5,137,610 | 5,279,272 | |
Recurring | Level 3 | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Total investments | 345,483 | 330,970 | |
Recurring | Managed investments | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 5,120,482 | 5,384,699 | |
Short-term investments, at fair value | 258,646 | 228,386 | |
Other investments, at fair value | 471,300 | 405,712 | |
Total investments | 5,942,507 | 6,119,228 | |
Recurring | Managed investments | U.S. government and government agency | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 595,694 | 804,126 | |
Recurring | Managed investments | Non-US government and government agency | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 290,538 | 240,791 | |
Recurring | Managed investments | U.S. states, municipalities and political subdivisions | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 206,667 | 271,830 | |
Recurring | Managed investments | Agency residential mortgage-backed securities | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 828,400 | 679,595 | |
Recurring | Managed investments | Non-Agency residential mortgage-backed securities | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 38,993 | 15,477 | |
Recurring | Managed investments | U.S. corporate | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 1,466,739 | 1,534,508 | |
Recurring | Managed investments | Non-U.S. corporate | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 392,242 | 410,227 | |
Recurring | Managed investments | Bank loans | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 464,464 | 570,399 | |
Recurring | Managed investments | Asset-backed securities | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 522,524 | 526,814 | |
Recurring | Managed investments | Commercial mortgage-backed securities | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 314,221 | 330,932 | |
Recurring | Managed investments | Fund of hedge funds | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Other investments, at fair value | 955 | ||
Recurring | Managed investments | Hedge funds | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Other investments, at fair value | 19,233 | 17,381 | |
Recurring | Managed investments | Private equity investments | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Other investments, at fair value | 107,230 | 82,627 | |
Recurring | Managed investments | Fixed income investment funds | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Other investments, at fair value | 285,034 | 249,275 | |
Recurring | Managed investments | Overseas deposits | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Other investments, at fair value | 55,775 | 50,106 | |
Recurring | Managed investments | Mutual funds | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Other investments, at fair value | 4,028 | 5,368 | |
Recurring | Managed investments | Level 1 | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 0 | 0 | |
Short-term investments, at fair value | 251,578 | 209,651 | |
Other investments, at fair value | 0 | 0 | |
Total investments | 251,578 | 209,651 | |
Recurring | Managed investments | Level 1 | U.S. government and government agency | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 0 | 0 | |
Recurring | Managed investments | Level 1 | Non-US government and government agency | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 0 | 0 | |
Recurring | Managed investments | Level 1 | U.S. states, municipalities and political subdivisions | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 0 | 0 | |
Recurring | Managed investments | Level 1 | Agency residential mortgage-backed securities | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 0 | 0 | |
Recurring | Managed investments | Level 1 | Non-Agency residential mortgage-backed securities | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 0 | 0 | |
Recurring | Managed investments | Level 1 | U.S. corporate | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 0 | 0 | |
Recurring | Managed investments | Level 1 | Non-U.S. corporate | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 0 | 0 | |
Recurring | Managed investments | Level 1 | Bank loans | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 0 | 0 | |
Recurring | Managed investments | Level 1 | Asset-backed securities | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 0 | 0 | |
Recurring | Managed investments | Level 1 | Commercial mortgage-backed securities | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 0 | 0 | |
Recurring | Managed investments | Level 1 | Fund of hedge funds | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Other investments, at fair value | 0 | ||
Recurring | Managed investments | Level 1 | Hedge funds | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Other investments, at fair value | 0 | 0 | |
Recurring | Managed investments | Level 1 | Private equity investments | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Other investments, at fair value | 0 | 0 | |
Recurring | Managed investments | Level 1 | Fixed income investment funds | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Other investments, at fair value | 0 | 0 | |
Recurring | Managed investments | Level 1 | Overseas deposits | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Other investments, at fair value | 0 | 0 | |
Recurring | Managed investments | Level 1 | Mutual funds | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Other investments, at fair value | 0 | 0 | |
Recurring | Managed investments | Level 2 | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 4,860,594 | 5,114,272 | |
Short-term investments, at fair value | 7,068 | 18,735 | |
Other investments, at fair value | 39,173 | 36,309 | |
Total investments | 4,906,835 | 5,169,316 | |
Recurring | Managed investments | Level 2 | U.S. government and government agency | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 595,694 | 804,126 | |
Recurring | Managed investments | Level 2 | Non-US government and government agency | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 290,538 | 240,791 | |
Recurring | Managed investments | Level 2 | U.S. states, municipalities and political subdivisions | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 206,667 | 271,830 | |
Recurring | Managed investments | Level 2 | Agency residential mortgage-backed securities | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 828,400 | 679,595 | |
Recurring | Managed investments | Level 2 | Non-Agency residential mortgage-backed securities | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 38,993 | 15,477 | |
Recurring | Managed investments | Level 2 | U.S. corporate | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 1,466,739 | 1,534,508 | |
Recurring | Managed investments | Level 2 | Non-U.S. corporate | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 392,242 | 410,227 | |
Recurring | Managed investments | Level 2 | Bank loans | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 240,563 | 323,903 | |
Recurring | Managed investments | Level 2 | Asset-backed securities | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 486,537 | 502,883 | |
Recurring | Managed investments | Level 2 | Commercial mortgage-backed securities | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 314,221 | 330,932 | |
Recurring | Managed investments | Level 2 | Fund of hedge funds | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Other investments, at fair value | 0 | ||
Recurring | Managed investments | Level 2 | Hedge funds | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Other investments, at fair value | 0 | 0 | |
Recurring | Managed investments | Level 2 | Private equity investments | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Other investments, at fair value | 0 | 0 | |
Recurring | Managed investments | Level 2 | Fixed income investment funds | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Other investments, at fair value | 35,145 | 30,941 | |
Recurring | Managed investments | Level 2 | Overseas deposits | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Other investments, at fair value | 0 | 0 | |
Recurring | Managed investments | Level 2 | Mutual funds | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Other investments, at fair value | 4,028 | 5,368 | |
Recurring | Managed investments | Level 3 | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 259,888 | 270,427 | |
Short-term investments, at fair value | 0 | 0 | |
Other investments, at fair value | 16,886 | 12,168 | |
Total investments | 276,774 | 282,595 | |
Recurring | Managed investments | Level 3 | U.S. government and government agency | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 0 | 0 | |
Recurring | Managed investments | Level 3 | Non-US government and government agency | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 0 | 0 | |
Recurring | Managed investments | Level 3 | U.S. states, municipalities and political subdivisions | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 0 | 0 | |
Recurring | Managed investments | Level 3 | Agency residential mortgage-backed securities | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 0 | 0 | |
Recurring | Managed investments | Level 3 | Non-Agency residential mortgage-backed securities | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 0 | 0 | |
Recurring | Managed investments | Level 3 | U.S. corporate | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 0 | 0 | |
Recurring | Managed investments | Level 3 | Non-U.S. corporate | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 0 | 0 | |
Recurring | Managed investments | Level 3 | Bank loans | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 223,901 | 246,496 | |
Recurring | Managed investments | Level 3 | Asset-backed securities | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 35,987 | 23,931 | |
Recurring | Managed investments | Level 3 | Commercial mortgage-backed securities | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 0 | 0 | |
Recurring | Managed investments | Level 3 | Fund of hedge funds | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Other investments, at fair value | 0 | ||
Recurring | Managed investments | Level 3 | Hedge funds | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Other investments, at fair value | 0 | 0 | |
Recurring | Managed investments | Level 3 | Private equity investments | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Other investments, at fair value | 0 | 0 | |
Recurring | Managed investments | Level 3 | Fixed income investment funds | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Other investments, at fair value | 16,886 | 12,168 | |
Recurring | Managed investments | Level 3 | Overseas deposits | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Other investments, at fair value | 0 | 0 | |
Recurring | Managed investments | Level 3 | Mutual funds | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Other investments, at fair value | 0 | 0 | |
Recurring | Non-managed investments | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Short-term investments, at fair value | 2,734,600 | 2,567,784 | |
Total investments | 3,034,084 | 2,726,115 | |
Recurring | Non-managed investments | Catastrophe bonds | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 299,484 | 158,331 | |
Recurring | Non-managed investments | Level 1 | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Short-term investments, at fair value | 2,734,600 | 2,567,784 | |
Total investments | 2,734,600 | 2,567,784 | |
Recurring | Non-managed investments | Level 1 | Catastrophe bonds | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 0 | 0 | |
Recurring | Non-managed investments | Level 2 | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Short-term investments, at fair value | 0 | 0 | |
Total investments | 230,775 | 109,956 | |
Recurring | Non-managed investments | Level 2 | Catastrophe bonds | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 230,775 | 109,956 | |
Recurring | Non-managed investments | Level 3 | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Short-term investments, at fair value | 0 | 0 | |
Total investments | 68,709 | 48,375 | |
Recurring | Non-managed investments | Level 3 | Catastrophe bonds | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | 68,709 | 48,375 | |
Recurring | Fair value based on NAV practical expedient | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Total investments | [2] | 415,241 | 357,235 |
Recurring | Fair value based on NAV practical expedient | Managed investments | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | [2] | 0 | 0 |
Short-term investments, at fair value | [2] | 0 | 0 |
Other investments, at fair value | [2] | 415,241 | 357,235 |
Total investments | [2] | 415,241 | 357,235 |
Recurring | Fair value based on NAV practical expedient | Managed investments | U.S. government and government agency | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | [2] | 0 | 0 |
Recurring | Fair value based on NAV practical expedient | Managed investments | Non-US government and government agency | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | [2] | 0 | 0 |
Recurring | Fair value based on NAV practical expedient | Managed investments | U.S. states, municipalities and political subdivisions | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | [2] | 0 | 0 |
Recurring | Fair value based on NAV practical expedient | Managed investments | Agency residential mortgage-backed securities | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | [2] | 0 | 0 |
Recurring | Fair value based on NAV practical expedient | Managed investments | Non-Agency residential mortgage-backed securities | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | [2] | 0 | 0 |
Recurring | Fair value based on NAV practical expedient | Managed investments | U.S. corporate | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | [2] | 0 | 0 |
Recurring | Fair value based on NAV practical expedient | Managed investments | Non-U.S. corporate | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | [2] | 0 | 0 |
Recurring | Fair value based on NAV practical expedient | Managed investments | Bank loans | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | [2] | 0 | 0 |
Recurring | Fair value based on NAV practical expedient | Managed investments | Asset-backed securities | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | [2] | 0 | 0 |
Recurring | Fair value based on NAV practical expedient | Managed investments | Commercial mortgage-backed securities | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | [2] | 0 | 0 |
Recurring | Fair value based on NAV practical expedient | Managed investments | Fund of hedge funds | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Other investments, at fair value | [2] | 955 | |
Recurring | Fair value based on NAV practical expedient | Managed investments | Hedge funds | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Other investments, at fair value | [2] | 19,233 | 17,381 |
Recurring | Fair value based on NAV practical expedient | Managed investments | Private equity investments | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Other investments, at fair value | [2] | 107,230 | 82,627 |
Recurring | Fair value based on NAV practical expedient | Managed investments | Fixed income investment funds | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Other investments, at fair value | [2] | 233,003 | 206,166 |
Recurring | Fair value based on NAV practical expedient | Managed investments | Overseas deposits | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Other investments, at fair value | [2] | 55,775 | 50,106 |
Recurring | Fair value based on NAV practical expedient | Managed investments | Mutual funds | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Other investments, at fair value | [2] | 0 | 0 |
Recurring | Fair value based on NAV practical expedient | Non-managed investments | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Short-term investments, at fair value | [2] | 0 | 0 |
Total investments | [2] | 0 | 0 |
Recurring | Fair value based on NAV practical expedient | Non-managed investments | Catastrophe bonds | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Fixed maturities, at fair value | [2] | $ 0 | $ 0 |
[1] | The Company’s investments in investment affiliates have been treated as equity method investments with the corresponding gains and losses recorded inincome as “Income (loss) from investment affiliates.” | ||
[2] | In accordance with ASC Topic 820 “Fair Value Measurements,” investments measured at fair value using the net asset value (“NAV”) per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy. |
Fair value measurements (Level
Fair value measurements (Level 3 rollforward) (Details) - Recurring - Level 3 - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2017 | Sep. 30, 2016 | Sep. 30, 2017 | Sep. 30, 2016 | |
Reconciliation of beginning and ending balances for all investments measured at fair value on recurring basis | ||||
Level 3 investments - beginning of period | $ 344,518 | $ 293,049 | $ 330,970 | $ 245,837 |
Purchases | 31,312 | 32,769 | 151,821 | 119,412 |
Sales | (71) | (12,388) | (124) | (14,777) |
Settlements | (30,310) | (140,509) | (34,158) | |
Net realized gains | 3,350 | |||
Change in net unrealized (losses) gains | 34 | 1,001 | (25) | (1,883) |
Level 3 investments - end of period | 345,483 | 314,431 | 345,483 | 314,431 |
Bank loan portfolio | ||||
Reconciliation of beginning and ending balances for all investments measured at fair value on recurring basis | ||||
Level 3 investments - beginning of period | 224,172 | 243,148 | 246,496 | 232,337 |
Purchases | 31,312 | 21,256 | 71,245 | 72,244 |
Sales | 0 | (12,388) | 0 | (14,777) |
Settlements | (29,796) | (91,799) | (34,033) | |
Net realized gains | 0 | |||
Change in net unrealized (losses) gains | (1,787) | 484 | (2,041) | (3,271) |
Level 3 investments - end of period | 223,901 | 252,500 | 223,901 | 252,500 |
Catastrophe bonds | ||||
Reconciliation of beginning and ending balances for all investments measured at fair value on recurring basis | ||||
Level 3 investments - beginning of period | 68,025 | 37,518 | 48,375 | 13,500 |
Purchases | 0 | 0 | 66,091 | 23,272 |
Sales | 0 | 0 | 0 | 0 |
Settlements | (1,000) | (49,996) | (125) | |
Net realized gains | 3,350 | |||
Change in net unrealized (losses) gains | 1,684 | 517 | 889 | 1,388 |
Level 3 investments - end of period | 68,709 | 38,035 | 68,709 | 38,035 |
Fixed income investment funds | ||||
Reconciliation of beginning and ending balances for all investments measured at fair value on recurring basis | ||||
Level 3 investments - beginning of period | 16,400 | 12,168 | ||
Purchases | 0 | 3,432 | ||
Sales | 0 | 0 | ||
Settlements | 486 | 1,286 | ||
Net realized gains | 0 | |||
Change in net unrealized (losses) gains | 0 | 0 | ||
Level 3 investments - end of period | 16,886 | 16,886 | ||
Asset-backed securities | ||||
Reconciliation of beginning and ending balances for all investments measured at fair value on recurring basis | ||||
Level 3 investments - beginning of period | 35,921 | 12,383 | 23,931 | 0 |
Purchases | 0 | 11,513 | 11,053 | 23,896 |
Sales | (71) | 0 | (124) | 0 |
Settlements | 0 | 0 | 0 | |
Net realized gains | 0 | |||
Change in net unrealized (losses) gains | 137 | 0 | 1,127 | 0 |
Level 3 investments - end of period | $ 35,987 | $ 23,896 | $ 35,987 | $ 23,896 |
Fair value measurements (Narrat
Fair value measurements (Narrative) (Details) - USD ($) $ in Thousands | 9 Months Ended | |
Sep. 30, 2017 | Dec. 31, 2016 | |
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ||
Trading Securities | $ 8,976,591 | $ 8,845,343 |
Managed investments | ||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ||
Trading Securities | 5,942,507 | 6,119,228 |
Recurring | ||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ||
Trading Securities | $ 8,976,591 | 8,845,343 |
Recurring | Fund of hedge funds | ||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ||
Investment Time Lag Reporting | 3 months | |
Recurring | Hedge funds | ||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ||
Investment Time Lag Reporting | 3 months | |
Recurring | Minimum | Private equity investments | ||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ||
Investment Time Lag Reporting | 3 months | |
Recurring | Minimum | Fixed income investment funds | ||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ||
Investment Time Lag Reporting | 1 month | |
Recurring | Maximum | Private equity investments | ||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ||
Investment Time Lag Reporting | 6 months | |
Recurring | Maximum | Fixed income investment funds | ||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ||
Investment Time Lag Reporting | 3 months | |
Recurring | Managed investments | ||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ||
Trading Securities | $ 5,942,507 | 6,119,228 |
Recurring | Level 3 | ||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ||
Trading Securities | 345,483 | 330,970 |
Recurring | Level 3 | Managed investments | ||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ||
Trading Securities | $ 276,774 | $ 282,595 |
Ratio of Level 3 investments to total investments (percent) | 4.70% | 4.60% |
Variable interest entities (Not
Variable interest entities (Notes payable to AlphaCat investors) (Details) - Variable interest entities, primary beneficiary - AlphaCat ILS funds - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | 12 Months Ended | ||
Sep. 30, 2017 | Sep. 30, 2016 | Sep. 30, 2017 | Sep. 30, 2016 | Dec. 31, 2016 | |
Variable Interest Entity [Line Items] | |||||
Notes payable to AlphaCat investors, beginning of period | $ 1,066,159 | $ 370,982 | $ 278,202 | $ 75,493 | $ 75,493 |
Notes payable to AlphaCat investors recognized on deconsolidation of AlphaCat ILS fund | 423,269 | ||||
Issuance of notes payable to AlphaCat investors | 59,530 | 13,808 | 773,607 | 406,239 | |
Redemption of notes payable to AlphaCat investors | (18,627) | (12,028) | (367,733) | (109,712) | |
Foreign exchange gains | 556 | (32) | 273 | 710 | |
Notes payable to AlphaCat investors, end of period | 1,107,618 | 372,730 | 1,107,618 | 372,730 | 278,202 |
Variable Funding Notes | |||||
Variable Interest Entity [Line Items] | |||||
Notes payable to AlphaCat investors, beginning of period | 893,959 | 276,656 | 278,202 | 75,493 | 75,493 |
Notes payable to AlphaCat investors recognized on deconsolidation of AlphaCat ILS fund | 423,269 | ||||
Issuance of notes payable to AlphaCat investors | 59,530 | 13,808 | 601,407 | 311,913 | |
Redemption of notes payable to AlphaCat investors | (18,627) | (12,028) | (367,733) | (109,712) | |
Foreign exchange gains | 556 | (32) | 273 | 710 | |
Notes payable to AlphaCat investors, end of period | 935,418 | 278,404 | 935,418 | 278,404 | 278,202 |
Structured Notes | |||||
Variable Interest Entity [Line Items] | |||||
Notes payable to AlphaCat investors, beginning of period | 172,200 | 94,326 | 0 | 0 | 0 |
Notes payable to AlphaCat investors recognized on deconsolidation of AlphaCat ILS fund | 0 | ||||
Issuance of notes payable to AlphaCat investors | 0 | 0 | 172,200 | 94,326 | |
Redemption of notes payable to AlphaCat investors | 0 | 0 | 0 | 0 | |
Foreign exchange gains | 0 | 0 | 0 | 0 | |
Notes payable to AlphaCat investors, end of period | $ 172,200 | $ 94,326 | $ 172,200 | $ 94,326 | $ 0 |
Variable interest entities (Ass
Variable interest entities (Assets and liabilities of consolidated VIEs) (Details) - Variable interest entities, primary beneficiary - USD ($) $ in Thousands | Sep. 30, 2017 | Dec. 31, 2016 | |
AlphaCat sidecars | |||
Variable Interest Entity [Line Items] | |||
Total assets | $ 30,598 | $ 40,041 | |
Total liabilities | 3,708 | 3,206 | |
AlphaCat ILS funds - Lower Risk | |||
Variable Interest Entity [Line Items] | |||
Total assets | [1] | 1,019,072 | 1,498,276 |
Total liabilities | [1] | 234,192 | 42,457 |
AlphaCat ILS funds - Higher Risk | |||
Variable Interest Entity [Line Items] | |||
Total assets | [1] | 947,135 | 972,633 |
Total liabilities | [1] | 541,466 | 381,332 |
AlphaCat Re and AlphaCat Master Fund | |||
Variable Interest Entity [Line Items] | |||
Total assets | 3,427,625 | 2,510,415 | |
Total liabilities | 3,427,455 | 2,510,245 | |
BetaCat ILS funds | |||
Variable Interest Entity [Line Items] | |||
Total assets | 144,766 | 82,471 | |
Total liabilities | $ 291 | $ 30,663 | |
[1] | Lower risk AlphaCat ILS funds have a maximum permitted portfolio expected loss of less than 7%, whereas higher risk AlphaCat ILS funds have a maximum permitted portfolio expected loss of greater than 7%. Expected loss represents the average annual loss over the set of simulation scenarios divided by the total limit. |
Variable interest entities (Nar
Variable interest entities (Narrative) (Details) $ in Thousands | 3 Months Ended | 9 Months Ended | 12 Months Ended | ||
Sep. 30, 2017USD ($)fundssubsidiaries | Sep. 30, 2016USD ($) | Sep. 30, 2017USD ($)fundssubsidiaries | Sep. 30, 2016USD ($) | Dec. 31, 2016USD ($) | |
Variable Interest Entity [Line Items] | |||||
Loss on deconsolidation of AlphaCat ILS fund | $ (402) | $ 0 | |||
(Loss) income attributable to AlphaCat investors | $ (74,130) | $ 5,564 | (54,797) | 16,278 | |
Accounts payable and accrued expenses | |||||
Variable Interest Entity [Line Items] | |||||
(Loss) income attributable to AlphaCat investors | $ 9,737 | 17,068 | |||
Variable interest entities, primary beneficiary | |||||
Variable Interest Entity [Line Items] | |||||
Variable funding notes, typical minimum duration | 12 months | ||||
AlphaCat ILS funds | Variable interest entities, primary beneficiary | |||||
Variable Interest Entity [Line Items] | |||||
Variable Interest Entity Redemption Of Notes Payable To AlphaCat Investors | $ 18,627 | 12,028 | $ 367,733 | $ 109,712 | |
Risk profile percentage | 7.00% | ||||
AlphaCat ILS funds | Variable interest entities, primary beneficiary | Accounts payable and accrued expenses | |||||
Variable Interest Entity [Line Items] | |||||
Variable Interest Entity Redemption Of Notes Payable To AlphaCat Investors | $ 1,000 | ||||
ILS fund issuing structured notes | |||||
Variable Interest Entity [Line Items] | |||||
Number of AlphaCat ILS funds | funds | 1 | 1 | |||
BetaCat ILS funds | Variable interest entities, primary beneficiary | |||||
Variable Interest Entity [Line Items] | |||||
Number of consolidated VIE BetaCat ILS funds | subsidiaries | 2 | 2 | |||
Structured Notes | |||||
Variable Interest Entity [Line Items] | |||||
Structured notes interest rate percentage | 7.00% | 8.00% | |||
Structured Notes | AlphaCat ILS funds | Variable interest entities, primary beneficiary | |||||
Variable Interest Entity [Line Items] | |||||
Variable Interest Entity Redemption Of Notes Payable To AlphaCat Investors | $ 0 | $ 0 | $ 0 | $ 0 |
Noncontrolling interest (Detail
Noncontrolling interest (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | |||
Sep. 30, 2017 | Sep. 30, 2016 | Sep. 30, 2017 | Sep. 30, 2016 | Dec. 31, 2016 | |
Noncontrolling Interest [Line Items] | |||||
Balance, beginning of period | $ 1,667,318 | $ 1,744,437 | $ 1,693,978 | $ 1,266,376 | |
Issuance of shares | 26,999 | 700 | 495,499 | 553,624 | |
Adjustment to noncontrolling interests as a result of deconsolidation | (459,021) | 0 | |||
(Loss) income attributable to noncontrolling interests | (376,366) | 37,439 | (290,144) | 96,163 | |
Redemption of shares | (105,124) | 0 | (227,485) | (133,587) | |
Balance, end of period | 1,212,827 | 1,782,576 | 1,212,827 | 1,782,576 | |
Redeemable noncontrolling interest | |||||
Noncontrolling Interest [Line Items] | |||||
Balance, beginning of period | 1,251,660 | 1,532,283 | 1,528,001 | 1,111,714 | |
Issuance of shares | 26,999 | 700 | 237,199 | 381,950 | |
Adjustment to noncontrolling interests as a result of deconsolidation | (459,021) | 0 | |||
(Loss) income attributable to noncontrolling interests | (140,781) | 26,597 | (86,296) | 72,400 | |
Redemption of shares | (3,998) | 0 | (86,003) | (6,484) | |
Balance, end of period | 1,133,880 | 1,559,580 | 1,133,880 | 1,559,580 | |
Balances payable to noncontrolling interests | 0 | 0 | $ 71,530 | ||
Noncontrolling interest | |||||
Noncontrolling Interest [Line Items] | |||||
Balance, beginning of period | 415,658 | 212,154 | 165,977 | 154,662 | |
Issuance of shares | 0 | 0 | 258,300 | 171,674 | |
Adjustment to noncontrolling interests as a result of deconsolidation | 0 | 0 | |||
(Loss) income attributable to noncontrolling interests | (235,585) | 10,842 | (203,848) | 23,763 | |
Distributions | (101,126) | 0 | (141,482) | (127,103) | |
Balance, end of period | 78,947 | $ 222,996 | 78,947 | $ 222,996 | |
Balances payable to noncontrolling interests | $ 0 | $ 0 | $ 16,144 |
Derivative instruments (Amount
Derivative instruments (Amount and balance sheet location) (Details) - USD ($) $ in Thousands | Sep. 30, 2017 | Dec. 31, 2016 | |
Not designated as hedging instruments | Foreign exchange contracts | |||
Summary of derivatives | |||
Net Notional Exposure | $ 267,206 | $ 181,375 | |
Not designated as hedging instruments | Foreign exchange contracts | Other assets | |||
Summary of derivatives | |||
Fair value, derivative assets | [1] | 1,522 | 2,351 |
Not designated as hedging instruments | Foreign exchange contracts | Accounts payable and accrued expenses | |||
Summary of derivatives | |||
Fair value, derivative liabilities | [1] | 1,379 | 3,421 |
Not designated as hedging instruments | Interest rate swap contracts | |||
Summary of derivatives | |||
Net Notional Exposure | 200,000 | 0 | |
Not designated as hedging instruments | Interest rate swap contracts | Other assets | |||
Summary of derivatives | |||
Fair value, derivative assets | [1] | 440 | 0 |
Not designated as hedging instruments | Interest rate swap contracts | Accounts payable and accrued expenses | |||
Summary of derivatives | |||
Fair value, derivative liabilities | [1] | 1,607 | 0 |
Designated as hedging instruments | Interest rate swap contracts | |||
Summary of derivatives | |||
Net Notional Exposure | 552,263 | 552,263 | |
Designated as hedging instruments | Interest rate swap contracts | Other assets | |||
Summary of derivatives | |||
Fair value, derivative assets | [2] | 20 | 20 |
Designated as hedging instruments | Interest rate swap contracts | Accounts payable and accrued expenses | |||
Summary of derivatives | |||
Fair value, derivative liabilities | [2] | $ 1,347 | $ 1,479 |
[1] | Asset and liability derivatives are classified within other assets and accounts payable and accrued expenses, respectively, within the Company’s consolidated balance sheets. | ||
[2] | Asset and liability derivatives are classified within other assets and accounts payable and accrued expenses, respectively, within the Company’s consolidated balance sheets. |
Derivative instruments (Amoun62
Derivative instruments (Amount included in statement of operations) (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2017 | Sep. 30, 2016 | Sep. 30, 2017 | Sep. 30, 2016 | |
Not designated as hedging instruments | Foreign exchange gains (losses) | ||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||
Derivative gains (losses) recognized in earnings | $ (1,927) | $ 1,326 | $ (7,999) | $ 209 |
Not designated as hedging instruments | Other income | ||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||
Derivative gains (losses) recognized in earnings | 0 | (155) | (979) | (35) |
Not designated as hedging instruments | Gain (Loss) on Investments [Member] | ||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||
Derivative gains (losses) recognized in earnings | (848) | 566 | (1,167) | 566 |
Designated as hedging instruments | Cash flow hedge | Interest rate swap contracts | ||||
Derivative instruments designated as a cash flow hedge | ||||
Amount of ineffective portion excluded from effectiveness testing | 13 | (438) | (33) | (1,132) |
Designated as hedging instruments | Cash flow hedge | Interest rate swap contracts | Other comprehensive income | ||||
Derivative instruments designated as a cash flow hedge | ||||
Amount of effective portion recognized in other comprehensive income | 1,918 | 3,155 | 6,294 | 9,505 |
Designated as hedging instruments | Cash flow hedge | Interest rate swap contracts | Finance expenses | ||||
Derivative instruments designated as a cash flow hedge | ||||
Amount of effective portion subsequently reclassified to earnings | $ (1,931) | $ (2,717) | $ (6,261) | $ (8,373) |
Reserve for losses and loss e63
Reserve for losses and loss expenses (Components of reserves for losses and loss expenses) (Details) - USD ($) $ in Thousands | Sep. 30, 2017 | Jun. 30, 2017 | Dec. 31, 2016 | Sep. 30, 2016 | Jun. 30, 2016 | Dec. 31, 2015 |
Insurance Loss Reserves [Abstract] | ||||||
Case reserves | $ 1,271,580 | $ 1,237,772 | ||||
IBNR | 3,664,057 | 1,757,423 | ||||
Reserve for losses and loss expenses | $ 4,935,637 | $ 3,305,191 | $ 2,995,195 | $ 3,035,987 | $ 3,122,717 | $ 2,996,567 |
Reserve for losses and loss e64
Reserve for losses and loss expenses (Reserve rollforward) (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | |||
Sep. 30, 2017 | Sep. 30, 2016 | Sep. 30, 2017 | Sep. 30, 2016 | ||
Reserve for paid losses and unpaid loss expenses | |||||
Reserve for losses and loss expenses, beginning of period | $ 3,305,191 | $ 3,122,717 | $ 2,995,195 | $ 2,996,567 | |
Loss reserves recoverable, beginning of period | (600,207) | (442,987) | (430,421) | (350,586) | |
Net reserves for losses and loss expenses, beginning of period | 2,704,984 | 2,679,730 | 2,564,774 | 2,645,981 | |
Net reserves acquired | [1] | 0 | 0 | 23,753 | 0 |
Increase (decrease) in net losses and loss expenses incurred in respect of losses occurring in: | |||||
Current year | 1,329,666 | 311,279 | 1,999,921 | 959,376 | |
Prior years | (75,064) | (52,885) | (179,585) | (169,405) | |
Total incurred losses and loss expenses | 1,254,602 | 258,394 | 1,820,336 | 789,971 | |
Less net losses and loss expenses paid in respect of losses occurring in: | |||||
Current year | (191,612) | (178,707) | (242,068) | (240,362) | |
Prior years | (181,094) | (166,539) | (612,448) | (596,618) | |
Total net paid losses | (372,706) | (345,246) | (854,516) | (836,980) | |
Foreign exchange losses (gains) | 13,741 | (1,500) | 46,274 | (7,594) | |
Net reserve for losses and loss expenses, end of period | 3,600,621 | 2,591,378 | 3,600,621 | 2,591,378 | |
Loss reserves recoverable, end of period | 1,335,016 | 444,609 | 1,335,016 | 444,609 | |
Reserve for losses and loss expenses, end of period | 4,935,637 | 3,035,987 | 4,935,637 | 3,035,987 | |
Components of incurred losses and loss expenses | |||||
Gross losses and loss expenses | 2,104,914 | 284,413 | 2,866,722 | 952,129 | |
Reinsurance recoverable | (850,312) | (26,019) | (1,046,386) | (162,158) | |
Net incurred losses and loss expenses | 1,254,602 | $ 258,394 | 1,820,336 | $ 789,971 | |
Net loss reserves | $ 42,575 | 42,575 | |||
Commutation of reserves | $ 18,822 | ||||
[1] | Equals net reserves acquired of $42,575 less net reserves commuted at closing of $18,822. |
Reserve for losses and loss e65
Reserve for losses and loss expenses (Prior year development) (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2017 | Sep. 30, 2016 | Sep. 30, 2017 | Sep. 30, 2016 | |
Increase (decrease) in net reserves for losses and loss expenses in respect of losses occurring in: | ||||
Net (favorable) adverse development on prior years | $ (75,064) | $ (52,885) | $ (179,585) | $ (169,405) |
Loss events | ||||
Increase (decrease) in net reserves for losses and loss expenses in respect of losses occurring in: | ||||
Net (favorable) adverse development on prior years | (16,100) | (20,300) | (31,500) | (9,000) |
Attritional losses | ||||
Increase (decrease) in net reserves for losses and loss expenses in respect of losses occurring in: | ||||
Net (favorable) adverse development on prior years | (58,900) | (32,600) | (148,000) | (160,400) |
Validus Re | ||||
Increase (decrease) in net reserves for losses and loss expenses in respect of losses occurring in: | ||||
Net (favorable) adverse development on prior years | (48,137) | (33,033) | (100,016) | (89,594) |
Talbot | ||||
Increase (decrease) in net reserves for losses and loss expenses in respect of losses occurring in: | ||||
Net (favorable) adverse development on prior years | (23,614) | (18,691) | (68,304) | (69,739) |
Western World | ||||
Increase (decrease) in net reserves for losses and loss expenses in respect of losses occurring in: | ||||
Net (favorable) adverse development on prior years | (62) | (880) | (744) | (8,464) |
AlphaCat | ||||
Increase (decrease) in net reserves for losses and loss expenses in respect of losses occurring in: | ||||
Net (favorable) adverse development on prior years | (3,251) | (281) | (10,521) | (1,608) |
Property | ||||
Increase (decrease) in net reserves for losses and loss expenses in respect of losses occurring in: | ||||
Net (favorable) adverse development on prior years | (36,131) | (22,983) | (62,395) | (86,323) |
Property | Validus Re | ||||
Increase (decrease) in net reserves for losses and loss expenses in respect of losses occurring in: | ||||
Net (favorable) adverse development on prior years | (26,372) | (19,736) | (30,614) | (52,036) |
Property | Talbot | ||||
Increase (decrease) in net reserves for losses and loss expenses in respect of losses occurring in: | ||||
Net (favorable) adverse development on prior years | (8,752) | (2,429) | (19,980) | (30,969) |
Property | Western World | ||||
Increase (decrease) in net reserves for losses and loss expenses in respect of losses occurring in: | ||||
Net (favorable) adverse development on prior years | 464 | (553) | (2,838) | (2,576) |
Property | AlphaCat | ||||
Increase (decrease) in net reserves for losses and loss expenses in respect of losses occurring in: | ||||
Net (favorable) adverse development on prior years | (1,471) | (265) | (8,963) | (742) |
Marine | ||||
Increase (decrease) in net reserves for losses and loss expenses in respect of losses occurring in: | ||||
Net (favorable) adverse development on prior years | (9,842) | (13,051) | (74,636) | (25,478) |
Marine | Validus Re | ||||
Increase (decrease) in net reserves for losses and loss expenses in respect of losses occurring in: | ||||
Net (favorable) adverse development on prior years | (7,105) | (8,504) | (38,847) | (14,967) |
Marine | Talbot | ||||
Increase (decrease) in net reserves for losses and loss expenses in respect of losses occurring in: | ||||
Net (favorable) adverse development on prior years | (2,737) | (4,547) | (35,789) | (10,511) |
Specialty | ||||
Increase (decrease) in net reserves for losses and loss expenses in respect of losses occurring in: | ||||
Net (favorable) adverse development on prior years | (28,565) | (16,524) | (44,648) | (51,716) |
Specialty | Validus Re | ||||
Increase (decrease) in net reserves for losses and loss expenses in respect of losses occurring in: | ||||
Net (favorable) adverse development on prior years | (14,660) | (4,793) | (30,555) | (22,591) |
Specialty | Talbot | ||||
Increase (decrease) in net reserves for losses and loss expenses in respect of losses occurring in: | ||||
Net (favorable) adverse development on prior years | (12,125) | (11,715) | (12,535) | (28,259) |
Specialty | AlphaCat | ||||
Increase (decrease) in net reserves for losses and loss expenses in respect of losses occurring in: | ||||
Net (favorable) adverse development on prior years | (1,780) | (16) | (1,558) | (866) |
Liability | ||||
Increase (decrease) in net reserves for losses and loss expenses in respect of losses occurring in: | ||||
Net (favorable) adverse development on prior years | (526) | (327) | 2,094 | (5,888) |
Liability | Western World | ||||
Increase (decrease) in net reserves for losses and loss expenses in respect of losses occurring in: | ||||
Net (favorable) adverse development on prior years | $ (526) | $ (327) | $ 2,094 | $ (5,888) |
Reinsurance (Components of rein
Reinsurance (Components of reinsurance) (Details) - USD ($) $ in Thousands | Sep. 30, 2017 | Jun. 30, 2017 | Dec. 31, 2016 | Sep. 30, 2016 | Jun. 30, 2016 | Dec. 31, 2015 |
Reinsurance Disclosures [Abstract] | ||||||
Outstanding losses | $ 207,368 | $ 165,328 | ||||
IBNR | 1,127,648 | 265,093 | ||||
Total loss reserves recoverable | 1,335,016 | $ 600,207 | 430,421 | $ 444,609 | $ 442,987 | $ 350,586 |
Paid losses recoverable | 77,730 | 35,247 | ||||
Total reinsurance balances recoverable | $ 1,412,746 | $ 465,668 |
Reinsurance (Ceded credit risk)
Reinsurance (Ceded credit risk) (Details) - USD ($) $ in Thousands | 9 Months Ended | 12 Months Ended | |
Sep. 30, 2017 | Dec. 31, 2016 | ||
Ceded Credit Risk [Line Items] | |||
Provision for uncollectible reinsurance relating to losses recoverable | $ 8,326 | $ 5,153 | |
Reinsurance Recoverable | |||
Ceded Credit Risk [Line Items] | |||
Reinsurance recoverable | $ 1,412,746 | $ 465,668 | |
Percentage of total | 100.00% | 100.00% | |
Reinsurance Recoverable | A- or better | |||
Ceded Credit Risk [Line Items] | |||
Reinsurance recoverable | $ 1,400,430 | $ 461,369 | |
Percentage of total | 99.10% | 99.10% | |
Reinsurance Recoverable | Top 10 reinsurers | |||
Ceded Credit Risk [Line Items] | |||
Reinsurance recoverable | $ 1,208,003 | $ 395,308 | |
Percentage of total | 85.50% | 84.90% | |
Reinsurance Recoverable | Top 10 reinsurers | Fully collateralized reinsurers | NR | |||
Ceded Credit Risk [Line Items] | |||
Reinsurance recoverable | $ 564,714 | $ 83,088 | |
Percentage of total | 40.00% | 17.80% | |
Reinsurance Recoverable | Top 10 reinsurers | Munich Re | AA- rating | |||
Ceded Credit Risk [Line Items] | |||
Reinsurance recoverable | $ 164,131 | $ 18,214 | |
Percentage of total | 11.60% | 3.90% | |
Reinsurance Recoverable | Top 10 reinsurers | Everest Re | A plus | |||
Ceded Credit Risk [Line Items] | |||
Reinsurance recoverable | $ 95,759 | $ 36,912 | |
Percentage of total | 6.80% | 7.90% | |
Reinsurance Recoverable | Top 10 reinsurers | Lloyds Syndicates | A plus | |||
Ceded Credit Risk [Line Items] | |||
Reinsurance recoverable | $ 94,845 | $ 84,419 | |
Percentage of total | 6.70% | 18.20% | |
Reinsurance Recoverable | Top 10 reinsurers | Swiss Re | AA- rating | |||
Ceded Credit Risk [Line Items] | |||
Reinsurance recoverable | $ 81,921 | $ 84,044 | |
Percentage of total | 5.80% | 18.10% | |
Reinsurance Recoverable | Top 10 reinsurers | Hannover Re | AA- rating | |||
Ceded Credit Risk [Line Items] | |||
Reinsurance recoverable | $ 62,715 | $ 50,603 | |
Percentage of total | 4.40% | 10.90% | |
Reinsurance Recoverable | Top 10 reinsurers | Federal Crop Insurance Corporation | |||
Ceded Credit Risk [Line Items] | |||
Reinsurance recoverable | [1] | $ 49,503 | |
Percentage of total | [1] | 3.50% | |
Reinsurance Recoverable | Top 10 reinsurers | Qatar Insurance Company | A rating | |||
Ceded Credit Risk [Line Items] | |||
Reinsurance recoverable | $ 38,061 | ||
Percentage of total | 2.70% | ||
Reinsurance Recoverable | Top 10 reinsurers | Transatlantic Re | A plus | |||
Ceded Credit Risk [Line Items] | |||
Reinsurance recoverable | $ 29,795 | $ 10,593 | |
Percentage of total | 2.10% | 2.30% | |
Reinsurance Recoverable | Top 10 reinsurers | XL Catlin | A plus | |||
Ceded Credit Risk [Line Items] | |||
Reinsurance recoverable | $ 26,559 | ||
Percentage of total | 1.90% | ||
Reinsurance Recoverable | Top 10 reinsurers | Hamilton Re | A- rating | |||
Ceded Credit Risk [Line Items] | |||
Reinsurance recoverable | $ 10,343 | ||
Percentage of total | 2.20% | ||
Reinsurance Recoverable | Top 10 reinsurers | Toa Re | A plus | |||
Ceded Credit Risk [Line Items] | |||
Reinsurance recoverable | $ 9,510 | ||
Percentage of total | 2.00% | ||
Reinsurance Recoverable | Top 10 reinsurers | National Indemnity | AA plus | |||
Ceded Credit Risk [Line Items] | |||
Reinsurance recoverable | $ 7,582 | ||
Percentage of total | 1.60% | ||
Reinsurance Recoverable | Other reinsurers' balances greater than $1 million | |||
Ceded Credit Risk [Line Items] | |||
Reinsurance recoverable | $ 198,774 | $ 66,944 | |
Percentage of total | 14.10% | 14.40% | |
Reinsurance Recoverable | Other reinsurers' balances less than $1 million | |||
Ceded Credit Risk [Line Items] | |||
Reinsurance recoverable | $ 5,969 | $ 3,416 | |
Percentage of total | 0.40% | 0.70% | |
[1] | The Company participates in a crop reinsurance program sponsored by the U.S. federal government. The Company remains obligated for amounts ceded in the event that its reinsurers or retrocessionaires do not meet their obligations, except for amounts ceded to the U.S. federal government in the agriculture line of business. |
Share capital (Preferred stock)
Share capital (Preferred stock) (Details) $ / shares in Units, $ in Thousands | Jun. 12, 2017USD ($)$ / sharesshares | Jun. 13, 2016$ / sharesshares | Sep. 30, 2017USD ($)shares | Sep. 30, 2016USD ($)shares |
Preferred shares - Shareholders' Equity | ||||
Net proceeds on issuance of preferred shares | $ | $ 241,686 | $ 144,852 | ||
Preferred shares, shares issued, beginning of period | shares | 6,000 | 0 | ||
Preferred shares, shares outstanding, beginning of period | shares | 6,000 | 0 | ||
Preferred shares issued | shares | 10,000 | 6,000 | ||
Preferred shares, shares issued, end of period | shares | 16,000 | 6,000 | ||
Preferred shares, shares outstanding, end of period | shares | 16,000 | 6,000 | ||
Series A preferred shares | ||||
Preferred shares - Shareholders' Equity | ||||
Preferred shares, dividend rate, percentage | 5.875% | |||
Proportionate interest of preferred shares, per depositary share | 0.001 | |||
Preferred stock, par or stated value per share | $ / shares | $ 0.175 | |||
Preferred stock, liquidation preference, per share | $ / shares | $ 25,000 | |||
Preferred shares, shares issued, beginning of period | shares | 6,000 | |||
Preferred shares issued | shares | 6,000 | |||
Preferred shares, shares issued, end of period | shares | 6,000 | |||
Series A depositary share equivalent | ||||
Preferred shares - Shareholders' Equity | ||||
Preferred shares equivalent depositary shares number | shares | 6,000,000 | |||
Preferred stock, liquidation preference, per share | $ / shares | $ 25 | |||
Series B preferred shares | ||||
Preferred shares - Shareholders' Equity | ||||
Preferred shares, dividend rate, percentage | 5.80% | |||
Proportionate interest of preferred shares, per depositary share | 0.001 | |||
Preferred stock, par or stated value per share | $ / shares | $ 0.175 | |||
Preferred stock, liquidation preference, per share | $ / shares | $ 25,000 | |||
Net proceeds on issuance of preferred shares | $ | $ 241,686 | |||
Preferred shares issued | shares | 10,000 | |||
Preferred shares, shares issued, end of period | shares | 10,000 | |||
Series B preferred shares | On or after June 21, 2022 | ||||
Preferred shares - Shareholders' Equity | ||||
Preferred shares, redemption price per share | $ / shares | $ 25,000 | |||
Series B preferred shares | Prior to redemption in the event of amalgamation, consolidation, merger or similar | ||||
Preferred shares - Shareholders' Equity | ||||
Preferred shares, redemption price per share | $ / shares | 26,000 | |||
Series B preferred shares | Prior to redemption if change in tax law or capital disqualification event | ||||
Preferred shares - Shareholders' Equity | ||||
Preferred shares, redemption price per share | $ / shares | $ 25,000 | |||
Series B depositary share equivalent | ||||
Preferred shares - Shareholders' Equity | ||||
Preferred shares equivalent depositary shares number | shares | 10,000,000 | |||
Preferred stock, liquidation preference, per share | $ / shares | $ 25 | |||
Series B depositary share equivalent | On or after June 21, 2022 | ||||
Preferred shares - Shareholders' Equity | ||||
Preferred shares, redemption price per share | $ / shares | 25 | |||
Series B depositary share equivalent | Prior to redemption in the event of amalgamation, consolidation, merger or similar | ||||
Preferred shares - Shareholders' Equity | ||||
Preferred shares, redemption price per share | $ / shares | 26 | |||
Series B depositary share equivalent | Prior to redemption if change in tax law or capital disqualification event | ||||
Preferred shares - Shareholders' Equity | ||||
Preferred shares, redemption price per share | $ / shares | $ 25 |
Share capital (Common stock) (D
Share capital (Common stock) (Details) - USD ($) $ / shares in Units, $ in Thousands | Feb. 03, 2015 | Sep. 30, 2017 | Sep. 30, 2016 |
Share Capital (Narrative) | |||
Authorized share capital | 571,428,571 | ||
Common shares, par value | $ 0.175 | ||
Common stock voting rights | one vote per share | ||
Restriction on percentage of voting power | 9.09% | ||
Share repurchases | |||
Common share repurchase authorization | $ 750,000 | ||
Share repurchase program, cumulative shares repurchased | 80,860,661 | ||
Shares repurchased, cumulative | $ 2,274,401 | $ 2,722,749 | |
Remaining share repurchase authorization amount | $ 301,652 | ||
Summary of common shares issued and outstanding | |||
Common shares issued, beginning balance | 161,279,976 | 160,570,772 | |
Options exercised | 0 | 27,983 | |
Common shares issued, ending balance | 161,956,886 | 161,273,353 | |
Treasury shares, end of period | 82,499,633 | 81,830,323 | |
Common shares outstanding, ending balance | 79,457,253 | 79,443,030 | |
Restricted share awards | |||
Summary of common shares issued and outstanding | |||
Vested, net of shares withheld | 619,046 | 608,024 | |
Restricted share units | |||
Summary of common shares issued and outstanding | |||
Vested, net of shares withheld | 15,454 | 18,486 | |
Performance shares | |||
Summary of common shares issued and outstanding | |||
Vested, net of shares withheld | 42,410 | 48,088 |
Share capital (Dividends) (Deta
Share capital (Dividends) (Details) - $ / shares | 3 Months Ended | 9 Months Ended | ||||||
Sep. 30, 2017 | Jun. 30, 2017 | Mar. 31, 2017 | Sep. 30, 2016 | Jun. 30, 2016 | Mar. 31, 2016 | Sep. 30, 2017 | Sep. 30, 2016 | |
Class of Stock [Line Items] | ||||||||
Cash dividends declared per share - common shares | $ 0.38 | $ 0.38 | $ 0.38 | $ 0.35 | $ 0.35 | $ 0.35 | $ 1.14 | $ 1.05 |
Series A depositary share equivalent | ||||||||
Class of Stock [Line Items] | ||||||||
Cash dividends declared per share - preferred shares | 0.3671875 | $ 0.3671875 | $ 0.3671875 | $ 0.3753472 | ||||
Series B depositary share equivalent | ||||||||
Class of Stock [Line Items] | ||||||||
Cash dividends declared per share - preferred shares | $ 0.3423611 |
Stock plans (Options activity)
Stock plans (Options activity) (Details) - $ / shares | 9 Months Ended | |
Sep. 30, 2017 | Sep. 30, 2016 | |
Options activities: | ||
Options outstanding, beginning balance (in shares) | 26,136 | 65,401 |
Options exercised during period (in shares) | 0 | (35,351) |
Options outstanding, ending balance (in shares) | 26,136 | 30,050 |
Weighted Average Grant Date Fair Value | ||
Weighted average grant date fair value, beginning balance (in dollars per share) | $ 6.78 | $ 7.74 |
Weighted average grant date fair value, options exercised (in dollars per share) | 0 | 8.16 |
Weighted average grant date fair value, ending balance (in dollars per share) | 6.78 | 7.24 |
Weighted Average Grant Date Exercise Price | ||
Weighted average grant date exercise price, beginning balance (in dollars per share) | 23.48 | 20.17 |
Weighted average grant date exercise price, options exercised (in dollars per share) | 0 | 17.82 |
Weighted average grant date exercise price, ending balance (in dollars per share) | $ 23.48 | $ 22.93 |
Stock plans (Other awards activ
Stock plans (Other awards activity) (Details) - $ / shares | 9 Months Ended | |
Sep. 30, 2017 | Sep. 30, 2016 | |
Restricted share awards | ||
Activities | ||
Beginning balance (in shares) | 2,469,982 | 2,739,446 |
Granted (in shares) | 508,186 | 559,516 |
Vested (in shares) | (828,800) | (789,547) |
Forfeited (in shares) | (53,775) | (33,070) |
Ending balance (in shares) | 2,095,593 | 2,476,345 |
Weighted average grant date fair value | ||
Weighted average grant date fair value, beginning balance (in dollars per share) | $ 40.89 | $ 38.25 |
Weighted average grant date fair value, granted (in dollars per share) | 53.25 | 48.78 |
Weighted average grant date fair value, vested (in dollars per share) | 41.25 | 37.36 |
Weighted average grant date fair value, forfeited (in dollars per share) | 43.38 | 40.25 |
Weighted average grant date fair value, ending balance (in dollars per share) | $ 43.69 | $ 40.88 |
Restricted share units | ||
Activities | ||
Beginning balance (in shares) | 112,808 | 114,337 |
Granted (in shares) | 12,236 | 21,609 |
Vested (in shares) | (18,748) | (23,982) |
Issued in lieu of cash dividends (in shares) | 2,260 | 2,436 |
Forfeited (in shares) | 0 | (8,338) |
Ending balance (in shares) | 108,556 | 106,062 |
Weighted average grant date fair value | ||
Weighted average grant date fair value, beginning balance (in dollars per share) | $ 40.95 | $ 38.47 |
Weighted average grant date fair value, granted (in dollars per share) | 53.40 | 48.83 |
Weighted average grant date fair value, vested (in dollars per share) | 41.91 | 38.18 |
Weighted average grant date fair value, issued in lieu of cash dividends (in dollars per share) | 41.42 | 39.10 |
Weighted average grant date fair value, forfeited (in dollars per share) | 0 | 44.34 |
Weighted average grant date fair value, ending balance (in dollars per share) | $ 42.20 | $ 40.20 |
Performance shares | ||
Activities | ||
Beginning balance (in shares) | 285,820 | 172,594 |
Granted (in shares) | 107,209 | 125,290 |
Vested (in shares) | (52,639) | (57,581) |
Conversion adjustment (in shares) | (26,322) | 45,517 |
Ending balance (in shares) | 314,068 | 285,820 |
Weighted average grant date fair value | ||
Weighted average grant date fair value, beginning balance (in dollars per share) | $ 44.53 | $ 40.70 |
Weighted average grant date fair value, granted (in dollars per share) | 53.40 | 48.75 |
Weighted average grant date fair value, vested (in dollars per share) | 37.33 | 36.11 |
Weighted average grant date fair value, conversion adjustment (in dollars per share) | 36.82 | 36.82 |
Weighted average grant date fair value, ending balance (in dollars per share) | $ 49.37 | $ 44.53 |
Stock plans (Components of shar
Stock plans (Components of share compensation expenses) (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2017 | Sep. 30, 2016 | Sep. 30, 2017 | Sep. 30, 2016 | |
Total share compensation expenses | ||||
Share compensation expenses | $ 9,443 | $ 10,501 | $ 30,080 | $ 32,465 |
Restricted share awards | ||||
Total share compensation expenses | ||||
Share compensation expenses | 7,814 | 9,159 | 26,603 | 27,805 |
Restricted share units | ||||
Total share compensation expenses | ||||
Share compensation expenses | 340 | 290 | 982 | 978 |
Performance shares | ||||
Total share compensation expenses | ||||
Share compensation expenses | $ 1,289 | $ 1,052 | $ 2,495 | $ 3,682 |
Stock plans (Narrative) (Detail
Stock plans (Narrative) (Details) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | 9 Months Ended | 12 Months Ended | ||
Sep. 30, 2017 | Sep. 30, 2016 | Sep. 30, 2017 | Sep. 30, 2016 | Dec. 31, 2016 | |
Stock plans (other details) | |||||
Number of shares reserved for issuance under the LTIP and STIP | 2,753,292 | 2,753,292 | |||
Remaining number of shares reserved for issuance | 701,617 | 701,617 | |||
Share compensation expenses | $ 9,443 | $ 10,501 | $ 30,080 | $ 32,465 | |
Options exercised during period (in shares) | 0 | (35,351) | |||
Share Based Compensation Arrangement By Share Based Payment Award Options Exercised In Period Weighted Average Grant Date Fair Value | $ 0 | $ 8.16 | |||
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | $ 0 | $ 17.82 | |||
Options | |||||
Stock plans (other details) | |||||
Life of options | 10 years | ||||
Restricted share awards | |||||
Stock plans (other details) | |||||
Share compensation expenses | 7,814 | 9,159 | $ 26,603 | $ 27,805 | |
Unrecognized share compensation expenses | 57,065 | $ 57,065 | $ 58,804 | ||
Weighted average period of recognizing share based compensation expenses | 2 years 5 months 12 days | 2 years 3 months 3 days | |||
Restricted share units | |||||
Stock plans (other details) | |||||
Share compensation expenses | 340 | 290 | $ 982 | 978 | |
Unrecognized share compensation expenses | 2,233 | $ 2,233 | $ 2,542 | ||
Weighted average period of recognizing share based compensation expenses | 2 years 5 months 23 days | 2 years 6 months 21 days | |||
Performance shares | |||||
Stock plans (other details) | |||||
Share compensation expenses | 1,289 | $ 1,052 | $ 2,495 | $ 3,682 | |
Unrecognized share compensation expenses | $ 9,031 | $ 9,031 | $ 6,902 | ||
Weighted average period of recognizing share based compensation expenses | 2 years 1 month 17 days | 2 years 21 days | |||
Performance share awards performance period | 3 years |
Debt and financing arrangemen75
Debt and financing arrangements (Summary of outstanding debentures and senior notes payable) (Details) - USD ($) $ in Thousands | Sep. 30, 2017 | Dec. 31, 2016 |
Debt Instruments [Line Items] | ||
Debentures payable | $ 538,910 | $ 537,226 |
Debt instrument, commitment | 250,000 | 250,000 |
Less: Unamortized debt issuance costs | (4,487) | (4,638) |
Total senior notes payable | 245,513 | 245,362 |
Debentures payable | 784,423 | 782,588 |
2006 Junior Subordinated | ||
Debt Instruments [Line Items] | ||
Debentures payable | 150,000 | 150,000 |
Debt instrument, commitment | 150,000 | |
2007 Junior Subordinated | ||
Debt Instruments [Line Items] | ||
Debentures payable | 139,800 | 139,800 |
Debt instrument, commitment | 200,000 | |
Flagstone 2006 Junior Subordinated | ||
Debt Instruments [Line Items] | ||
Debentures payable | 135,360 | 133,676 |
Debt instrument, commitment | 135,360 | |
Flagstone 2007 Junior Subordinated | ||
Debt Instruments [Line Items] | ||
Debentures payable | $ 113,750 | $ 113,750 |
Debt and financing arrangemen76
Debt and financing arrangements (Summary of key terms of senior notes and debentures) (Details) - USD ($) $ in Thousands | 9 Months Ended | ||
Sep. 30, 2017 | Dec. 31, 2016 | ||
Debt Instruments [Line Items] | |||
Commitment | $ 250,000 | $ 250,000 | |
Junior Subordinated Debt | |||
Debt Instruments [Line Items] | |||
Payments expected to be made after 2022 | $ 538,910 | ||
2006 Junior Subordinated | |||
Debt Instruments [Line Items] | |||
Issuance date | Jun. 15, 2006 | ||
Commitment | $ 150,000 | ||
Maturity date | Jun. 15, 2036 | ||
Interest payments due | Quarterly | ||
Interest rate term | 5 years | ||
2006 Junior Subordinated | Three month LIBOR | |||
Debt Instruments [Line Items] | |||
Spread on variable rate (in percent) | 3.55% | ||
Flagstone 2006 Junior Subordinated | |||
Debt Instruments [Line Items] | |||
Issuance date | Aug. 23, 2006 | ||
Commitment | $ 135,360 | ||
Maturity date | Sep. 15, 2036 | ||
Interest payments due | Quarterly | ||
2007 Junior Subordinated | |||
Debt Instruments [Line Items] | |||
Issuance date | Jun. 21, 2007 | ||
Commitment | $ 200,000 | ||
Maturity date | Jun. 15, 2037 | ||
Interest payments due | Quarterly | ||
Interest rate term | 5 years | ||
2007 Junior Subordinated | Three month LIBOR | |||
Debt Instruments [Line Items] | |||
Spread on variable rate (in percent) | 2.95% | ||
Flagstone 2007 Due July 30 2037 | |||
Debt Instruments [Line Items] | |||
Issuance date | Jun. 8, 2007 | ||
Commitment | $ 100,000 | ||
Maturity date | Jul. 30, 2037 | ||
Interest payments due | Quarterly | ||
Flagstone 2007 Due September 15 2037 | |||
Debt Instruments [Line Items] | |||
Issuance date | Sep. 20, 2007 | ||
Commitment | $ 25,000 | ||
Maturity date | Sep. 15, 2037 | ||
Interest payments due | Quarterly | ||
2010 Senior Notes Due 2040 | |||
Debt Instruments [Line Items] | |||
Issuance date | Jan. 26, 2010 | ||
Commitment | $ 250,000 | ||
Maturity date | Jan. 26, 2040 | ||
Interest payments due | Semi-annually in arrears | ||
Payments expected to be made after 2022 | $ 250,000 | ||
At Issuance | 2006 Junior Subordinated | |||
Debt Instruments [Line Items] | |||
Fixed interest rate (in percent) | [1] | 9.069% | |
At Issuance | Flagstone 2006 Junior Subordinated | Three month LIBOR | |||
Debt Instruments [Line Items] | |||
Spread on variable rate (in percent) | [2] | 3.54% | |
At Issuance | 2007 Junior Subordinated | |||
Debt Instruments [Line Items] | |||
Fixed interest rate (in percent) | [3] | 8.48% | |
At Issuance | Flagstone 2007 Due July 30 2037 | Three month LIBOR | |||
Debt Instruments [Line Items] | |||
Spread on variable rate (in percent) | [2] | 3.00% | |
At Issuance | Flagstone 2007 Due September 15 2037 | Three month LIBOR | |||
Debt Instruments [Line Items] | |||
Spread on variable rate (in percent) | [2] | 3.10% | |
At Issuance | 2010 Senior Notes Due 2040 | |||
Debt Instruments [Line Items] | |||
Fixed interest rate (in percent) | [4] | 8.875% | |
Outstanding | 2006 Junior Subordinated | |||
Debt Instruments [Line Items] | |||
Effective percentage | [5] | 5.831% | |
Outstanding | Flagstone 2006 Junior Subordinated | |||
Debt Instruments [Line Items] | |||
Effective percentage | [5] | 6.463% | |
Outstanding | 2007 Junior Subordinated | |||
Debt Instruments [Line Items] | |||
Effective percentage | [5] | 5.18% | |
Outstanding | Flagstone 2007 Due July 30 2037 | |||
Debt Instruments [Line Items] | |||
Effective percentage | [5] | 5.90% | |
Outstanding | Flagstone 2007 Due September 15 2037 | |||
Debt Instruments [Line Items] | |||
Effective percentage | [5] | 5.983% | |
Outstanding | 2010 Senior Notes Due 2040 | |||
Debt Instruments [Line Items] | |||
Fixed interest rate (in percent) | [4] | 8.875% | |
[1] | Fixed interest rate for 5 years, floating interest rate of three-month LIBOR plus 3.550% thereafter, reset quarterly. | ||
[2] | Floating interest rate of three-month LIBOR plus amount stated, reset quarterly. | ||
[3] | Fixed interest rate for 5 years, floating interest rate of three-month LIBOR plus 2.950% thereafter, reset quarterly. | ||
[4] | Fixed interest rate. | ||
[5] | Fixed interest rate as a result of interest rate swap contracts entered into by the Company. |
Debt and financing arrangemen77
Debt and financing arrangements (Credit facilities outstanding) (Details) - USD ($) $ in Thousands | Sep. 30, 2017 | Aug. 07, 2017 | Dec. 31, 2016 | |
Line of Credit Facility [Line Items] | ||||
Commitment | $ 835,000 | $ 690,000 | ||
Outstanding | [1] | 358,361 | 311,163 | |
Drawn | [2] | 165,000 | ||
Cash and investments pledged as collateral | 265,089 | 442,184 | ||
$85,000 syndicated unsecured letter of credit facility | ||||
Line of Credit Facility [Line Items] | ||||
Commitment | 85,000 | 85,000 | ||
Outstanding | [1] | 0 | 0 | |
Cash and investments pledged as collateral | 0 | |||
$300,000 syndicated secured letter of credit facility | ||||
Line of Credit Facility [Line Items] | ||||
Commitment | 300,000 | 300,000 | ||
Outstanding | [1] | 89,449 | 121,428 | |
Cash and investments pledged as collateral | 108,265 | 157,597 | ||
$24,000 secured bi-lateral letter of credit facility | ||||
Line of Credit Facility [Line Items] | ||||
Commitment | 24,000 | 24,000 | ||
Outstanding | [1] | 5,767 | 4,553 | |
Cash and investments pledged as collateral | 22,342 | 48,097 | ||
$20,000 AlphaCat Re secured letter of credit facility | ||||
Line of Credit Facility [Line Items] | ||||
Commitment | [3] | 20,000 | ||
Outstanding | [1],[3] | 20,000 | ||
Cash and investments pledged as collateral | [3] | 20,032 | ||
$25,000 IPC bi-lateral facility | ||||
Line of Credit Facility [Line Items] | ||||
Commitment | 25,000 | 25,000 | ||
Outstanding | [1] | 7,755 | 8,807 | |
Cash and investments pledged as collateral | 0 | |||
$236,000 Flagstone bi-lateral facility | ||||
Line of Credit Facility [Line Items] | ||||
Commitment | 236,000 | 236,000 | ||
Outstanding | [1] | 90,390 | 156,375 | |
Cash and investments pledged as collateral | 134,482 | $ 216,458 | ||
$65,000 unsecured revolving credit facility | ||||
Line of Credit Facility [Line Items] | ||||
Commitment | 65,000 | $ 65,000 | ||
Outstanding | [1] | 65,000 | ||
Drawn | [2] | 65,000 | ||
$100,000 unsecured revolving credit facility | ||||
Line of Credit Facility [Line Items] | ||||
Commitment | 100,000 | $ 100,000 | ||
Outstanding | [1] | 100,000 | ||
Drawn | [2] | $ 100,000 | ||
[1] | Indicates utilization of commitment amount, not drawn borrowings. | |||
[2] | Represents drawn borrowings included in accounts payable and accrued expenses. | |||
[3] | The Company terminated its AlphaCat Re secured letter of credit facility on January 6, 2017. |
Debt and financing arrangemen78
Debt and financing arrangements (Components of finance expenses) (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||||
Sep. 30, 2017 | Sep. 30, 2016 | Sep. 30, 2017 | Sep. 30, 2016 | |||
Debt Instruments [Line Items] | ||||||
Finance expenses | $ 14,523 | $ 14,521 | $ 42,675 | $ 43,890 | ||
2006 Junior Subordinated | ||||||
Debt Instruments [Line Items] | ||||||
Finance expenses | 2,235 | 2,135 | 6,633 | 6,557 | ||
2007 Junior Subordinated | ||||||
Debt Instruments [Line Items] | ||||||
Finance expenses | 1,851 | 1,851 | 5,492 | 5,512 | ||
Flagstone 2006 Junior Subordinated | ||||||
Debt Instruments [Line Items] | ||||||
Finance expenses | 2,272 | 2,271 | 6,741 | 6,760 | ||
Flagstone 2007 Junior Subordinated | ||||||
Debt Instruments [Line Items] | ||||||
Finance expenses | 1,775 | 1,784 | 5,249 | 5,317 | ||
2010 Senior Notes Due 2040 | ||||||
Debt Instruments [Line Items] | ||||||
Finance expenses | 5,597 | 5,597 | 16,792 | 16,791 | ||
Credit facilities | ||||||
Debt Instruments [Line Items] | ||||||
Finance expenses | 575 | 463 | 1,196 | 1,359 | ||
Bank and other charges | ||||||
Debt Instruments [Line Items] | ||||||
Finance expenses | 183 | 276 | 465 | 489 | ||
AlphaCat fees | ||||||
Debt Instruments [Line Items] | ||||||
Finance expenses | $ 35 | [1] | $ 144 | [1] | $ 107 | $ 1,105 |
[1] | Includes finance expenses incurred by AlphaCat Managers Ltd. in relation to fund raising for the AlphaCat sidecars, the AlphaCat ILS funds and AlphaCat direct. |
Debt and financing arrangemen79
Debt and financing arrangements (Narrative) (Details) - USD ($) $ in Thousands | 9 Months Ended | ||
Sep. 30, 2017 | Aug. 07, 2017 | Dec. 31, 2016 | |
Line of Credit Facility [Line Items] | |||
Commitment | $ 835,000 | $ 690,000 | |
Credit Facilities | |||
Line of Credit Facility [Line Items] | |||
Minimum level of consolidated net worth | $ 2,789,131 | ||
Percent of consolidated net income quarterly increase under covenant | 25.00% | ||
Percent of consolidated shareholders' equity quarterly increase under covenant | 50.00% | ||
Ratio consolidated total debt to net worth under covenant | 0.35:1.00 | ||
$65,000 unsecured revolving credit facility | |||
Line of Credit Facility [Line Items] | |||
Commitment | $ 65,000 | $ 65,000 | |
$100,000 unsecured revolving credit facility | |||
Line of Credit Facility [Line Items] | |||
Commitment | $ 100,000 | $ 100,000 | |
Federal Funds Rate | $65,000 unsecured revolving credit facility | |||
Line of Credit Facility [Line Items] | |||
Spread on variable rate (in percent) | 0.50% | ||
Federal Funds Rate | $100,000 unsecured revolving credit facility | |||
Line of Credit Facility [Line Items] | |||
Spread on variable rate (in percent) | 0.50% | ||
Three month LIBOR | $65,000 unsecured revolving credit facility | |||
Line of Credit Facility [Line Items] | |||
Spread on variable rate (in percent) | 1.00% | ||
Three month LIBOR | $100,000 unsecured revolving credit facility | |||
Line of Credit Facility [Line Items] | |||
Spread on variable rate (in percent) | 1.00% |
Accumulated other comprehensi80
Accumulated other comprehensive loss (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2017 | Sep. 30, 2016 | Sep. 30, 2017 | Sep. 30, 2016 | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||
Balance, beginning of period, net of tax | $ 4,004,268 | |||
Total shareholders' equity | $ 4,015,234 | $ 4,090,616 | 4,015,234 | $ 4,090,616 |
Other comprehensive (loss) income | 1,494 | (2,910) | 4,786 | (8,523) |
Accumulated other comprehensive loss | ||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||
Balance, beginning of period, net of tax | (19,924) | (18,182) | (23,216) | (12,569) |
Net current period other comprehensive loss, net of tax | 1,494 | (2,910) | (8,523) | |
Total shareholders' equity | (18,430) | (21,092) | (18,430) | (21,092) |
Other comprehensive (loss) income | 4,786 | (8,523) | ||
Foreign currency translation adjustment | ||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||
Balance, beginning of period, net of tax | (20,188) | (17,149) | (22,274) | (11,834) |
Net current period other comprehensive loss, net of tax | 1,481 | (1,370) | 3,567 | (6,685) |
Total shareholders' equity | (18,707) | (18,519) | (18,707) | (18,519) |
Minimum pension liability | ||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||
Balance, beginning of period, net of tax | 1,102 | 730 | (150) | 334 |
Net current period other comprehensive loss, net of tax | 0 | (1,101) | 1,252 | (705) |
Total shareholders' equity | 1,102 | (371) | 1,102 | (371) |
Cash flow hedge | ||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||
Balance, beginning of period, net of tax | (838) | (1,763) | (792) | (1,069) |
Net current period other comprehensive loss, net of tax | 13 | (439) | (33) | (1,133) |
Total shareholders' equity | $ (825) | $ (2,202) | $ (825) | $ (2,202) |
Commitments and contingencies81
Commitments and contingencies (Lloyd's syndicate) (Details) - 9 months ended Sep. 30, 2017 - Lloyd's Syndicate 1183 £ in Thousands, $ in Thousands | USD ($) | GBP (£) |
Funds at Lloyd's and Lloyd's Central Fund | ||
Maximum premium levies assessable, percent | 3.00% | 3.00% |
Estimated underwriting capacity | £ | £ 600,000 | |
Exchange rate | £1 equals $1.34 | £1 equals $1.34 |
Maximum premium levies assessable, amount | $ 24,120 | |
2017 Underwriting Year | ||
Loss Contingencies [Line Items] | ||
Components of required capital | 583,600 | |
2016 Underwriting year | ||
Loss Contingencies [Line Items] | ||
Components of required capital | $ 617,000 |
Commitments and contingencies82
Commitments and contingencies (Other commitments) (Details) - USD ($) $ in Thousands | May 01, 2017 | Sep. 30, 2017 | Sep. 30, 2017 | Dec. 31, 2016 | |
Investment commitment | |||||
Other Commitments [Line Items] | |||||
Capital commitment | $ 313,000 | $ 313,000 | $ 308,000 | ||
Remaining commitment | 210,413 | 210,413 | 258,704 | ||
Investment commitment | Fixed maturity investments | |||||
Other Commitments [Line Items] | |||||
Remaining commitment | [1] | 21,959 | 21,959 | 28,499 | |
Investment commitment | Other investments | |||||
Other Commitments [Line Items] | |||||
Remaining commitment | [2] | 101,082 | 101,082 | 156,134 | |
Investment commitment | Investments in investment affiliates | |||||
Other Commitments [Line Items] | |||||
Remaining commitment | [3] | 87,372 | 87,372 | 64,071 | |
Investment commitment | AlphaCat ILS funds | |||||
Other Commitments [Line Items] | |||||
Remaining commitment | 0 | 0 | $ 10,000 | ||
Marketing services agreement | |||||
Other Commitments [Line Items] | |||||
Annual fee for services commitment | $ 2,000 | ||||
Services commitment period | 7 years | ||||
Services commitment extension period | 3 years | ||||
Marketing expense | $ 500 | $ 833 | |||
[1] | The Company has an outstanding commitment to participate in certain secured loan facilities through participation agreements with an established loan originator. | ||||
[2] | The Company’s total capital commitments related to other investments as at September 30, 2017 was $313,000 (December 31, 2016: $308,000). | ||||
[3] | Refer to Note 4(c), “Investments in Investment Affiliates.” |
Related party transactions (Det
Related party transactions (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||||
Sep. 30, 2017 | Sep. 30, 2016 | Sep. 30, 2017 | Sep. 30, 2016 | Dec. 31, 2016 | ||
Related Party Transaction [Line Items] | ||||||
Investments in affiliates | $ 92,079 | $ 92,079 | $ 100,431 | |||
Group Ark Insurance Holdings Ltd | ||||||
Related Party Transaction [Line Items] | ||||||
Gross premiums written | $ 1,096 | $ 3,067 | ||||
Reinsurance premiums ceded | 41 | 41 | ||||
Earned premium adjustments | 1,276 | 2,275 | ||||
Premiums receivable | 292 | |||||
Loss reserves recoverable | 798 | |||||
Wellington Insurance Company | ||||||
Related Party Transaction [Line Items] | ||||||
Gross premiums written | 78 | 0 | 4,196 | 0 | ||
Earned premium adjustments | 943 | 0 | 3,480 | 0 | ||
Premiums receivable | 468 | 468 | 666 | |||
Investment affiliate | ||||||
Related Party Transaction [Line Items] | ||||||
Investments in affiliates | 100,431 | |||||
Partnership fees incurred | 106 | $ 520 | 592 | $ 1,535 | ||
Investment commitment | ||||||
Related Party Transaction [Line Items] | ||||||
Remaining commitment | 210,413 | 210,413 | 258,704 | |||
Investment commitment | Investment affiliate | ||||||
Related Party Transaction [Line Items] | ||||||
Remaining commitment | [1] | $ 87,372 | $ 87,372 | $ 64,071 | ||
[1] | Refer to Note 4(c), “Investments in Investment Affiliates.” |
Earnings per share (Details)
Earnings per share (Details) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2017 | Sep. 30, 2016 | Sep. 30, 2017 | Sep. 30, 2016 | |
Basic earnings per share | ||||
Net (loss) income (attributable) available to Validus common shareholders | $ (250,446) | $ 89,844 | $ (54,790) | $ 351,617 |
Weighted average number of common shares outstanding | 78,994,335 | 80,134,394 | 79,132,856 | 81,635,496 |
Basic earnings per share available to common shareholders | $ (3.17) | $ 1.12 | $ (0.69) | $ 4.31 |
Earnings per diluted share | ||||
Net (loss) income (attributable) available to Validus common shareholders | $ (250,446) | $ 89,844 | $ (54,790) | $ 351,617 |
Weighted average number of common shares outstanding | 78,994,335 | 80,134,394 | 79,132,856 | 81,635,496 |
Weighted average number of diluted common shares outstanding | 78,994,335 | 81,244,556 | 79,132,856 | 82,938,624 |
Earnings per diluted share available to common shareholders | $ (3.17) | $ 1.11 | $ (0.69) | $ 4.24 |
Other details: | ||||
Anti-dilutive securities excluded from the calculation of diluted earnings per share | 19,808 | 175,690 | ||
Stock options | ||||
Earnings per diluted share | ||||
Share equivalents | 0 | 26,705 | 0 | 32,126 |
Unvested restricted shares | ||||
Earnings per diluted share | ||||
Share equivalents | 0 | 1,083,457 | 0 | 1,271,002 |
Segment information (Summary of
Segment information (Summary of results of operating and other segments) (Details) $ in Thousands | 3 Months Ended | 9 Months Ended | |||||
Sep. 30, 2017USD ($) | Sep. 30, 2016USD ($) | Sep. 30, 2017USD ($)segments | Sep. 30, 2016USD ($) | ||||
Segment Reporting Information [Line Items] | |||||||
Number of operating segments | segments | 4 | ||||||
Underwriting revenues | |||||||
Gross premiums written | $ 523,856 | $ 372,418 | $ 2,507,615 | $ 2,309,251 | |||
Reinsurance premiums ceded | (116,860) | (45,006) | (373,188) | (249,070) | |||
Net premiums written | 406,996 | 327,412 | 2,134,427 | 2,060,181 | |||
Change in unearned premiums | 316,212 | 236,363 | (204,816) | (351,415) | |||
Net premiums earned | 723,208 | 563,775 | 1,929,611 | 1,708,766 | |||
Other insurance related income (loss) | 3,536 | 919 | 5,937 | 2,400 | |||
Segmental revenues | 726,744 | 564,694 | 1,935,548 | 1,711,166 | |||
Underwriting deductions | |||||||
Losses and loss expenses | 1,254,602 | 258,394 | 1,820,336 | 789,971 | |||
Policy acquisition costs | 115,590 | 113,434 | 344,486 | 328,593 | |||
General and administrative expenses | 70,342 | 82,443 | 254,615 | 258,339 | |||
Share compensation expenses | 9,443 | 10,501 | 30,080 | 32,465 | |||
Total underwriting deductions | 1,449,977 | 464,772 | 2,449,517 | 1,409,368 | |||
Segmental (loss) income | (723,233) | 99,922 | (513,969) | 301,798 | |||
Investment (loss) income from AlphaCat Funds and Sidecars | 44,458 | 43,514 | 128,913 | 112,232 | |||
Other items | (18,887) | [1] | (20,898) | [1] | (56,828) | (36,591) | |
Dividends on preferred shares | (5,627) | (2,252) | (10,033) | (2,252) | |||
Transaction expenses | 0 | 0 | (4,427) | 0 | |||
Loss (income) attributable to AlphaCat investors | 74,130 | (5,564) | 54,797 | (16,278) | |||
Net (income) attributable to noncontrolling interests | 376,366 | (37,439) | 290,144 | (96,163) | |||
Finance expenses | 14,523 | 14,521 | 42,675 | 43,890 | |||
Tax (benefit) expense | (2,632) | 1,830 | (7,168) | 1,418 | |||
Net realized gains on investments | 906 | 4,397 | 2,016 | 6,537 | |||
Change in net unrealized gains on managed investments | (5,197) | 5,459 | 24,472 | 84,331 | |||
Income (loss) from investment affiliates | 1,011 | 453 | 15,665 | (4,249) | |||
Net investment return | [2] | 41,178 | 53,823 | 171,066 | 198,851 | ||
Foreign exchange gains (losses) | 1,404 | 766 | 7,164 | (11,765) | |||
Net (loss) income (attributable) available to Validus | (244,819) | 92,096 | (44,757) | 353,869 | |||
Selected ratios: | |||||||
Net (loss) income (attributable) available to Validus common shareholders | (250,446) | 89,844 | (54,790) | 351,617 | |||
Operating Segments | Validus Re | |||||||
Underwriting revenues | |||||||
Gross premiums written | 153,890 | 94,741 | 1,071,409 | 1,072,219 | |||
Reinsurance premiums ceded | (40,988) | (15,967) | (161,188) | (111,658) | |||
Net premiums written | 112,902 | 78,774 | 910,221 | 960,561 | |||
Change in unearned premiums | 154,145 | 149,705 | (184,155) | (241,129) | |||
Net premiums earned | 267,047 | 228,479 | 726,066 | 719,432 | |||
Other insurance related income (loss) | 68 | 58 | 204 | (107) | |||
Segmental revenues | 267,115 | 228,537 | 726,270 | 719,325 | |||
Underwriting deductions | |||||||
Losses and loss expenses | 347,484 | 98,425 | 538,323 | 313,432 | |||
Policy acquisition costs | 45,422 | 42,837 | 133,836 | 127,660 | |||
General and administrative expenses | 12,444 | 17,528 | 48,550 | 52,579 | |||
Share compensation expenses | 2,606 | 2,695 | 7,746 | 8,371 | |||
Total underwriting deductions | 407,956 | 161,485 | 728,455 | 502,042 | |||
Segmental (loss) income | (140,841) | 67,052 | (2,185) | 217,283 | |||
Validus share of segmental (loss) income | $ (140,841) | $ 67,052 | $ (2,185) | $ 217,283 | |||
Selected ratios: | |||||||
Net premiums written / Gross premiums written | 73.40% | 83.10% | 85.00% | 89.60% | |||
Losses and loss expenses | 130.10% | 43.10% | 74.10% | 43.60% | |||
Policy acquisition costs | 17.00% | 18.70% | 18.40% | 17.70% | |||
General and administrative expenses | [3] | 5.70% | 8.90% | 7.80% | 8.50% | ||
Expense ratio | 22.70% | 27.60% | 26.20% | 26.20% | |||
Combined ratio | 152.80% | 70.70% | 100.30% | 69.80% | |||
Operating Segments | Talbot Segment | |||||||
Underwriting revenues | |||||||
Gross premiums written | $ 192,883 | $ 189,674 | $ 702,535 | $ 752,058 | |||
Reinsurance premiums ceded | (36,462) | (22,877) | (154,263) | (137,496) | |||
Net premiums written | 156,421 | 166,797 | 548,272 | 614,562 | |||
Change in unearned premiums | 23,191 | 32,258 | 18,279 | (7,166) | |||
Net premiums earned | 179,612 | 199,055 | 566,551 | 607,396 | |||
Other insurance related income (loss) | 692 | 99 | 1,512 | 389 | |||
Segmental revenues | 180,304 | 199,154 | 568,063 | 607,785 | |||
Underwriting deductions | |||||||
Losses and loss expenses | 178,440 | 109,860 | 378,241 | 319,271 | |||
Policy acquisition costs | 41,493 | 46,488 | 129,074 | 134,444 | |||
General and administrative expenses | 23,069 | 32,333 | 97,094 | 109,929 | |||
Share compensation expenses | 2,310 | 3,163 | 8,292 | 9,955 | |||
Total underwriting deductions | 245,312 | 191,844 | 612,701 | 573,599 | |||
Segmental (loss) income | (65,008) | 7,310 | (44,638) | 34,186 | |||
Validus share of segmental (loss) income | $ (65,008) | $ 7,310 | $ (44,638) | $ 34,186 | |||
Selected ratios: | |||||||
Net premiums written / Gross premiums written | 81.10% | 87.90% | 78.00% | 81.70% | |||
Losses and loss expenses | 99.30% | 55.20% | 66.80% | 52.60% | |||
Policy acquisition costs | 23.10% | 23.40% | 22.80% | 22.10% | |||
General and administrative expenses | [3] | 14.20% | 17.80% | 18.50% | 19.70% | ||
Expense ratio | 37.30% | 41.20% | 41.30% | 41.80% | |||
Combined ratio | 136.60% | 96.40% | 108.10% | 94.40% | |||
Operating Segments | Western World | |||||||
Underwriting revenues | |||||||
Gross premiums written | $ 156,517 | $ 85,260 | $ 459,628 | $ 236,190 | |||
Reinsurance premiums ceded | (43,207) | (6,202) | (72,005) | (15,347) | |||
Net premiums written | 113,310 | 79,058 | 387,623 | 220,843 | |||
Change in unearned premiums | 61,603 | (8,260) | 15,256 | (22,890) | |||
Net premiums earned | 174,913 | 70,798 | 402,879 | 197,953 | |||
Other insurance related income (loss) | 662 | 219 | 1,566 | 696 | |||
Segmental revenues | 175,575 | 71,017 | 404,445 | 198,649 | |||
Underwriting deductions | |||||||
Losses and loss expenses | 157,709 | 45,748 | 329,642 | 129,623 | |||
Policy acquisition costs | 20,721 | 17,094 | 60,187 | 46,704 | |||
General and administrative expenses | 21,553 | 10,171 | 50,623 | 33,704 | |||
Share compensation expenses | 354 | 702 | 1,655 | 1,825 | |||
Total underwriting deductions | 200,337 | 73,715 | 442,107 | 211,856 | |||
Segmental (loss) income | (24,762) | (2,698) | (37,662) | (13,207) | |||
Validus share of segmental (loss) income | $ (24,762) | $ (2,698) | $ (37,662) | $ (13,207) | |||
Selected ratios: | |||||||
Net premiums written / Gross premiums written | 72.40% | 92.70% | 84.30% | 93.50% | |||
Losses and loss expenses | 90.20% | 64.60% | 81.80% | 65.50% | |||
Policy acquisition costs | 11.80% | 24.10% | 14.90% | 23.60% | |||
General and administrative expenses | [3] | 12.50% | 15.40% | 13.00% | 17.90% | ||
Expense ratio | 24.30% | 39.50% | 27.90% | 41.50% | |||
Combined ratio | 114.50% | 104.10% | 109.70% | 107.00% | |||
Operating Segments | AlphaCat | |||||||
Underwriting revenues | |||||||
Gross premiums written | $ 27,213 | $ 4,413 | $ 297,821 | $ 270,666 | |||
Third party management fees | 5,095 | 7,025 | 15,288 | 14,843 | |||
Related party management fees | 457 | 1,373 | 1,732 | 2,592 | |||
Segmental revenues | 5,552 | 8,398 | 17,020 | 17,435 | |||
Underwriting deductions | |||||||
General and administrative expenses | 2,929 | 3,324 | 10,322 | 7,557 | |||
Share compensation expenses | 183 | (107) | 348 | 167 | |||
Total underwriting deductions | 3,086 | 3,253 | 10,853 | 8,655 | |||
Segmental (loss) income | 2,466 | 5,145 | 6,167 | 8,780 | |||
Investment (loss) income from AlphaCat Funds and Sidecars | [4] | (30,090) | 6,031 | (21,135) | 16,059 | ||
Finance expenses | 32 | 31 | 107 | 914 | |||
Tax (benefit) expense | (65) | 0 | 69 | ||||
Foreign exchange gains (losses) | 7 | 5 | 7 | 17 | |||
Operating Segments | AlphaCat | AlphaCat sidecars | |||||||
Underwriting revenues | |||||||
Gross premiums written | 0 | (112) | 66 | (178) | |||
Underwriting deductions | |||||||
Investment (loss) income from AlphaCat Funds and Sidecars | [4] | 201 | (72) | 68 | 593 | ||
Operating Segments | AlphaCat | AlphaCat ILS funds - Lower Risk | |||||||
Underwriting revenues | |||||||
Gross premiums written | [5] | 10,979 | 2,049 | 117,519 | 112,241 | ||
Underwriting deductions | |||||||
Investment (loss) income from AlphaCat Funds and Sidecars | [4],[5] | (7,553) | 2,321 | (4,063) | 6,903 | ||
Operating Segments | AlphaCat | AlphaCat ILS funds - Higher Risk | |||||||
Underwriting revenues | |||||||
Gross premiums written | [5] | 16,275 | 1,797 | 153,483 | 140,127 | ||
Underwriting deductions | |||||||
Investment (loss) income from AlphaCat Funds and Sidecars | [4],[5] | (21,816) | 2,479 | (16,849) | 5,607 | ||
Operating Segments | AlphaCat | BetaCat ILS funds | |||||||
Underwriting deductions | |||||||
Investment (loss) income from AlphaCat Funds and Sidecars | [4] | (922) | 1,303 | (291) | 2,979 | ||
Operating Segments | AlphaCat | PaCRe funds | |||||||
Underwriting deductions | |||||||
Investment (loss) income from AlphaCat Funds and Sidecars | [4] | 0 | 0 | 0 | (23) | ||
Operating Segments | AlphaCat | AlphaCat direct | |||||||
Underwriting revenues | |||||||
Gross premiums written | [6] | (41) | 679 | 26,753 | 18,476 | ||
Operating Segments | AlphaCat And Consolidated Variable Interest Entities | |||||||
Underwriting revenues | |||||||
Gross premiums written | 27,213 | 4,413 | 297,821 | 270,666 | |||
Reinsurance premiums ceded | (2,850) | (1,630) | (9,510) | (6,451) | |||
Net premiums written | 24,363 | 2,783 | 288,311 | 264,215 | |||
Change in unearned premiums | 77,273 | 62,660 | (54,196) | (80,230) | |||
Net premiums earned | 101,636 | 65,443 | 234,115 | 183,985 | |||
Other insurance related income (loss) | 6,083 | 8,656 | 17,118 | 17,722 | |||
Segmental revenues | 107,719 | 74,099 | 251,233 | 201,707 | |||
Underwriting deductions | |||||||
Losses and loss expenses | 570,969 | 4,361 | 574,130 | 27,645 | |||
Policy acquisition costs | 8,314 | 7,075 | 22,380 | 19,762 | |||
General and administrative expenses | 7,687 | 12,255 | 27,096 | 26,272 | |||
Share compensation expenses | 183 | (107) | 348 | 167 | |||
Total underwriting deductions | 587,153 | 23,584 | 623,954 | 73,846 | |||
Segmental (loss) income | (479,434) | 50,515 | (372,721) | 127,861 | |||
Other items | 82 | [1] | 97 | [1] | 269 | (1,139) | |
Loss (income) attributable to AlphaCat investors | 74,130 | (5,564) | 54,797 | (16,278) | |||
Net (income) attributable to noncontrolling interests | 376,366 | (37,439) | 290,144 | (96,163) | |||
Validus share of segmental (loss) income | (27,624) | 11,176 | (14,968) | 24,839 | |||
Net investment return | [2] | 1,232 | 3,567 | 12,543 | 10,558 | ||
Operating Segments | Corporate and investment | |||||||
Segment Reporting Information [Line Items] | |||||||
Net Investment Income | [7] | 37,091 | 41,071 | 111,346 | 105,843 | ||
Underwriting deductions | |||||||
General and administrative expenses | 9,539 | 18,221 | 45,563 | 52,276 | |||
Share compensation expenses | 3,990 | 4,048 | 12,039 | 12,147 | |||
Total underwriting deductions | 13,529 | 22,269 | 57,602 | 64,423 | |||
Segmental (loss) income | (13,529) | (22,269) | (57,602) | (64,423) | |||
Other items | (18,969) | [1] | (20,995) | [1] | (57,097) | (35,452) | |
Dividends on preferred shares | (5,627) | (2,252) | (10,033) | (2,252) | |||
Transaction expenses | 0 | 0 | (4,427) | 0 | |||
Finance expenses | [7] | 14,449 | 14,317 | 42,462 | 42,637 | ||
Tax (benefit) expense | (2,567) | 1,830 | (7,237) | 1,418 | |||
Total expenses | 31,038 | 40,668 | 102,860 | 110,730 | |||
Validus share of segmental (loss) income | 7,448 | 6,992 | 43,824 | 89,015 | |||
Net realized gains on investments | [7] | 903 | 4,080 | 280 | 5,514 | ||
Change in net unrealized gains on managed investments | [7] | 941 | 4,652 | 31,232 | 81,782 | ||
Income (loss) from investment affiliates | 1,011 | 453 | 15,665 | (4,249) | |||
Net investment return | [2] | 39,946 | 50,256 | 158,523 | 188,890 | ||
Foreign exchange gains (losses) | [7] | 1,495 | 1,067 | 7,715 | (11,628) | ||
Other income | 35 | (1,529) | 303 | (773) | |||
Total other items | (1,460) | (2,596) | (11,839) | 10,855 | |||
Eliminations | |||||||
Underwriting revenues | |||||||
Gross premiums written | (6,647) | (1,670) | (23,778) | (21,882) | |||
Reinsurance premiums ceded | 6,647 | 1,670 | 23,778 | 21,882 | |||
Net premiums written | 0 | 0 | |||||
Change in unearned premiums | 0 | 0 | |||||
Net premiums earned | 0 | 0 | |||||
Other insurance related income (loss) | (3,969) | (8,113) | (14,463) | (16,300) | |||
Segmental revenues | (3,969) | (8,113) | (14,463) | (16,300) | |||
Underwriting deductions | |||||||
Losses and loss expenses | 0 | 0 | |||||
Policy acquisition costs | (360) | (60) | (991) | 23 | |||
General and administrative expenses | (3,950) | (8,065) | (14,311) | (16,421) | |||
Total underwriting deductions | (4,310) | (8,125) | (15,302) | (16,398) | |||
Segmental (loss) income | 341 | 12 | 839 | 98 | |||
Validus share of segmental (loss) income | $ 341 | $ 12 | $ 839 | (499) | |||
Net investment return | [2] | $ (597) | |||||
[1] | Other items includes finance expenses, transaction expenses, dividends on preferred shares, tax benefit (expense), foreign exchange gains (losses), income (loss) from operating affiliate and other income (loss). | ||||||
[2] | Net investment return includes net investment income, net realized and change in net unrealized gains (losses) on investments and income (loss) from investment affiliates. | ||||||
[3] | The general and administrative expense ratio includes share compensation expenses. | ||||||
[4] | The investment (loss) income from the AlphaCat funds and sidecars is based on equity accounting. | ||||||
[5] | Lower risk AlphaCat ILS funds have a maximum permitted portfolio expected loss of less than 7%, whereas higher risk AlphaCat ILS funds have a maximum permitted portfolio expected loss of greater than 7%. Expected loss represents the average annual loss over the set of simulation scenarios divided by the total limit. | ||||||
[6] | AlphaCat Direct includes direct investments from third party investors in AlphaCat Re. | ||||||
[7] | These items exclude the components which are included in Validus’ share of AlphaCat and amounts which are consolidated from VIEs. |
Segment information (Gross prem
Segment information (Gross premiums written by geographic location and segment) (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||||
Sep. 30, 2017 | Sep. 30, 2016 | Sep. 30, 2017 | Sep. 30, 2016 | |||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | $ 523,856 | $ 372,418 | $ 2,507,615 | $ 2,309,251 | ||
Percent of gross premiums written | 100.00% | 100.00% | 100.00% | 100.10% | ||
United States | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | $ 253,079 | $ 138,303 | $ 1,027,853 | $ 840,133 | ||
Percent of gross premiums written | 48.30% | 37.10% | 41.00% | 36.40% | ||
Worldwide excluding United States | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | $ 51,122 | [1] | $ 43,876 | [1] | $ 164,051 | $ 178,543 |
Percent of gross premiums written | 9.80% | [1] | 11.70% | [1] | 6.60% | 7.80% |
Australia and New Zealand | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | $ 3,255 | $ 3,301 | $ 14,373 | $ 19,361 | ||
Percent of gross premiums written | 0.60% | 0.90% | 0.60% | 0.80% | ||
Europe | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | $ 10,327 | $ 9,533 | $ 58,284 | $ 58,581 | ||
Percent of gross premiums written | 2.00% | 2.60% | 2.20% | 2.50% | ||
Latin America and Caribbean | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | $ 39,702 | $ 41,416 | $ 105,658 | $ 106,857 | ||
Percent of gross premiums written | 7.60% | 11.10% | 4.20% | 4.60% | ||
Japan | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | $ 1,601 | $ 971 | $ 51,092 | $ 48,668 | ||
Percent of gross premiums written | 0.30% | 0.30% | 2.00% | 2.10% | ||
Canada | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | $ 2,296 | $ 2,122 | $ 9,495 | $ 9,317 | ||
Percent of gross premiums written | 0.40% | 0.60% | 0.40% | 0.40% | ||
Rest of the world | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | $ 22,982 | [2] | $ 21,592 | [2] | $ 86,627 | $ 96,487 |
Percent of gross premiums written | 4.40% | [2] | 5.80% | [2] | 3.50% | 4.20% |
Sub-total, non United States | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | $ 131,285 | $ 122,811 | $ 489,580 | $ 517,814 | ||
Percent of gross premiums written | 25.10% | 33.00% | 19.50% | 22.40% | ||
Worldwide including United States | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | $ 54,919 | [1] | $ 37,204 | [1] | $ 416,418 | $ 405,747 |
Percent of gross premiums written | 10.50% | [1] | 10.00% | [1] | 16.60% | 17.60% |
Other location non-specific | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | $ 84,573 | [3] | $ 74,100 | [3] | $ 573,764 | $ 545,557 |
Percent of gross premiums written | 16.10% | [3] | 19.90% | [3] | 22.90% | 23.60% |
Operating Segments | Validus Re | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | $ 153,890 | $ 94,741 | $ 1,071,409 | $ 1,072,219 | ||
Operating Segments | Validus Re | United States | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | 59,838 | 31,345 | 374,018 | 455,826 | ||
Operating Segments | Validus Re | Worldwide excluding United States | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | 7,198 | [1] | 4,145 | [1] | 45,803 | 51,384 |
Operating Segments | Validus Re | Australia and New Zealand | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | (450) | 57 | 3,745 | 6,906 | ||
Operating Segments | Validus Re | Europe | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | 4,744 | 4,536 | 35,108 | 30,270 | ||
Operating Segments | Validus Re | Latin America and Caribbean | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | 19,430 | 17,036 | 40,646 | 36,610 | ||
Operating Segments | Validus Re | Japan | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | 436 | (33) | 40,902 | 39,892 | ||
Operating Segments | Validus Re | Canada | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | 24 | 149 | 4,894 | 3,646 | ||
Operating Segments | Validus Re | Rest of the world | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | 1,447 | [2] | 2,360 | [2] | 20,229 | 22,307 |
Operating Segments | Validus Re | Sub-total, non United States | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | 32,829 | 28,250 | 191,327 | 191,015 | ||
Operating Segments | Validus Re | Worldwide including United States | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | 33,724 | [1] | 22,399 | [1] | 189,669 | 169,737 |
Operating Segments | Validus Re | Other location non-specific | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | 27,499 | [3] | 12,747 | [3] | 316,395 | 255,641 |
Operating Segments | Talbot Segment | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | 192,883 | 189,674 | 702,535 | 752,058 | ||
Operating Segments | Talbot Segment | United States | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | 24,584 | 19,937 | 88,139 | 85,182 | ||
Operating Segments | Talbot Segment | Worldwide excluding United States | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | 43,136 | [1] | 40,058 | [1] | 110,094 | 105,590 |
Operating Segments | Talbot Segment | Australia and New Zealand | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | 3,696 | 3,238 | 8,726 | 7,613 | ||
Operating Segments | Talbot Segment | Europe | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | 5,372 | 4,957 | 22,944 | 25,673 | ||
Operating Segments | Talbot Segment | Latin America and Caribbean | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | 20,726 | 25,173 | 69,703 | 76,577 | ||
Operating Segments | Talbot Segment | Japan | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | 1,165 | 997 | 6,371 | 5,579 | ||
Operating Segments | Talbot Segment | Canada | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | 1,820 | 2,015 | 4,068 | 5,577 | ||
Operating Segments | Talbot Segment | Rest of the world | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | 21,478 | [2] | 19,166 | [2] | 67,918 | 76,456 |
Operating Segments | Talbot Segment | Sub-total, non United States | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | 97,393 | 95,604 | 289,824 | 303,065 | ||
Operating Segments | Talbot Segment | Worldwide including United States | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | 16,293 | [1] | 12,771 | [1] | 74,385 | 75,423 |
Operating Segments | Talbot Segment | Other location non-specific | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | 54,613 | [3] | 61,362 | [3] | 250,187 | 288,388 |
Operating Segments | Western World | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | 156,517 | 85,260 | 459,628 | 236,190 | ||
Operating Segments | Western World | United States | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | 156,517 | 85,260 | 459,628 | 236,190 | ||
Operating Segments | Western World | Worldwide excluding United States | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | 0 | [1] | 0 | [1] | 0 | 0 |
Operating Segments | Western World | Australia and New Zealand | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | 0 | 0 | 0 | 0 | ||
Operating Segments | Western World | Europe | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | 0 | 0 | 0 | 0 | ||
Operating Segments | Western World | Latin America and Caribbean | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | 0 | 0 | 0 | 0 | ||
Operating Segments | Western World | Japan | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | 0 | 0 | 0 | 0 | ||
Operating Segments | Western World | Canada | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | 0 | 0 | 0 | 0 | ||
Operating Segments | Western World | Rest of the world | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | 0 | [2] | 0 | [2] | 0 | 0 |
Operating Segments | Western World | Sub-total, non United States | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | 0 | 0 | 0 | 0 | ||
Operating Segments | Western World | Worldwide including United States | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | 0 | [1] | 0 | [1] | 0 | 0 |
Operating Segments | Western World | Other location non-specific | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | 0 | [3] | 0 | [3] | 0 | 0 |
Operating Segments | AlphaCat | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | 27,213 | 4,413 | 297,821 | 270,666 | ||
Operating Segments | AlphaCat | United States | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | 18,440 | 1,837 | 116,691 | 64,566 | ||
Operating Segments | AlphaCat | Worldwide excluding United States | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | 712 | [1] | (288) | [1] | 8,617 | 22,219 |
Operating Segments | AlphaCat | Australia and New Zealand | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | 0 | 0 | 2,003 | 4,949 | ||
Operating Segments | AlphaCat | Europe | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | 149 | 0 | 600 | 3,306 | ||
Operating Segments | AlphaCat | Latin America and Caribbean | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | 0 | 0 | 46 | 0 | ||
Operating Segments | AlphaCat | Japan | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | 0 | 0 | 3,855 | 3,221 | ||
Operating Segments | AlphaCat | Canada | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | 458 | 0 | 588 | 223 | ||
Operating Segments | AlphaCat | Rest of the world | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | 0 | [2] | 0 | [2] | 0 | 0 |
Operating Segments | AlphaCat | Sub-total, non United States | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | 1,319 | (288) | 15,709 | 33,918 | ||
Operating Segments | AlphaCat | Worldwide including United States | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | 4,993 | [1] | 2,872 | [1] | 158,239 | 170,639 |
Operating Segments | AlphaCat | Other location non-specific | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | 2,461 | [3] | (8) | [3] | 7,182 | 1,543 |
Operating Segments | AlphaCat And Consolidated Variable Interest Entities | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | 27,213 | 4,413 | 297,821 | 270,666 | ||
Eliminations | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | (6,647) | (1,670) | (23,778) | (21,882) | ||
Eliminations | United States | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | (6,300) | (76) | (10,623) | (1,631) | ||
Eliminations | Worldwide excluding United States | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | 76 | [1] | (39) | [1] | (463) | (650) |
Eliminations | Australia and New Zealand | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | 9 | 6 | (101) | (107) | ||
Eliminations | Europe | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | 62 | 40 | (368) | (668) | ||
Eliminations | Latin America and Caribbean | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | (454) | (793) | (4,737) | (6,330) | ||
Eliminations | Japan | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | 0 | 7 | (36) | (24) | ||
Eliminations | Canada | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | (6) | (42) | (55) | (129) | ||
Eliminations | Rest of the world | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | 57 | [2] | 66 | [2] | (1,520) | (2,276) |
Eliminations | Sub-total, non United States | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | (256) | (755) | (7,280) | (10,184) | ||
Eliminations | Worldwide including United States | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | (91) | [1] | (838) | [1] | (5,875) | (10,052) |
Eliminations | Other location non-specific | ||||||
Gross premiums written allocated to the territory of coverage exposure | ||||||
Gross premiums written | $ 0 | [3] | $ (1) | [3] | $ 0 | $ (15) |
[1] | Represents risks in two or more geographic zones. | |||||
[2] | Represents risks in one geographic zone. | |||||
[3] | The Other locations non-specific category refers to business for which an analysis of exposure by geographic zone is not applicable since these exposures can span multiple geographic areas and, in some instances, are not fixed locations. |
Subsequent events - Narrative (
Subsequent events - Narrative (Details) - $ / shares | Nov. 01, 2017 | Sep. 30, 2017 | Jun. 30, 2017 | Mar. 31, 2017 | Sep. 30, 2016 | Jun. 30, 2016 | Mar. 31, 2016 | Sep. 30, 2017 | Sep. 30, 2016 |
Subsequent Event [Line Items] | |||||||||
Cash dividends declared per share - common shares | $ 0.38 | $ 0.38 | $ 0.38 | $ 0.35 | $ 0.35 | $ 0.35 | $ 1.14 | $ 1.05 | |
Series A depositary share equivalent | |||||||||
Subsequent Event [Line Items] | |||||||||
Cash dividends declared per share - preferred shares | 0.3671875 | $ 0.3671875 | $ 0.3671875 | $ 0.3753472 | |||||
Series B depositary share equivalent | |||||||||
Subsequent Event [Line Items] | |||||||||
Cash dividends declared per share - preferred shares | $ 0.3423611 | ||||||||
Subsequent Event | |||||||||
Subsequent Event [Line Items] | |||||||||
Cash dividends declared per share - common shares | $ 0.38 | ||||||||
Subsequent Event | Series A depositary share equivalent | |||||||||
Subsequent Event [Line Items] | |||||||||
Cash dividends declared per share - preferred shares | 0.3671875 | ||||||||
Subsequent Event | Series B depositary share equivalent | |||||||||
Subsequent Event [Line Items] | |||||||||
Cash dividends declared per share - preferred shares | $ 0.3625000 |